Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Schizophrenia

  Free Subscription


Articles published in Schizophr Res

Retrieve available abstracts of 768 articles:
HTML format
Text format



Single Articles


    October 2017
  1. MCKINNEY BC, Lin H, Ding Y, Lewis DA, et al
    DNA methylation age is not accelerated in brain or blood of subjects with schizophrenia.
    Schizophr Res. 2017 Oct 5. pii: S0920-9964(17)30587.
    PubMed     Text format     Abstract available


  2. KOSHIYAMA D, Kirihara K, Tada M, Nagai T, et al
    Association between mismatch negativity and global functioning is specific to duration deviance in early stages of psychosis.
    Schizophr Res. 2017 Oct 3. pii: S0920-9964(17)30607.
    PubMed     Text format     Abstract available


  3. CELLA M, Okruszek L, Lawrence M, Zarlenga V, et al
    Using wearable technology to detect the autonomic signature of illness severity in schizophrenia.
    Schizophr Res. 2017 Oct 3. pii: S0920-9964(17)30590.
    PubMed     Text format     Abstract available


  4. GOWDA GS, Rai D, Nadella RK, Tiwari S, et al
    Schizophrenia in Wolfram Syndrome (DIDMOAD Syndrome): A case report in support of the mitochondrial dysfunction hypothesis.
    Schizophr Res. 2017 Oct 3. pii: S0920-9964(17)30606.
    PubMed     Text format    


  5. BLOKLAND GAM, Del Re EC, Mesholam-Gately RI, Jovicich J, et al
    The Genetics of Endophenotypes of Neurofunction to Understand Schizophrenia (GENUS) consortium: A collaborative cognitive and neuroimaging genetics project.
    Schizophr Res. 2017 Oct 2. pii: S0920-9964(17)30586.
    PubMed     Text format     Abstract available


  6. MCGINTY J, Sayeed Haque M, Upthegrove R
    Depression during first episode psychosis and subsequent suicide risk: A systematic review and meta-analysis of longitudinal studies.
    Schizophr Res. 2017 Oct 2. pii: S0920-9964(17)30602.
    PubMed     Text format     Abstract available


    September 2017
  7. TURETSKY BI, Moberg PJ, Quarmley M, Dress E, et al
    Structural anomalies of the peripheral olfactory system in psychosis high-risk subjects.
    Schizophr Res. 2017 Sep 30. pii: S0920-9964(17)30577.
    PubMed     Text format     Abstract available


  8. FOND G, Boyer L, Leboyer M, Godin O, et al
    Influence of Venus and Mars in the cognitive sky of schizophrenia. Results from the first-step national FACE-SZ cohort.
    Schizophr Res. 2017 Sep 30. pii: S0920-9964(17)30589.
    PubMed     Text format     Abstract available


  9. GONZALEZ LE, Lopez-Carrilero R, Barrigon ML, Grasa E, et al
    Neuropsychological functioning and jumping to conclusions in recent onset psychosis patients.
    Schizophr Res. 2017 Sep 29. pii: S0920-9964(17)30601.
    PubMed     Text format     Abstract available


  10. SCHOFIELD P, Thygesen M, Das-Munshi J, Becares L, et al
    Neighbourhood ethnic density and psychosis - Is there a difference according to generation?
    Schizophr Res. 2017 Sep 29. pii: S0920-9964(17)30591.
    PubMed     Text format     Abstract available


  11. ROMER THOMSEN K, Thylstrup B, Pedersen MM, Pedersen MU, et al
    Drug-related predictors of readmission for schizophrenia among patients admitted to treatment for drug use disorders.
    Schizophr Res. 2017 Sep 28. pii: S0920-9964(17)30588.
    PubMed     Text format     Abstract available


  12. WYNN JK, Green MF, Hellemann G, Karunaratne K, et al
    The effects of curcumin on brain-derived neurotrophic factor and cognition in schizophrenia: A randomized controlled study.
    Schizophr Res. 2017 Sep 28. pii: S0920-9964(17)30608.
    PubMed     Text format    


  13. KELLY SM, Eack SM
    White matter microstructure and cognitive remediation outcomes in schizophrenia.
    Schizophr Res. 2017 Sep 28. pii: S0920-9964(17)30599.
    PubMed     Text format    


  14. RUBIN LH, Wehring HJ, Demyanovich H, Sue Carter C, et al
    Peripheral oxytocin and vasopressin are associated with clinical symptom severity and cognitive functioning in midlife women with chronic schizophrenia.
    Schizophr Res. 2017 Sep 28. pii: S0920-9964(17)30603.
    PubMed     Text format    


  15. LEE EE, Liu J, Tu X, Palmer BW, et al
    A widening longevity gap between people with schizophrenia and general population: A literature review and call for action.
    Schizophr Res. 2017 Sep 27. pii: S0920-9964(17)30542.
    PubMed     Text format     Abstract available


  16. VOGEL BO, Lett TA, Erk S, Mohnke S, et al
    The influence of MIR137 on white matter fractional anisotropy and cortical surface area in individuals with familial risk for psychosis.
    Schizophr Res. 2017 Sep 25. pii: S0920-9964(17)30592.
    PubMed     Text format     Abstract available


  17. WLODARCZYK A
    Benzodiazepine use in schizophrenia.
    Schizophr Res. 2017 Sep 25. pii: S0920-9964(17)30594.
    PubMed     Text format    


  18. SIDDIQUI I, Remington G, Fletcher PJ, Voineskos AN, et al
    Objective assessment of exploratory behaviour in schizophrenia using wireless motion capture.
    Schizophr Res. 2017 Sep 24. pii: S0920-9964(17)30570.
    PubMed     Text format     Abstract available


  19. ORHAN F, Fatouros-Bergman H, Schwieler L, Cervenka S, et al
    First-episode psychosis patients display increased plasma IL-18 that correlates with cognitive dysfunction.
    Schizophr Res. 2017 Sep 23. pii: S0920-9964(17)30576.
    PubMed     Text format    


  20. DAVISON J, O'Gorman A, Brennan L, Cotter DR, et al
    A systematic review of metabolite biomarkers of schizophrenia.
    Schizophr Res. 2017 Sep 22. pii: S0920-9964(17)30580.
    PubMed     Text format     Abstract available


  21. LI H, Li J, Yu X, Zheng H, et al
    The incidence rate of cancer in patients with schizophrenia: A meta-analysis of cohort studies.
    Schizophr Res. 2017 Sep 21. pii: S0920-9964(17)30541.
    PubMed     Text format     Abstract available


  22. BERRIOS GE, Markova IS
    Historical and conceptual aspects of motor disorders in the psychoses.
    Schizophr Res. 2017 Sep 20. pii: S0920-9964(17)30549.
    PubMed     Text format     Abstract available


  23. ZAROGIANNI E, Storkey AJ, Borgwardt S, Smieskova R, et al
    Individualized prediction of psychosis in subjects with an at-risk mental state.
    Schizophr Res. 2017 Sep 19. pii: S0920-9964(17)30537.
    PubMed     Text format     Abstract available


  24. COMBS T, Roseberry JE, Rubin LH, Hill SK, et al
    Deficient single item maintenance following intact updating in schizophrenia.
    Schizophr Res. 2017 Sep 18. pii: S0920-9964(17)30578.
    PubMed     Text format    


  25. GRIVEL MM, Leong W, Masucci MD, Altschuler RA, et al
    Impact of lifetime traumatic experiences on suicidality and likelihood of conversion in a cohort of individuals at clinical high-risk for psychosis.
    Schizophr Res. 2017 Sep 18. pii: S0920-9964(17)30547.
    PubMed     Text format     Abstract available


  26. MUNOZ-ESTRADA J, Lora-Castellanos A, Meza I, Alarcon Elizalde S, et al
    Primary cilia formation is diminished in schizophrenia and bipolar disorder: A possible marker for these psychiatric diseases.
    Schizophr Res. 2017 Sep 16. pii: S0920-9964(17)30530.
    PubMed     Text format     Abstract available


  27. JOSHI YB, Breitenstein B, Tarasenko M, Thomas ML, et al
    Mismatch negativity impairment is associated with deficits in identifying real-world environmental sounds in schizophrenia.
    Schizophr Res. 2017 Sep 15. pii: S0920-9964(17)30279.
    PubMed     Text format     Abstract available


  28. GILL KM, Miller SA, Grace AA
    Impaired contextual fear-conditioning in MAM rodent model of schizophrenia.
    Schizophr Res. 2017 Sep 15. pii: S0920-9964(17)30540.
    PubMed     Text format     Abstract available


  29. SCHJERNING O, Damkier P, Lykkegaard SE, Jakobsen KD, et al
    Pregabalin for anxiety in patients with schizophrenia - A randomized, double-blind placebo-controlled study.
    Schizophr Res. 2017 Sep 14. pii: S0920-9964(17)30575.
    PubMed     Text format     Abstract available


  30. HURFORD IM, Ventura J, Marder SR, Reise SP, et al
    A 10-minute measure of global cognition: Validation of the Brief Cognitive Assessment Tool for Schizophrenia (B-CATS).
    Schizophr Res. 2017 Sep 13. pii: S0920-9964(17)30510.
    PubMed     Text format     Abstract available


  31. BOUSMAN CA, Lee TY, Kim M, Lee J, et al
    Genetic variation in cytokine genes and risk for transition to psychosis among individuals at ultra-high risk.
    Schizophr Res. 2017 Sep 12. pii: S0920-9964(17)30516.
    PubMed     Text format    


  32. DUGRE JR, Guay JP, Dumais A
    Risk factors of compliance with self-harm command hallucinations in individuals with affective and non-affective psychosis.
    Schizophr Res. 2017 Sep 11. pii: S0920-9964(17)30545.
    PubMed     Text format     Abstract available


  33. LIU Y, Rao S, Xu Y, Zhang F, et al
    Changes in the level of Long Non-Coding RNA Gomafu gene expression in schizophrenia patients before and after antipsychotic medication.
    Schizophr Res. 2017 Sep 11. pii: S0920-9964(17)30502.
    PubMed     Text format    


  34. JOHANSSON M, Hjarthag F, Helldin L
    What could be learned from a decade with standardized remission criteria in schizophrenia spectrum disorders: An exploratory follow-up study.
    Schizophr Res. 2017 Sep 9. pii: S0920-9964(17)30548.
    PubMed     Text format     Abstract available


  35. SELVARAJ S, Bloomfield PS, Cao B, Veronese M, et al
    Brain TSPO imaging and gray matter volume in schizophrenia patients and in people at ultra high risk of psychosis: An [11C]PBR28 study.
    Schizophr Res. 2017 Sep 8. pii: S0920-9964(17)30539.
    PubMed     Text format     Abstract available


  36. CUESTA MJ, Garcia de Jalon E, Campos MS, Moreno-Izco L, et al
    Motor abnormalities in first-episode psychosis patients and long-term psychosocial functioning.
    Schizophr Res. 2017 Sep 7. pii: S0920-9964(17)30526.
    PubMed     Text format     Abstract available


  37. FOND G, Boyer L, Andrianarisoa M, Godin O, et al
    Risk factors for increased duration of untreated psychosis. Results from the FACE-SZ dataset.
    Schizophr Res. 2017 Sep 6. pii: S0920-9964(17)30534.
    PubMed     Text format     Abstract available


  38. JOAQUIM HPG, Zanetti MV, Serpa MH, Van de Bilt MT, et al
    Increased platelet glycogen sysnthase kinase 3beta in first-episode psychosis.
    Schizophr Res. 2017 Sep 6. pii: S0920-9964(17)30538.
    PubMed     Text format     Abstract available


  39. NORMAN RMG, MacDougall A, Manchanda R, Harricharan R, et al
    An examination of components of recovery after five years of treatment in an early intervention program for psychosis.
    Schizophr Res. 2017 Sep 6. pii: S0920-9964(17)30531.
    PubMed     Text format     Abstract available


  40. WAMPERS M, Schrauwen S, De Hert M, Gielen L, et al
    Patients with psychosis struggle with scalar implicatures.
    Schizophr Res. 2017 Sep 6. pii: S0920-9964(17)30529.
    PubMed     Text format     Abstract available


  41. HO RWH, Chang WC, Kwong VWY, Lau ESK, et al
    Prediction of self-stigma in early psychosis: 3-Year follow-up of the randomized-controlled trial on extended early intervention.
    Schizophr Res. 2017 Sep 6. pii: S0920-9964(17)30544.
    PubMed     Text format     Abstract available


  42. CIHAKOVA D, Eaton WW, Talor MV, Harkus UH, et al
    Gliadin-related antibodies in schizophrenia.
    Schizophr Res. 2017 Sep 5. pii: S0920-9964(17)30527.
    PubMed     Text format    


  43. MOLINA V, Bachiller A, Gomez-Pilar J, Lubeiro A, et al
    Deficit of entropy modulation of the EEG in schizophrenia associated to cognitive performance and symptoms. A replication study.
    Schizophr Res. 2017 Sep 5. pii: S0920-9964(17)30533.
    PubMed     Text format     Abstract available


  44. SANDOVAL LR, Gonzalez BL, Stone WS, Guimond S, et al
    Effects of peer social interaction on performance during computerized cognitive remediation therapy in patients with early course schizophrenia: A pilot study.
    Schizophr Res. 2017 Sep 4. pii: S0920-9964(17)30525.
    PubMed     Text format     Abstract available


  45. GOMES JS, Ducos DV, Gadelha A, Ortiz BB, et al
    Hemoencephalography self-regulation training and its impact on cognition: A study with schizophrenia and healthy participants.
    Schizophr Res. 2017 Sep 4. pii: S0920-9964(17)30520.
    PubMed     Text format     Abstract available


    August 2017
  46. LI Z, Yan C, Lv QY, Yi ZH, et al
    Striatal dysfunction in patients with schizophrenia and their unaffected first-degree relatives.
    Schizophr Res. 2017 Aug 31. pii: S0920-9964(17)30519.
    PubMed     Text format     Abstract available


  47. SEVILLA-LLEWELLYN-JONES J, Cano-Dominguez P, de-Luis-Matilla A, Espina-Eizaguirre A, et al
    Personality traits in recent-onset-of-psychosis patients compared to a control sample by gender.
    Schizophr Res. 2017 Aug 31. pii: S0920-9964(17)30518.
    PubMed     Text format     Abstract available


  48. ACAR S, Chen X, Cayirdag N
    Schizophrenia and creativity: A meta-analytic review.
    Schizophr Res. 2017 Aug 31. pii: S0920-9964(17)30512.
    PubMed     Text format     Abstract available


  49. SILVA RO, Amato IA, Santos A Jr, Bobbo VC, et al
    Paradoxical elevation of systemic inflammatory markers and physical activity in patients with schizophrenia.
    Schizophr Res. 2017 Aug 30. pii: S0920-9964(17)30514.
    PubMed     Text format    


  50. BOSE A, Shivakumar V, Agarwal SM, Kalmady SV, et al
    Efficacy of fronto-temporal transcranial direct current stimulation for refractory auditory verbal hallucinations in schizophrenia: A randomized, double-blind, sham-controlled study.
    Schizophr Res. 2017 Aug 30. pii: S0920-9964(17)30523.
    PubMed     Text format     Abstract available


  51. PERALTA V, de Jalon EG, Campos MS, Cuesta MJ, et al
    Covariation between motor signs and negative symptoms in drug-naive subjects with schizophrenia-spectrum disorders before and after antipsychotic treatment.
    Schizophr Res. 2017 Aug 29. pii: S0920-9964(17)30515.
    PubMed     Text format     Abstract available


  52. SHAD MU
    What do we know about insight into illness and its association with the underlying biology of schizophrenia?
    Schizophr Res. 2017 Aug 29. pii: S0920-9964(17)30493.
    PubMed     Text format    


  53. KLINE E, Thomas L
    Commentary: Cultural factors in first episode psychosis treatment engagement.
    Schizophr Res. 2017 Aug 29. pii: S0920-9964(17)30511.
    PubMed     Text format     Abstract available


  54. VAN DER GAAG M, van den Berg D, Ising H
    CBT in the prevention of psychosis and other severe mental disorders in patients with an at risk mental state: A review and proposed next steps.
    Schizophr Res. 2017 Aug 28. pii: S0920-9964(17)30494.
    PubMed     Text format     Abstract available


  55. ZOU YM, Ni K, Yang ZY, Li Y, et al
    Profiling of experiential pleasure, emotional regulation and emotion expression in patients with schizophrenia.
    Schizophr Res. 2017 Aug 28. pii: S0920-9964(17)30524.
    PubMed     Text format     Abstract available


  56. HUDGENS-HANEY ME, Ethridge LE, McDowell JE, Keedy SK, et al
    Psychosis subgroups differ in intrinsic neural activity but not task-specific processing.
    Schizophr Res. 2017 Aug 24. pii: S0920-9964(17)30498.
    PubMed     Text format     Abstract available


  57. BOU KHALIL R
    Maternal infection and anemia as prenatal predisposing factors for schizophrenia: The link with zinc deficiency.
    Schizophr Res. 2017 Aug 24. pii: S0920-9964(17)30506.
    PubMed     Text format    


  58. TREEN CALVO D, Gimenez-Donoso S, Setien-Suero E, Toll Privat A, et al
    Targeting recovery in first episode psychosis: The importance of neurocognition and premorbid adjustment in a 3-year longitudinal study.
    Schizophr Res. 2017 Aug 24. pii: S0920-9964(17)30509.
    PubMed     Text format     Abstract available


  59. SINT K, Rosenheck R, Robinson DG, Schooler NR, et al
    Accounting for group differences in study retention in a randomized trial of specialized treatment for first episode psychosis.
    Schizophr Res. 2017 Aug 24. pii: S0920-9964(17)30505.
    PubMed     Text format     Abstract available


  60. MATHIAS SR, Knowles EEM, Barrett J, Beetham T, et al
    Deficits in visual working-memory capacity and general cognition in African Americans with psychosis.
    Schizophr Res. 2017 Aug 23. pii: S0920-9964(17)30490.
    PubMed     Text format     Abstract available


  61. TAKEUCHI H, Thiyanavadivel S, Agid O, Remington G, et al
    Rapid vs. slow antipsychotic initiation in schizophrenia: A systematic review and meta-analysis.
    Schizophr Res. 2017 Aug 22. pii: S0920-9964(17)30487.
    PubMed     Text format     Abstract available


  62. VAN ROOIJEN G, Isvoranu AM, Kruijt OH, van Borkulo CD, et al
    A state-independent network of depressive, negative and positive symptoms in male patients with schizophrenia spectrum disorders.
    Schizophr Res. 2017 Aug 22. pii: S0920-9964(17)30446.
    PubMed     Text format     Abstract available


  63. QIAO Y, Mei Y, Han H, Liu F, et al
    Effects of Omega-3 in the treatment of violent schizophrenia patients.
    Schizophr Res. 2017 Aug 19. pii: S0920-9964(17)30501.
    PubMed     Text format     Abstract available


  64. UPTHEGROVE R, Abu-Akel A, Chisholm K, Lin A, et al
    Autism and psychosis: Clinical implications for depression and suicide.
    Schizophr Res. 2017 Aug 18. pii: S0920-9964(17)30504.
    PubMed     Text format     Abstract available


  65. WHITFIELD-GABRIELI S, Fischer AS, Henricks AM, Khokhar JY, et al
    Understanding marijuana's effects on functional connectivity of the default mode network in patients with schizophrenia and co-occurring cannabis use disorder: A pilot investigation.
    Schizophr Res. 2017 Aug 17. pii: S0920-9964(17)30431.
    PubMed     Text format     Abstract available


  66. ZHANG T, Cui H, Wei Y, Tang Y, et al
    Progressive decline of cognition during the conversion from prodrome to psychosis with a characteristic pattern of the theory of mind compensated by neurocognition.
    Schizophr Res. 2017 Aug 17. pii: S0920-9964(17)30496.
    PubMed     Text format     Abstract available


  67. LOPEZ-DIAZ A, Galiano-Rus S, Herruzo-Rivas A
    Differences in the impairment of insight between deficit syndrome and non-deficit syndrome patients with first-episode schizophrenia.
    Schizophr Res. 2017 Aug 15. pii: S0920-9964(17)30491.
    PubMed     Text format    


  68. DEMJAHA A
    On the brink of precision medicine for psychosis: Treating the patient, not the disease: A commentary on: Association between serum levels of glutamate and neurotrophic factors and response to clozapine treatment by Krivoj et al. 2017.
    Schizophr Res. 2017 Aug 15. pii: S0920-9964(17)30485.
    PubMed     Text format    


  69. UNGVARI GS, Gerevich J, Takacs R, Gazdag G, et al
    Schizophrenia with prominent catatonic features: A selective review.
    Schizophr Res. 2017 Aug 14. pii: S0920-9964(17)30474.
    PubMed     Text format     Abstract available


  70. GRUBER J, Strauss GP, Dombrecht L, Mittal VA, et al
    Neuroleptic-free youth at ultrahigh risk for psychosis evidence diminished emotion reactivity that is predicted by depression and anxiety.
    Schizophr Res. 2017 Aug 12. pii: S0920-9964(17)30486.
    PubMed     Text format     Abstract available


  71. MARAJ A, Veru F, Morrison L, Joober R, et al
    Disengagement in immigrant groups receiving services for a first episode of psychosis.
    Schizophr Res. 2017 Aug 10. pii: S0920-9964(17)30465.
    PubMed     Text format     Abstract available


  72. NOGUERA A, Castro-Fornieles J, Romero S, de la Serna E, et al
    Attenuated psychotic symptoms in children and adolescent offspring of patients with schizophrenia.
    Schizophr Res. 2017 Aug 9. pii: S0920-9964(17)30461.
    PubMed     Text format    


  73. VLATKOVIC S, Sagud M, Svob Strac D, Sviben M, et al
    Increased prevalence of Toxoplasma gondii seropositivity in patients with treatment-resistant schizophrenia.
    Schizophr Res. 2017 Aug 9. pii: S0920-9964(17)30472.
    PubMed     Text format    


  74. MAGLIANO L, Petrillo M, Ruggiero G, Schioppa G, et al
    Schizophrenia and psychosis: Does changing the label change the beliefs?
    Schizophr Res. 2017 Aug 9. pii: S0920-9964(17)30473.
    PubMed     Text format    


  75. PALMER BW, Moore RC, Eyler LT, Pinto LL, et al
    Avoidance of accelerated aging in schizophrenia?: Clinical and biological characterization of an exceptionally high functioning individual.
    Schizophr Res. 2017 Aug 8. pii: S0920-9964(17)30463.
    PubMed     Text format     Abstract available


  76. LEUNG LS, Ma J
    Medial septum modulates hippocampal gamma activity and prepulse inhibition in an N-methyl-d-aspartate receptor antagonist model of schizophrenia.
    Schizophr Res. 2017 Aug 8. pii: S0920-9964(17)30464.
    PubMed     Text format     Abstract available


  77. COOPER PS, Hughes ME
    Impaired theta and alpha oscillations underlying stopsignal response inhibition deficits in schizophrenia.
    Schizophr Res. 2017 Aug 7. pii: S0920-9964(17)30469.
    PubMed     Text format    


  78. JOE P, Getz M, Redman S, Kranz TM, et al
    Transglutaminase-5 related schizophrenia.
    Schizophr Res. 2017 Aug 7. pii: S0920-9964(17)30470.
    PubMed     Text format    


  79. KOUTSOUKOS E, Angelopoulos E
    Investigating the role of metastability in the disturbed brain functional connectivity observed under the experience of thought blocks in schizophrenia.
    Schizophr Res. 2017 Aug 5. pii: S0920-9964(17)30466.
    PubMed     Text format    


  80. STRAUSS GP, Chapman HC
    Preliminary psychometric properties of the brief Negative Symptom Scale in youth at Clinical High-Risk for psychosis.
    Schizophr Res. 2017 Aug 2. pii: S0920-9964(17)30462.
    PubMed     Text format     Abstract available


  81. MCCARTHY JM, Bradshaw KR, Catalano LT, Garcia CP, et al
    Negative symptoms and the formation of social affiliative bonds in schizophrenia.
    Schizophr Res. 2017 Aug 2. pii: S0920-9964(17)30445.
    PubMed     Text format     Abstract available


  82. LEE M, Sehatpour P, Dias EC, Silipo GS, et al
    A tale of two sites: Differential impairment of frequency and duration mismatch negativity across a primarily inpatient versus a primarily outpatient site in schizophrenia.
    Schizophr Res. 2017 Aug 2. pii: S0920-9964(17)30443.
    PubMed     Text format     Abstract available


  83. SRIHARI VH
    Working toward changing the Duration of Untreated Psychosis (DUP).
    Schizophr Res. 2017 Aug 2. pii: S0920-9964(17)30456.
    PubMed     Text format    


  84. MURALIDHARAN A, Finch A, Bowie CR, Harvey PD, et al
    Thought, language, and communication deficits and association with everyday functional outcomes among community-dwelling middle-aged and older adults with schizophrenia.
    Schizophr Res. 2017 Aug 1. pii: S0920-9964(17)30418.
    PubMed     Text format     Abstract available


    July 2017
  85. HOOPER SR, Shashi V
    Completing the puzzle: The search for pieces in the understanding of psychosis risk in 22q11.2 deletion syndrome.
    Schizophr Res. 2017 Jul 30. pii: S0920-9964(17)30451.
    PubMed     Text format    


  86. EACK SM
    Promoting long-term functional improvement after cognitive remediation in schizophrenia.
    Schizophr Res. 2017 Jul 30. pii: S0920-9964(17)30454.
    PubMed     Text format    


  87. FEATHERSTONE RE, Melnychenko O, Siegel SJ
    Mismatch negativity in preclinical models of schizophrenia.
    Schizophr Res. 2017 Jul 30. pii: S0920-9964(17)30450.
    PubMed     Text format     Abstract available


  88. BRAEUTIGAM S, Dima D, Frangou S, James A, et al
    Dissociable auditory mismatch response and connectivity patterns in adolescents with schizophrenia and adolescents with bipolar disorder with psychosis: A magnetoencephalography study.
    Schizophr Res. 2017 Jul 28. pii: S0920-9964(17)30459.
    PubMed     Text format     Abstract available


  89. LALLY J, Ajnakina O, Stubbs B, Williams HR, et al
    Hyperprolactinaemia in first episode psychosis - A longitudinal assessment.
    Schizophr Res. 2017 Jul 27. pii: S0920-9964(17)30448.
    PubMed     Text format     Abstract available


  90. ADAMS SA, Nasrallah HA
    Multiple retinal anomalies in schizophrenia.
    Schizophr Res. 2017 Jul 26. pii: S0920-9964(17)30419.
    PubMed     Text format     Abstract available


  91. AJNAKINA O, Lally J, Di Forti M, Stilo SA, et al
    Utilising symptom dimensions with diagnostic categories improves prediction of time to first remission in first-episode psychosis.
    Schizophr Res. 2017 Jul 25. pii: S0920-9964(17)30453.
    PubMed     Text format     Abstract available


  92. GILLESPIE SM, Abu-Akel AM
    Evidence for benefits in comorbid psychopathy and schizophrenia.
    Schizophr Res. 2017 Jul 25. pii: S0920-9964(17)30457.
    PubMed     Text format    


  93. CHIU PW, Lui SSY, Hung KSY, Chan RCK, et al
    In vivo gamma-aminobutyric acid and glutamate levels in people with first-episode schizophrenia: A proton magnetic resonance spectroscopy study.
    Schizophr Res. 2017 Jul 24. pii: S0920-9964(17)30422.
    PubMed     Text format     Abstract available


  94. WANG HY, Guo WJ, Li XJ, Tao YJ, et al
    Higher required dosage of antipsychotics to relieve the symptoms of first-onset Acute and Transient Psychotic Disorder (ATPD) predicted the subsequent diagnostic transition to schizophrenia: A longitudinal study.
    Schizophr Res. 2017 Jul 21. pii: S0920-9964(17)30412.
    PubMed     Text format    


  95. EBISCH SJH, Gallese V, Salone A, Martinotti G, et al
    Disrupted relationship between "resting state" connectivity and task-evoked activity during social perception in schizophrenia.
    Schizophr Res. 2017 Jul 20. pii: S0920-9964(17)30421.
    PubMed     Text format     Abstract available


  96. GANELLA EP, Seguin C, Bartholomeusz CF, Whittle S, et al
    Risk and resilience brain networks in treatment-resistant schizophrenia.
    Schizophr Res. 2017 Jul 20. pii: S0920-9964(17)30415.
    PubMed     Text format     Abstract available


  97. FUSAR-POLI P, Palombini E, Davies C, Oliver D, et al
    Why transition risk to psychosis is not declining at the OASIS ultra high risk service: The hidden role of stable pretest risk enrichment.
    Schizophr Res. 2017 Jul 19. pii: S0920-9964(17)30353.
    PubMed     Text format     Abstract available


  98. PILLAI A, Schooler NR, Peter D, Looney SW, et al
    Predicting relapse in schizophrenia: Is BDNF a plausible biological marker?
    Schizophr Res. 2017 Jul 19. pii: S0920-9964(17)30398.
    PubMed     Text format     Abstract available


  99. MORITZ S, Bentall RP, Kolbeck K, Roesch-Ely D, et al
    Monocausal attribution and its relationship with reasoning biases in schizophrenia.
    Schizophr Res. 2017 Jul 18. pii: S0920-9964(17)30396.
    PubMed     Text format     Abstract available


  100. FARGOTSTEIN M, Hasenkamp W, Gross R, Cuthbert B, et al
    The effect of antipsychotic medications on acoustic startle latency in schizophrenia.
    Schizophr Res. 2017 Jul 18. pii: S0920-9964(17)30432.
    PubMed     Text format     Abstract available


  101. ZULIANI R, Delvecchio G, Bonivento C, Cattarinussi G, et al
    Increased gyrification in schizophrenia and non affective first episode of psychosis.
    Schizophr Res. 2017 Jul 17. pii: S0920-9964(17)30399.
    PubMed     Text format     Abstract available


  102. LU ML, Chen CH, Kuo PT, Lin CH, et al
    Application of plasma levels of olanzapine and N-desmethyl-olanzapine to monitor metabolic parameters in patients with schizophrenia.
    Schizophr Res. 2017 Jul 15. pii: S0920-9964(17)30423.
    PubMed     Text format     Abstract available


  103. O'REILLY K, O'Connell P, Corvin A, O'Sullivan D, et al
    Moral cognition and homicide amongst forensic patients with schizophrenia and schizoaffective disorder: A cross-sectional cohort study.
    Schizophr Res. 2017 Jul 14. pii: S0920-9964(17)30428.
    PubMed     Text format     Abstract available


  104. GAWEDA L, Prochwicz K, Adamczyk P, Frydecka D, et al
    The role of self-disturbances and cognitive biases in the relationship between traumatic life events and psychosis proneness in a non-clinical sample.
    Schizophr Res. 2017 Jul 13. pii: S0920-9964(17)30424.
    PubMed     Text format     Abstract available


  105. HORAN WP, Green MF
    Treatment of social cognition in schizophrenia: Current status and future directions.
    Schizophr Res. 2017 Jul 13. pii: S0920-9964(17)30414.
    PubMed     Text format     Abstract available


  106. REKHI G, Ng WY, Lee J
    Clinical utility of the Calgary Depression Scale for Schizophrenia in individuals at ultra-high risk of psychosis.
    Schizophr Res. 2017 Jul 13. pii: S0920-9964(17)30395.
    PubMed     Text format     Abstract available


  107. COMPARELLI A, Corigliano V, Lamis DA, De Carolis A, et al
    Positive symptoms and social cognition impairment affect severity of suicidal ideation in schizophrenia.
    Schizophr Res. 2017 Jul 13. pii: S0920-9964(17)30427.
    PubMed     Text format    


  108. HATTORI S, Kishida I, Suda A, Miyauchi M, et al
    Effects of four atypical antipsychotics on autonomic nervous system activity in schizophrenia.
    Schizophr Res. 2017 Jul 12. pii: S0920-9964(17)30405.
    PubMed     Text format     Abstract available


  109. LINDGREN M, Torniainen-Holm M, Harkanen T, Dickerson F, et al
    The association between toxoplasma and the psychosis continuum in a general population setting.
    Schizophr Res. 2017 Jul 12. pii: S0920-9964(17)30391.
    PubMed     Text format     Abstract available


  110. RETSA C, Knebel JF, Geiser E, Ferrari C, et al
    Treatment in early psychosis with N-acetyl-cysteine for 6months improves low-level auditory processing: Pilot study.
    Schizophr Res. 2017 Jul 12. pii: S0920-9964(17)30409.
    PubMed     Text format     Abstract available


  111. VERAS AB, Peixoto C, Messinger JW, Getz M, et al
    Early trauma and clinical features of schizophrenia cases influenced by the BDNF met allele.
    Schizophr Res. 2017 Jul 12. pii: S0920-9964(17)30400.
    PubMed     Text format    


  112. HAMILTON HK, D'Souza DC, Ford JM, Roach BJ, et al
    Interactive effects of an N-methyl-d-aspartate receptor antagonist and a nicotinic acetylcholine receptor agonist on mismatch negativity: Implications for schizophrenia.
    Schizophr Res. 2017 Jul 12. pii: S0920-9964(17)30379.
    PubMed     Text format     Abstract available


  113. HOLMEN TL, Egeland J, Andersen E, Bigseth TT, et al
    The association between cardio-respiratory fitness and cognition in schizophrenia.
    Schizophr Res. 2017 Jul 11. pii: S0920-9964(17)30416.
    PubMed     Text format     Abstract available


  114. BONFIOLI E, Mazzi MA, Berti L, Burti L, et al
    Physical health promotion in patients with functional psychoses receiving community psychiatric services: Results of the PHYSICO-DSM-VR study.
    Schizophr Res. 2017 Jul 11. pii: S0920-9964(17)30356.
    PubMed     Text format     Abstract available


  115. DUTSCHKE LL, Stegmayer K, Ramseyer F, Bohlhalter S, et al
    Gesture impairments in schizophrenia are linked to increased movement and prolonged motor planning and execution.
    Schizophr Res. 2017 Jul 11. pii: S0920-9964(17)30413.
    PubMed     Text format     Abstract available


  116. AVISSAR M, Xie S, Vail B, Lopez-Calderon J, et al
    Meta-analysis of mismatch negativity to simple versus complex deviants in schizophrenia.
    Schizophr Res. 2017 Jul 11. pii: S0920-9964(17)30410.
    PubMed     Text format     Abstract available


  117. KOOLA MM, Sklar J, Davis W, Nikiforuk A, et al
    Kynurenine pathway in schizophrenia: Galantamine-memantine combination for cognitive impairments.
    Schizophr Res. 2017 Jul 10. pii: S0920-9964(17)30406.
    PubMed     Text format    


  118. KONRADI C, Ongur D
    Role of mitochondria and energy metabolism in schizophrenia and psychotic disorders.
    Schizophr Res. 2017 Jul 10. pii: S0920-9964(17)30408.
    PubMed     Text format    


  119. GARDSJORD ES, Romm KL, Rossberg JI, Friis S, et al
    Is going into stable symptomatic remission associated with a more positive development of life satisfaction? A 10-year follow-up study of first episode psychosis.
    Schizophr Res. 2017 Jul 9. pii: S0920-9964(17)30407.
    PubMed     Text format     Abstract available


  120. BRUNETTE MF, Mueser KT, Babbin S, Meyer-Kalos P, et al
    Demographic and clinical correlates of substance use disorders in first episode psychosis.
    Schizophr Res. 2017 Jul 8. pii: S0920-9964(17)30378.
    PubMed     Text format     Abstract available


  121. XAVIER RM, Pan W, Dungan JR, Keefe RSE, et al
    Unraveling interrelationships among psychopathology symptoms, cognitive domains and insight dimensions in chronic schizophrenia.
    Schizophr Res. 2017 Jul 7. pii: S0920-9964(17)30403.
    PubMed     Text format     Abstract available


  122. BERRY C, Greenwood K
    Direct and indirect associations between dysfunctional attitudes, self-stigma, hopefulness and social inclusion in young people experiencing psychosis.
    Schizophr Res. 2017 Jul 7. pii: S0920-9964(17)30377.
    PubMed     Text format     Abstract available


  123. SUBRAMANIAM K, Gill J, Fisher M, Mukherjee P, et al
    White matter microstructure predicts cognitive training-induced improvements in attention and executive functioning in schizophrenia.
    Schizophr Res. 2017 Jul 6. pii: S0920-9964(17)30401.
    PubMed     Text format     Abstract available


  124. RAMYEAD A, Kometer M, Studerus E, Andreou C, et al
    Abnormal brain connectivity during error-monitoring in the psychosis high-risk state.
    Schizophr Res. 2017 Jul 6. pii: S0920-9964(17)30394.
    PubMed     Text format    


  125. SEDGWICK O, Young S, Greer B, Arnold J, et al
    Sensorimotor gating characteristics of violent men with comorbid psychosis and dissocial personality disorder: Relationship with antisocial traits and psychosocial deprivation.
    Schizophr Res. 2017 Jul 6. pii: S0920-9964(17)30384.
    PubMed     Text format     Abstract available


  126. KIRKPATRICK B, Kennedy BK
    Accelerated aging in schizophrenia and related disorders: Future research.
    Schizophr Res. 2017 Jul 6. pii: S0920-9964(17)30373.
    PubMed     Text format     Abstract available


  127. LU ML, Chen TT, Kuo PH, Hsu CC, et al
    Effects of adjunctive fluvoxamine on metabolic parameters and psychopathology in clozapine-treated patients with schizophrenia: A 12-week, randomized, double-blind, placebo-controlled study.
    Schizophr Res. 2017 Jul 5. pii: S0920-9964(17)30368.
    PubMed     Text format     Abstract available


  128. WHITFORD V, O'Driscoll GA, Titone D
    Reading deficits in schizophrenia and their relationship to developmental dyslexia: A review.
    Schizophr Res. 2017 Jul 5. pii: S0920-9964(17)30388.
    PubMed     Text format     Abstract available


  129. DONG D, Wang Y, Chang X, Chen X, et al
    Common and diagnosis-specific fractional anisotropy of white matter in schizophrenia, bipolar disorder, and major depressive disorder: Evidence from comparative voxel-based meta-analysis.
    Schizophr Res. 2017 Jul 4. pii: S0920-9964(17)30404.
    PubMed     Text format    


  130. LUCK M, Turner M, Shad MU
    Effectiveness of genetically-guided treatment in first-episode schizophrenia.
    Schizophr Res. 2017 Jul 2. pii: S0920-9964(17)30390.
    PubMed     Text format    


  131. COHEN CI, Murante T
    A prospective analysis of the role of cognition in three models of aging and schizophrenia.
    Schizophr Res. 2017 Jul 2. pii: S0920-9964(17)30361.
    PubMed     Text format     Abstract available


  132. MORAR B, Badcock JC, Phillips M, Almeida OP, et al
    The longevity gene Klotho is differentially associated with cognition in subtypes of schizophrenia.
    Schizophr Res. 2017 Jul 1. pii: S0920-9964(17)30393.
    PubMed     Text format     Abstract available


    June 2017
  133. JANSSENS S, Moens H, Coppens V, Vandendriessche F, et al
    Psychomotor assessment as a tool to differentiate schizophrenia from other psychotic disorders.
    Schizophr Res. 2017 Jun 30. pii: S0920-9964(17)30386.
    PubMed     Text format     Abstract available


  134. BISMARK AW, Thomas ML, Tarasenko M, Shiluk AL, et al
    Relationship between effortful motivation and neurocognition in schizophrenia.
    Schizophr Res. 2017 Jun 30. pii: S0920-9964(17)30381.
    PubMed     Text format     Abstract available


  135. MAK M, Misiak B, Frydecka D, Pelka-Wysiecka J, et al
    Polymorphisms in immune-inflammatory response genes and the risk of deficit schizophrenia.
    Schizophr Res. 2017 Jun 30. pii: S0920-9964(17)30389.
    PubMed     Text format     Abstract available


  136. SVERAK T, Albrechtova L, Lamos M, Rektorova I, et al
    Intensive repetitive transcranial magnetic stimulation changes EEG microstates in schizophrenia: A pilot study.
    Schizophr Res. 2017 Jun 30. pii: S0920-9964(17)30383.
    PubMed     Text format    


  137. BUCHY L, Makowski C, Malla A, Joober R, et al
    A longitudinal study of cognitive insight and cortical thickness in first-episode psychosis.
    Schizophr Res. 2017 Jun 29. pii: S0920-9964(17)30387.
    PubMed     Text format     Abstract available


  138. MAZIADE M, Paccalet T, Gilbert E
    Defective compensation over early dysneurogenesis in schizophrenia and mood disorder.
    Schizophr Res. 2017 Jun 27. pii: S0920-9964(17)30380.
    PubMed     Text format    


  139. JAVITT DC, Lee M, Kantrowitz JT, Martinez A, et al
    Mismatch negativity as a biomarker of theta band oscillatory dysfunction in schizophrenia.
    Schizophr Res. 2017 Jun 27. pii: S0920-9964(17)30362.
    PubMed     Text format     Abstract available


  140. MISDRAHI D, Tessier A, Husky M, Lange AC, et al
    Evaluation of adherence patterns in schizophrenia using electronic monitoring (MEMS(R)): A six-month post-discharge prospective study.
    Schizophr Res. 2017 Jun 26. pii: S0920-9964(17)30365.
    PubMed     Text format     Abstract available


  141. BIOQUE M, Garcia-Portilla MAP, Garcia-Rizo C, Cabrera B, et al
    Evolution of metabolic risk factors over a two-year period in a cohort of first episodes of psychosis.
    Schizophr Res. 2017 Jun 26. pii: S0920-9964(17)30370.
    PubMed     Text format     Abstract available


  142. VILLA J, Choi J, Kangas JL, Kaufmann CN, et al
    Associations of suicidality with cognitive ability and cognitive insight in outpatients with Schizophrenia.
    Schizophr Res. 2017 Jun 24. pii: S0920-9964(17)30351.
    PubMed     Text format     Abstract available


  143. LIANG S, Brown MRG, Deng W, Wang Q, et al
    Convergence and divergence of neurocognitive patterns in schizophrenia and depression.
    Schizophr Res. 2017 Jun 23. pii: S0920-9964(17)30332.
    PubMed     Text format     Abstract available


  144. DAI J, Du X, Yin G, Zhang Y, et al
    Prevalence, demographic and clinical features of comorbid depressive symptoms in drug naive patients with schizophrenia presenting with first episode psychosis.
    Schizophr Res. 2017 Jun 23. pii: S0920-9964(17)30369.
    PubMed     Text format     Abstract available


  145. DAVIDSON CA, Lesser R, Parente LT, Fiszdon JM, et al
    Psychometrics of social cognitive measures for psychosis treatment research.
    Schizophr Res. 2017 Jun 22. pii: S0920-9964(17)30357.
    PubMed     Text format     Abstract available


  146. HORN M, D'Hondt F, Gharib A, Gangloff L, et al
    Association between familiarity disorders and serious violence among inmates with schizophrenia.
    Schizophr Res. 2017 Jun 21. pii: S0920-9964(17)30371.
    PubMed     Text format    


  147. SUN Z, Ma Y, Li W, He J, et al
    Associations between the DBH gene, plasma dopamine beta-hydroxylase activity and cognitive measures in Han Chinese patients with schizophrenia.
    Schizophr Res. 2017 Jun 21. pii: S0920-9964(17)30367.
    PubMed     Text format     Abstract available


  148. MEHTA UM, Ravishankar V, Thirthalli J
    Eszopiclone for persistent negative symptoms in schizophrenia - An unintended N-of-1 study.
    Schizophr Res. 2017 Jun 21. pii: S0920-9964(17)30374.
    PubMed     Text format     Abstract available


  149. UHL I, Kulik A, Roser P, Theodoridou A, et al
    Central serotonergic function in patients with predominantly negative symptoms of schizophrenia.
    Schizophr Res. 2017 Jun 19. pii: S0920-9964(17)30327.
    PubMed     Text format    


  150. FRIES GR, Dimitrov DH, Lee S, Braida N, et al
    Genome-wide expression in veterans with schizophrenia further validates the immune hypothesis for schizophrenia.
    Schizophr Res. 2017 Jun 19. pii: S0920-9964(17)30355.
    PubMed     Text format     Abstract available


  151. STUBBS B, Vancampfort D, Firth J, Hallgren M, et al
    Physical activity correlates among people with psychosis: Data from 47 low- and middle-income countries.
    Schizophr Res. 2017 Jun 18. pii: S0920-9964(17)30364.
    PubMed     Text format     Abstract available


  152. BORA E, Yalincetin B, Akdede BB, Alptekin K, et al
    Duration of untreated psychosis and neurocognition in first-episode psychosis: A meta-analysis.
    Schizophr Res. 2017 Jun 17. pii: S0920-9964(17)30360.
    PubMed     Text format     Abstract available


  153. KOH MT, Shao Y, Rosenzweig-Lipson S, Gallagher M, et al
    Treatment with levetiracetam improves cognition in a ketamine rat model of schizophrenia.
    Schizophr Res. 2017 Jun 17. pii: S0920-9964(17)30366.
    PubMed     Text format     Abstract available


  154. MILLMAN ZB, Pitts SC, Thompson E, Kline ER, et al
    Perceived social stress and symptom severity among help-seeking adolescents with versus without clinical high-risk for psychosis.
    Schizophr Res. 2017 Jun 16. pii: S0920-9964(17)30330.
    PubMed     Text format     Abstract available


  155. HSU CW, Lee SY, Wang LJ
    Comparison of the effectiveness of brand-name and generic antipsychotic drugs for treating patients with schizophrenia in Taiwan.
    Schizophr Res. 2017 Jun 16. pii: S0920-9964(17)30359.
    PubMed     Text format     Abstract available


  156. ZHANG T, Guo X, Tang Y, Cui H, et al
    Time consumption in mind-reading: A potentially important factor for social cognition assessment in early psychosis.
    Schizophr Res. 2017 Jun 15. pii: S0920-9964(17)30354.
    PubMed     Text format    


  157. BENDELS MHK, Bauer J, Schoffel N, Groneberg DA, et al
    The gender gap in schizophrenia research.
    Schizophr Res. 2017 Jun 15. pii: S0920-9964(17)30358.
    PubMed     Text format    


  158. LEE TY, Lee J, Kim M, Kwon JS, et al
    The effect of transcranial direct current stimulation on auditory hallucination in patients with schizophrenia.
    Schizophr Res. 2017 Jun 15. pii: S0920-9964(17)30352.
    PubMed     Text format    


  159. AN H, Zhou L, Yu Y, Fan H, et al
    Serum NCAM levels and cognitive deficits in first episode schizophrenia patients versus health controls.
    Schizophr Res. 2017 Jun 15. pii: S0920-9964(17)30348.
    PubMed     Text format     Abstract available


  160. SIMOILA L, Isometsa E, Gissler M, Suvisaari J, et al
    Schizophrenia and induced abortions: A national register-based follow-up study among Finnish women born between 1965-1980 with schizophrenia or schizoaffective disorder.
    Schizophr Res. 2017 Jun 11. pii: S0920-9964(17)30313.
    PubMed     Text format     Abstract available


  161. APPIANI FJ, Castro GS
    Catatonia is not schizophrenia and it is treatable.
    Schizophr Res. 2017 Jun 10. pii: S0920-9964(17)30305.
    PubMed     Text format     Abstract available


  162. KELLER-VARADY K, Varady PA, Roh A, Schmitt A, et al
    A systematic review of trials investigating strength training in schizophrenia spectrum disorders.
    Schizophr Res. 2017 Jun 8. pii: S0920-9964(17)30336.
    PubMed     Text format     Abstract available


  163. LANGBEIN K, Schmidt U, Schack S, Biesel NJ, et al
    State marker properties of niacin skin sensitivity in ultra-high risk groups for psychosis - An optical reflection spectroscopy study.
    Schizophr Res. 2017 Jun 8. pii: S0920-9964(17)30335.
    PubMed     Text format     Abstract available


  164. GREENWOOD LM, Leung S, Michie PT, Green A, et al
    The effects of glycine on auditory mismatch negativity in schizophrenia.
    Schizophr Res. 2017 Jun 8. pii: S0920-9964(17)30306.
    PubMed     Text format     Abstract available


  165. BHAVSAR V, Fusar-Poli P, McGuire P
    Neighbourhood deprivation is positively associated with detection of the ultra-high risk (UHR) state for psychosis in South East London.
    Schizophr Res. 2017 Jun 8. pii: S0920-9964(17)30334.
    PubMed     Text format     Abstract available


  166. WEI Y, Collin G, Mandl RCW, Cahn W, et al
    Cortical magnetization transfer abnormalities and connectome dysconnectivity in schizophrenia.
    Schizophr Res. 2017 Jun 7. pii: S0920-9964(17)30304.
    PubMed     Text format     Abstract available


  167. MOLINA V, Alvarez-Astorga A, Lubeiro A, Ortega D, et al
    Early neglect associated to prefrontal structural disconnectivity in schizophrenia.
    Schizophr Res. 2017 Jun 7. pii: S0920-9964(17)30333.
    PubMed     Text format    


  168. ORBAN P, Dansereau C, Desbois L, Mongeau-Perusse V, et al
    Multisite generalizability of schizophrenia diagnosis classification based on functional brain connectivity.
    Schizophr Res. 2017 Jun 7. pii: S0920-9964(17)30302.
    PubMed     Text format     Abstract available


  169. GAWEDA L, Prochwicz K, Krezolek M, Klosowska J, et al
    Self-reported cognitive distortions in the psychosis continuum: A Polish 18-item version of the Davos Assessment of Cognitive Biases Scale (DACOBS-18).
    Schizophr Res. 2017 Jun 7. pii: S0920-9964(17)30328.
    PubMed     Text format     Abstract available


  170. LYNN STARR H, Bermak J, Mao L, Rodriguez S, et al
    Comparison of long-acting and oral antipsychotic treatment effects in patients with schizophrenia, comorbid substance abuse, and a history of recent incarceration: An exploratory analysis of the PRIDE study.
    Schizophr Res. 2017 Jun 7. pii: S0920-9964(17)30264.
    PubMed     Text format     Abstract available


  171. LLERENA K, Reddy LF, Kern RS
    The role of experiential and expressive negative symptoms on job obtainment and work outcome in individuals with schizophrenia.
    Schizophr Res. 2017 Jun 6. pii: S0920-9964(17)30329.
    PubMed     Text format     Abstract available


  172. SEARLES S, Makarewicz JA, Dumas JA
    The role of estradiol in schizophrenia diagnosis and symptoms in postmenopausal women.
    Schizophr Res. 2017 Jun 3. pii: S0920-9964(17)30299.
    PubMed     Text format     Abstract available


  173. DEAN DJ, Samson AT, Newberry R, Mittal VA, et al
    Motion energy analysis reveals altered body movement in youth at risk for psychosis.
    Schizophr Res. 2017 Jun 3. pii: S0920-9964(17)30310.
    PubMed     Text format     Abstract available


  174. WANG S, Zhang Y, Lv L, Wu R, et al
    Abnormal regional homogeneity as a potential imaging biomarker for adolescent-onset schizophrenia: A resting-state fMRI study and support vector machine analysis.
    Schizophr Res. 2017 Jun 3. pii: S0920-9964(17)30315.
    PubMed     Text format     Abstract available


  175. BEASLEY CL, Honer WG, Ramos-Miguel A, Vila-Rodriguez F, et al
    Prefrontal fatty acid composition in schizophrenia and bipolar disorder: Association with reelin expression.
    Schizophr Res. 2017 Jun 2. pii: S0920-9964(17)30309.
    PubMed     Text format     Abstract available


  176. KAMP D, Engelke C, Wobrock T, Kunze B, et al
    Letter to the Editor: Influence of rTMS on smoking in patients with schizophrenia.
    Schizophr Res. 2017 Jun 1. pii: S0920-9964(17)30312.
    PubMed     Text format    


  177. TAKAHASHI H, Kamio Y
    Acoustic startle response and its modulation in schizophrenia and autism spectrum disorder in Asian subjects.
    Schizophr Res. 2017 Jun 1. pii: S0920-9964(17)30308.
    PubMed     Text format     Abstract available


  178. HORAT SK, Favre G, Prevot A, Ventura J, et al
    Impaired social cognition in schizophrenia during the Ultimatum Game: An EEG study.
    Schizophr Res. 2017 Jun 1. pii: S0920-9964(17)30311.
    PubMed     Text format     Abstract available


    May 2017
  179. HASTRUP LH, Haahr UH, Jansen JE, Simonsen E, et al
    Determinants of duration of untreated psychosis among first-episode psychosis patients in Denmark: A nationwide register-based study.
    Schizophr Res. 2017 May 31. pii: S0920-9964(17)30301.
    PubMed     Text format     Abstract available


  180. SCHALINSKI I, Teicher MH, Carolus AM, Rockstroh B, et al
    Defining the impact of childhood adversities on cognitive deficits in psychosis: An exploratory analysis.
    Schizophr Res. 2017 May 30. pii: S0920-9964(17)30273.
    PubMed     Text format     Abstract available


  181. NEUHAUS AH, Popescu FC
    Impact of sample size and matching on single-subject classification of schizophrenia: A meta-analysis.
    Schizophr Res. 2017 May 30. pii: S0920-9964(17)30300.
    PubMed     Text format    


  182. VYAS NS, Buchsbaum MS, Lehrer DS, Merrill BM, et al
    D2/D3 dopamine receptor binding with [F-18]fallypride correlates of executive function in medication-naive patients with schizophrenia.
    Schizophr Res. 2017 May 30. pii: S0920-9964(17)30276.
    PubMed     Text format     Abstract available


  183. SWERDLOW NR, Light GA, Thomas ML, Sprock J, et al
    Deficient prepulse inhibition in schizophrenia in a multi-site cohort: Internal replication and extension.
    Schizophr Res. 2017 May 23. pii: S0920-9964(17)30272.
    PubMed     Text format     Abstract available


  184. LOUISE S, Fitzpatrick M, Strauss C, Rossell SL, et al
    Mindfulness- and acceptance-based interventions for psychosis: Our current understanding and a meta-analysis.
    Schizophr Res. 2017 May 22. pii: S0920-9964(17)30298.
    PubMed     Text format     Abstract available


  185. BUONOCORE M, Spangaro M, Bechi M, Baraldi MA, et al
    Integrated cognitive remediation and standard rehabilitation therapy in patients of schizophrenia: persistence after 5years.
    Schizophr Res. 2017 May 22. pii: S0920-9964(17)30297.
    PubMed     Text format     Abstract available


  186. PERRIN MA, Kantrowitz JT, Silipo G, Dias E, et al
    Mismatch negativity (MMN) to spatial deviants and behavioral spatial discrimination ability in the etiology of auditory verbal hallucinations and thought disorder in schizophrenia.
    Schizophr Res. 2017 May 19. pii: S0920-9964(17)30271.
    PubMed     Text format     Abstract available


  187. FORCELLINI G, O'Donoghue S, Kenney J, McInerney S, et al
    Structural connectivity and rich-club organization in recent onset psychosis.
    Schizophr Res. 2017 May 17. pii: S0920-9964(17)30277.
    PubMed     Text format    


  188. GIANNITELLI M, Consoli A, Raffin M, Jardri R, et al
    An overview of medical risk factors for childhood psychosis: Implications for research and treatment.
    Schizophr Res. 2017 May 16. pii: S0920-9964(17)30270.
    PubMed     Text format     Abstract available


  189. FLIPPO KH, Strack S
    An emerging role for mitochondrial dynamics in schizophrenia.
    Schizophr Res. 2017 May 16. pii: S0920-9964(17)30261.
    PubMed     Text format     Abstract available


  190. SALISBURY DF, McCathern AG, Coffman BA, Murphy TK, et al
    Complex mismatch negativity to tone pair deviants in long-term schizophrenia and in the first-episode schizophrenia spectrum.
    Schizophr Res. 2017 May 12. pii: S0920-9964(17)30253.
    PubMed     Text format     Abstract available


  191. HARVEY PD, Rosenthal JB
    Cognitive and functional deficits in people with schizophrenia: Evidence for accelerated or exaggerated aging?
    Schizophr Res. 2017 May 12. pii: S0920-9964(17)30268.
    PubMed     Text format     Abstract available


  192. CROCKER CE, Tibbo PG
    The interaction of gender and cannabis in early phase psychosis.
    Schizophr Res. 2017 May 12. pii: S0920-9964(17)30255.
    PubMed     Text format     Abstract available


  193. RABIN RA, Kozak K, Zakzanis KK, Remington G, et al
    A method to achieve extended cannabis abstinence in cannabis dependent patients with schizophrenia and non-psychiatric controls.
    Schizophr Res. 2017 May 12. pii: S0920-9964(17)30265.
    PubMed     Text format     Abstract available


  194. JOO SW, Chon MW, Rathi Y, Shenton ME, et al
    Abnormal asymmetry of white matter tracts between ventral posterior cingulate cortex and middle temporal gyrus in recent-onset schizophrenia.
    Schizophr Res. 2017 May 12. pii: S0920-9964(17)30267.
    PubMed     Text format     Abstract available


  195. MARTINELLI C, Rigoli F, Averbeck B, Shergill SS, et al
    The value of novelty in schizophrenia.
    Schizophr Res. 2017 May 8. pii: S0920-9964(17)30266.
    PubMed     Text format     Abstract available


  196. ROSSI A, Amore M, Galderisi S, Rocca P, et al
    The complex relationship between self-reported 'personal recovery' and clinical recovery in schizophrenia.
    Schizophr Res. 2017 May 8. pii: S0920-9964(17)30247.
    PubMed     Text format     Abstract available


  197. LEE BS, McIntyre RS, Gentle JE, Park NS, et al
    A computational algorithm for personalized medicine in schizophrenia.
    Schizophr Res. 2017 May 8. pii: S0920-9964(17)30260.
    PubMed     Text format     Abstract available


  198. XIAO X, Yu H, Li J, Wang L, et al
    Further evidence for the association between LRP8 and schizophrenia.
    Schizophr Res. 2017 May 8. pii: S0920-9964(17)30262.
    PubMed     Text format     Abstract available


  199. CHIAPPELLI J, Chen S, Hackman A, Elliot Hong L, et al
    Evidence for differential opioid use disorder in schizophrenia in an addiction treatment population.
    Schizophr Res. 2017 May 6. pii: S0920-9964(17)30263.
    PubMed     Text format     Abstract available


  200. RATHEESH A, Cotton SM, Davey CG, Lin A, et al
    Pre-onset risk characteristics for mania among young people at clinical high risk for psychosis.
    Schizophr Res. 2017 May 4. pii: S0920-9964(17)30223.
    PubMed     Text format     Abstract available


  201. KASKIE RE, Ferrarelli F
    Investigating the neurobiology of schizophrenia and other major psychiatric disorders with Transcranial Magnetic Stimulation.
    Schizophr Res. 2017 May 3. pii: S0920-9964(17)30254.
    PubMed     Text format     Abstract available


  202. CAROL EE, Mittal VA
    Corrigendum to "self-reported cannabis use is inconsistent with the results from drug-screening in youth at ultra high-risk for psychosis in Colorado" [Schizophr. Res. 157 (0) (August 2014) 317-318].
    Schizophr Res. 2017 May 2. pii: S0920-9964(17)30248.
    PubMed     Text format    


  203. KUNUTSOR SK, Laukkanen T, Laukkanen JA
    Cardiorespiratory fitness is associated with reduced risk of future psychosis: A long-term prospective cohort study.
    Schizophr Res. 2017 May 2. pii: S0920-9964(17)30249.
    PubMed     Text format    


  204. LIU Y, Zhang Y, Lv L, Wu R, et al
    Abnormal neural activity as a potential biomarker for drug-naive first-episode adolescent-onset schizophrenia with coherence regional homogeneity and support vector machine analyses.
    Schizophr Res. 2017 May 2. pii: S0920-9964(17)30215.
    PubMed     Text format     Abstract available


  205. PANDEY GN, Rizavi HS, Zhang H, Ren X, et al
    Abnormal gene and protein expression of inflammatory cytokines in the postmortem brain of schizophrenia patients.
    Schizophr Res. 2017 May 2. pii: S0920-9964(17)30252.
    PubMed     Text format     Abstract available


    April 2017
  206. PEDROS ROSELLO A
    Clinical and cognitive insight in patients with psychosis. Is there a relationship?
    Schizophr Res. 2017 Apr 28. pii: S0920-9964(17)30209.
    PubMed     Text format    


  207. MANTERE O, Saarela M, Kieseppa T, Raij T, et al
    Anti-neuronal anti-bodies in patients with early psychosis.
    Schizophr Res. 2017 Apr 28. pii: S0920-9964(17)30214.
    PubMed     Text format     Abstract available


  208. RANDENIYA R, Oestreich LKL, Garrido MI
    Sensory prediction errors in the continuum of psychosis.
    Schizophr Res. 2017 Apr 27. pii: S0920-9964(17)30206.
    PubMed     Text format     Abstract available


  209. MISIAK B, Stanczykiewicz B, Laczmanski L, Frydecka D, et al
    Lipid profile disturbances in antipsychotic-naive patients with first-episode non-affective psychosis: Authors' reply.
    Schizophr Res. 2017 Apr 26. pii: S0920-9964(17)30219.
    PubMed     Text format    


  210. MCDONNELL J, Stahl D, Day F, McGuire P, et al
    Interpersonal sensitivity in those at clinical high risk for psychosis mediates the association between childhood bullying victimisation and paranoid ideation: A virtual reality study.
    Schizophr Res. 2017 Apr 26. pii: S0920-9964(17)30216.
    PubMed     Text format     Abstract available


  211. RAWAT VS, Ganesh S, Bijjal S, Shanivaram Reddy K, et al
    Prevalence and predictors of metabolic syndrome in patients with schizophrenia and healthy controls: A study in rural South Indian population.
    Schizophr Res. 2017 Apr 25. pii: S0920-9964(17)30246.
    PubMed     Text format     Abstract available


  212. GUPTA T, Hespos SJ, Horton WS, Mittal VA, et al
    Automated analysis of written narratives reveals abnormalities in referential cohesion in youth at ultra high risk for psychosis.
    Schizophr Res. 2017 Apr 25. pii: S0920-9964(17)30212.
    PubMed     Text format     Abstract available


  213. SCHWARZ E, Maukonen J, Hyytiainen T, Kieseppa T, et al
    Analysis of microbiota in first episode psychosis identifies preliminary associations with symptom severity and treatment response.
    Schizophr Res. 2017 Apr 22. pii: S0920-9964(17)30204.
    PubMed     Text format     Abstract available


  214. OHMURO N, Katsura M, Obara C, Kikuchi T, et al
    The relationship between cognitive insight and cognitive performance among individuals with at-risk mental state for developing psychosis.
    Schizophr Res. 2017 Apr 22. pii: S0920-9964(17)30217.
    PubMed     Text format     Abstract available


  215. GERAETS CNW, van Beilen M, Pot-Kolder R, Counotte J, et al
    Social environments and interpersonal distance regulation in psychosis: A virtual reality study.
    Schizophr Res. 2017 Apr 22. pii: S0920-9964(17)30221.
    PubMed     Text format     Abstract available


  216. LIU J, Chen J, Perrone-Bizzozero NI, Turner JA, et al
    Regional enrichment analyses on genetic profiles for schizophrenia and bipolar disorder.
    Schizophr Res. 2017 Apr 22. pii: S0920-9964(17)30220.
    PubMed     Text format     Abstract available


  217. TSAI MT, Chang TH, Wu BJ
    Prognostic impact of nutritional risk assessment in patients with chronic schizophrenia.
    Schizophr Res. 2017 Apr 22. pii: S0920-9964(17)30198.
    PubMed     Text format     Abstract available


  218. PAWELCZYK A, Kotlicka-Antczak M, Lojek E, Ruszpel A, et al
    Schizophrenia patients have higher-order language and extralinguistic impairments.
    Schizophr Res. 2017 Apr 21. pii: S0920-9964(17)30218.
    PubMed     Text format     Abstract available


  219. PREMKUMAR P, Bream D, Sapara A, Fannon D, et al
    Pituitary volume reduction in schizophrenia following cognitive behavioural therapy.
    Schizophr Res. 2017 Apr 20. pii: S0920-9964(17)30222.
    PubMed     Text format     Abstract available


  220. BRADSHAW NJ, Trossbach SV, Kober S, Walter S, et al
    Disrupted in Schizophrenia 1 regulates the processing of reelin in the perinatal cortex.
    Schizophr Res. 2017 Apr 19. pii: S0920-9964(17)30200.
    PubMed     Text format     Abstract available


  221. GEORGIADES A, Davis VG, Atkins AS, Khan A, et al
    Psychometric characteristics of the MATRICS Consensus Cognitive Battery in a large pooled cohort of stable schizophrenia patients.
    Schizophr Res. 2017 Apr 19. pii: S0920-9964(17)30180.
    PubMed     Text format     Abstract available


  222. ZURAWEK D, Salerno-Kochan A, Dziedzicka-Wasylewska M, Nikiforuk A, et al
    Changes in the expression of metabotropic glutamate receptor 5 (mGluR5) in a ketamine-based animal model of schizophrenia.
    Schizophr Res. 2017 Apr 19. pii: S0920-9964(17)30201.
    PubMed     Text format     Abstract available


  223. NABER D, Baker RA, Eramo A, Forray C, et al
    Long-term effectiveness of aripiprazole once-monthly for schizophrenia is maintained in the QUALIFY extension study.
    Schizophr Res. 2017 Apr 19. pii: S0920-9964(17)30199.
    PubMed     Text format     Abstract available


  224. LIBUY N, de Angel V, Ibanez C, Murray RM, et al
    The relative prevalence of schizophrenia among cannabis and cocaine users attending addiction services.
    Schizophr Res. 2017 Apr 18. pii: S0920-9964(17)30197.
    PubMed     Text format     Abstract available


  225. LI J, Yoshikawa A, Brennan MD, Ramsey TL, et al
    Genetic predictors of antipsychotic response to lurasidone identified in a genome wide association study and by schizophrenia risk genes.
    Schizophr Res. 2017 Apr 18. pii: S0920-9964(17)30196.
    PubMed     Text format     Abstract available


  226. VARGAS T, Mittal V
    Issues affecting reliable and valid assessment of early life stressors in psychosis.
    Schizophr Res. 2017 Apr 17. pii: S0920-9964(17)30208.
    PubMed     Text format    


  227. DURGAM S, Earley W, Li R, Li D, et al
    Corrigendum to "Long-term cariprazine treatment for the prevention of relapse in patients with schizophrenia: A randomized, double-blind, placebo-controlled trial" [Schizophr. Res. 176 (2016) 264-271].
    Schizophr Res. 2017 Apr 17. pii: S0920-9964(17)30207.
    PubMed     Text format    


  228. KHOKHAR JY, Dwiel LL, Henricks AM, Doucette WT, et al
    The link between schizophrenia and substance use disorder: A unifying hypothesis.
    Schizophr Res. 2017 Apr 14. pii: S0920-9964(17)30203.
    PubMed     Text format     Abstract available


  229. KIM M, Yoon YB, Lee TH, Lee TY, et al
    The effect of tDCS on auditory hallucination and P50 sensory gating in patients with schizophrenia: A pilot study.
    Schizophr Res. 2017 Apr 14. pii: S0920-9964(17)30210.
    PubMed     Text format    


  230. GRAHAM-SCHMIDT KT, Martin-Iverson MT, Waters FAV
    Self- and other-agency in people with passivity (first rank) symptoms in schizophrenia.
    Schizophr Res. 2017 Apr 13. pii: S0920-9964(17)30211.
    PubMed     Text format     Abstract available


  231. MISIAK B, Stanczykiewicz B, Kotowicz K, Rybakowski JK, et al
    Cytokines and C-reactive protein alterations with respect to cognitive impairment in schizophrenia and bipolar disorder: A systematic review.
    Schizophr Res. 2017 Apr 13. pii: S0920-9964(17)30202.
    PubMed     Text format     Abstract available


  232. MEZQUIDA G, Savulich G, Garcia-Rizo C, Garcia-Portilla MP, et al
    Inverse association between negative symptoms and body mass index in chronic schizophrenia.
    Schizophr Res. 2017 Apr 12. pii: S0920-9964(17)30189.
    PubMed     Text format     Abstract available


  233. HICKLING LM, Perez-Iglesias R, Ortiz-Garcia de la Foz V, Balanza-Martinez V, et al
    Tobacco smoking and its association with cognition in first episode psychosis patients.
    Schizophr Res. 2017 Apr 12. pii: S0920-9964(17)30205.
    PubMed     Text format     Abstract available


  234. KIM M, Lee TH, Kim JH, Hong H, et al
    Decomposing P300 into correlates of genetic risk and current symptoms in schizophrenia: An inter-trial variability analysis.
    Schizophr Res. 2017 Apr 8. pii: S0920-9964(17)30188.
    PubMed     Text format     Abstract available


  235. RICARTE JJ, Del Rey F, Ros L, Latorre JM, et al
    Abstract and experiential thinking differentially account for anomalous perception of reality in people with or without schizophrenia.
    Schizophr Res. 2017 Apr 7. pii: S0920-9964(17)30194.
    PubMed     Text format     Abstract available


  236. CASSETTA BD, Kim HS, Hodgins DC, McGrath DS, et al
    Disordered gambling and psychosis: Prevalence and clinical correlates.
    Schizophr Res. 2017 Apr 6. pii: S0920-9964(17)30193.
    PubMed     Text format    


  237. LI AW, Vinas-Guasch N, Hui CL, Chang WC, et al
    Verbal working memory in schizophrenia: The role of syntax in facilitating serial recall.
    Schizophr Res. 2017 Apr 6. pii: S0920-9964(17)30195.
    PubMed     Text format     Abstract available


  238. BOGGS DL, Surti TS, Esterlis I, Pittman B, et al
    Minimal effects of prolonged smoking abstinence or resumption on cognitive performance challenge the "self-medication" hypothesis in schizophrenia.
    Schizophr Res. 2017 Apr 6. pii: S0920-9964(17)30187.
    PubMed     Text format     Abstract available


  239. PERRY BI, Singh SP
    Letter to the Editor: Lipid profile disturbances in antipsychotic-naive patients with first-episode non-affective psychosis.
    Schizophr Res. 2017 Apr 5. pii: S0920-9964(17)30186.
    PubMed     Text format    


    March 2017
  240. ADDINGTON J, Piskulic D, Liu L, Lockwood J, et al
    Comorbid diagnoses for youth at clinical high risk of psychosis.
    Schizophr Res. 2017 Mar 31. pii: S0920-9964(17)30183.
    PubMed     Text format     Abstract available


  241. TSENG HH, Chen KC, Chen PS, Lee IH, et al
    Dopamine transporter availability in drug-naive patients with schizophrenia and later psychotic symptoms severity.
    Schizophr Res. 2017 Mar 29. pii: S0920-9964(17)30174.
    PubMed     Text format    


  242. WANG LJ, Lin PY, Lee Y, Huang YC, et al
    Increased serum levels of cysteine in patients with schizophrenia: A potential marker of cognitive function preservation.
    Schizophr Res. 2017 Mar 28. pii: S0920-9964(17)30181.
    PubMed     Text format     Abstract available


  243. TAN EJ, Rossell SL
    Formal thought disorder and neurocognition in schizophrenia: The question of individual mechanisms.
    Schizophr Res. 2017 Mar 28. pii: S0920-9964(17)30179.
    PubMed     Text format    


  244. MACHIELSEN MW, Veltman DJ, van den Brink W, de Haan L, et al
    Comparing the effect of clozapine and risperidone on cue reactivity in male patients with schizophrenia and a cannabis use disorder: A randomized fMRI study.
    Schizophr Res. 2017 Mar 25. pii: S0920-9964(17)30168.
    PubMed     Text format     Abstract available


  245. CORRELL CU, Skuban A, Hobart M, Ouyang J, et al
    Corrigendum to "Efficacy of brexpiprazole in patients with acute schizophrenia: Review of three randomized, double-blind, placebo-controlled studies" [Schizophr. Res. 174 (2016) 82-92].
    Schizophr Res. 2017 Mar 25. pii: S0920-9964(17)30120.
    PubMed     Text format    


  246. LENZI J, Iozzino L, De Girolamo G, Rucci P, et al
    Predictors of 9-month hospitalization in patients with first-episode affective and non-affective psychosis. Results from the GET UP pragmatic cluster randomized controlled trial.
    Schizophr Res. 2017 Mar 24. pii: S0920-9964(17)30178.
    PubMed     Text format    


  247. POTKIN SG, Risinger R, Du Y, Zummo J, et al
    Efficacy and safety of aripiprazole lauroxil in schizophrenic patients presenting with severe psychotic symptoms during an acute exacerbation.
    Schizophr Res. 2017 Mar 22. pii: S0920-9964(17)30124.
    PubMed     Text format     Abstract available


  248. CHEN CH, Cheng MC, Liu CM, Liu CC, et al
    Seroprevalence survey of selective anti-neuronal autoantibodies in patients with first-episode schizophrenia and chronic schizophrenia.
    Schizophr Res. 2017 Mar 21. pii: S0920-9964(17)30134.
    PubMed     Text format     Abstract available


  249. JAHSHAN C, Wynn JK, Mathalon DH, Green MF, et al
    Cognitive correlates of visual neural plasticity in schizophrenia.
    Schizophr Res. 2017 Mar 20. pii: S0920-9964(17)30133.
    PubMed     Text format     Abstract available


  250. CHOI SH, Kyeong S, Cho KI, Yun JY, et al
    Brain network characteristics separating individuals at clinical high risk for psychosis into normality or psychosis.
    Schizophr Res. 2017 Mar 18. pii: S0920-9964(17)30166.
    PubMed     Text format     Abstract available


  251. MISIAK B, Stanczykiewicz B, Laczmanski L, Frydecka D, et al
    Lipid profile disturbances in antipsychotic-naive patients with first-episode non-affective psychosis: A systematic review and meta-analysis.
    Schizophr Res. 2017 Mar 18. pii: S0920-9964(17)30169.
    PubMed     Text format     Abstract available


  252. STEGMAYER K, Strik W, Federspiel A, Wiest R, et al
    Specific cerebral perfusion patterns in three schizophrenia symptom dimensions.
    Schizophr Res. 2017 Mar 17. pii: S0920-9964(17)30131.
    PubMed     Text format     Abstract available


  253. KLINE E, Keshavan M
    Innovations in first episode psychosis interventions: The case for a "RAISE-Plus" approach.
    Schizophr Res. 2017 Mar 17. pii: S0920-9964(17)30173.
    PubMed     Text format     Abstract available


  254. KANTROWITZ JT, Epstein ML, Lee M, Lehrfeld N, et al
    Improvement in mismatch negativity generation during d-serine treatment in schizophrenia: Correlation with symptoms.
    Schizophr Res. 2017 Mar 17. pii: S0920-9964(17)30116.
    PubMed     Text format     Abstract available


  255. FLETCHER PJ, Li Z, Coen KM, Le AD, et al
    Acquisition of nicotine self-administration in amphetamine and phencyclidine models of schizophrenia: A role for stress?
    Schizophr Res. 2017 Mar 16. pii: S0920-9964(17)30117.
    PubMed     Text format     Abstract available


  256. LUNSFORD-AVERY JR, Dean DJ, Mittal VA
    Self-reported sleep disturbances associated with procedural learning impairment in adolescents at ultra-high risk for psychosis.
    Schizophr Res. 2017 Mar 16. pii: S0920-9964(17)30162.
    PubMed     Text format     Abstract available


  257. REAVIS EA, Lee J, Wynn JK, Narr KL, et al
    Linking optic radiation volume to visual perception in schizophrenia and bipolar disorder.
    Schizophr Res. 2017 Mar 16. pii: S0920-9964(17)30165.
    PubMed     Text format     Abstract available


  258. SCHOFIELD P, Thygesen M, Das-Munshi J, Becares L, et al
    Ethnic density, urbanicity and psychosis risk for migrant groups - A population cohort study.
    Schizophr Res. 2017 Mar 15. pii: S0920-9964(17)30170.
    PubMed     Text format     Abstract available


  259. ZHAI D, Lang Y, Feng Y, Liu Y, et al
    Early onset of cardiometabolic risk factor profiles in drug naive adolescents and young adults with first-episode schizophrenia.
    Schizophr Res. 2017 Mar 15. pii: S0920-9964(17)30126.
    PubMed     Text format     Abstract available


  260. LUDWIG KA, Pinkham AE, Harvey PD, Kelsven S, et al
    Social cognition psychometric evaluation (SCOPE) in people with early psychosis: A preliminary study.
    Schizophr Res. 2017 Mar 14. pii: S0920-9964(17)30121.
    PubMed     Text format     Abstract available


  261. FU S, Czajkowski N, Rund BR, Torgalsboen AK, et al
    The relationship between level of cognitive impairments and functional outcome trajectories in first-episode schizophrenia.
    Schizophr Res. 2017 Mar 14. pii: S0920-9964(17)30122.
    PubMed     Text format     Abstract available


  262. BORA E
    Relationship between insight and theory of mind in schizophrenia: A meta-analysis.
    Schizophr Res. 2017 Mar 14. pii: S0920-9964(17)30167.
    PubMed     Text format     Abstract available


  263. KOSHIYAMA D, Kirihara K, Tada M, Nagai T, et al
    Duration and frequency mismatch negativity shows no progressive reduction in early stages of psychosis.
    Schizophr Res. 2017 Mar 14. pii: S0920-9964(17)30132.
    PubMed     Text format     Abstract available


  264. ABORAYA A, Leucht S, Nasrallah HH, Samara M, et al
    A novel approach to measuring response and remission in schizophrenia in clinical trials.
    Schizophr Res. 2017 Mar 14. pii: S0920-9964(17)30139.
    PubMed     Text format     Abstract available


  265. KOZAK K, Dermody SS, Rabin RA, Zack M, et al
    Effects of varenicline on cognitive function in non-smokers with schizophrenia.
    Schizophr Res. 2017 Mar 10. pii: S0920-9964(17)30143.
    PubMed     Text format    


  266. AWAN NR, Jehangir SF, Irfan M, Naeem F, et al
    Explanatory model of illness of the patients with schizophrenia and the role of educational intervention.
    Schizophr Res. 2017 Mar 10. pii: S0920-9964(17)30125.
    PubMed     Text format     Abstract available


  267. EACK SM, Wojtalik JA, Keshavan MS, Minshew NJ, et al
    Social-cognitive brain function and connectivity during visual perspective-taking in autism and schizophrenia.
    Schizophr Res. 2017 Mar 10. pii: S0920-9964(17)30130.
    PubMed     Text format     Abstract available


  268. BARBATO M, Buchy L, Bray S, MacMaster F, et al
    Testing the feasibility of a computerized facial affect recognition training in early psychosis.
    Schizophr Res. 2017 Mar 9. pii: S0920-9964(17)30137.
    PubMed     Text format    


  269. KHOKHAR JY, Todd TP
    Behavioral predictors of alcohol drinking in a neurodevelopmental rat model of schizophrenia and co-occurring alcohol use disorder.
    Schizophr Res. 2017 Mar 9. pii: S0920-9964(17)30118.
    PubMed     Text format     Abstract available


  270. OKRUSZEK L, Pilecka I
    Biological motion processing in schizophrenia - Systematic review and meta-analysis.
    Schizophr Res. 2017 Mar 9. pii: S0920-9964(17)30135.
    PubMed     Text format     Abstract available


  271. VALAPARLA VL, Nehra R, Mehta UM, Thirthalli J, et al
    Social cognition of patients with schizophrenia across the phases of illness - A longitudinal study.
    Schizophr Res. 2017 Mar 8. pii: S0920-9964(17)30123.
    PubMed     Text format     Abstract available


  272. TAKASE M, Kanahara N, Oda Y, Niitsu T, et al
    The impacts of dopamine D2 receptor polymorphism and antipsychotic dosage on dopamine supersensitivity psychosis in schizophrenia.
    Schizophr Res. 2017 Mar 8. pii: S0920-9964(17)30136.
    PubMed     Text format    


  273. HARTZ SM, Horton AC, Hancock DB, Baker TB, et al
    Genetic correlation between smoking behaviors and schizophrenia.
    Schizophr Res. 2017 Mar 8. pii: S0920-9964(17)30111.
    PubMed     Text format     Abstract available


  274. GALLETLY C, Dhillon VS, Liu D, Balzan RP, et al
    Shorter telomere length in people with schizophrenia: A preliminary study from Australia.
    Schizophr Res. 2017 Mar 8. pii: S0920-9964(17)30128.
    PubMed     Text format     Abstract available


  275. RABIN RA, Kozak K, Zakzanis KK, Remington G, et al
    Effects of extended cannabis abstinence on clinical symptoms in cannabis dependent schizophrenia patients versus non-psychiatric controls.
    Schizophr Res. 2017 Mar 8. pii: S0920-9964(17)30129.
    PubMed     Text format     Abstract available


  276. LAXHMAN N, Greenberg L, Priebe S
    Satisfaction with sex life among patients with schizophrenia.
    Schizophr Res. 2017 Mar 5. pii: S0920-9964(17)30127.
    PubMed     Text format     Abstract available


  277. MWANSISYA TE, Hu A, Li Y, Chen X, et al
    Task and resting-state fMRI studies in first-episode schizophrenia: A systematic review.
    Schizophr Res. 2017 Mar 3. pii: S0920-9964(17)30115.
    PubMed     Text format     Abstract available


  278. FRAGUAS D, Diaz-Caneja CM, Corripio I, Gonzalez-Pinto A, et al
    Gene-environment interaction as a predictor of early adjustment in first episode psychosis.
    Schizophr Res. 2017 Mar 2. pii: S0920-9964(17)30110.
    PubMed     Text format     Abstract available


  279. DELISI LE
    Predicting Psychosis with Accuracy.
    Schizophr Res. 2017;181:4-5.
    PubMed     Text format    


    February 2017
  280. BROWN AS, Meyer U
    Comment on: "The serological evidence for maternal influenza as risk factor for psychosis in offspring is insufficient: Critical review and meta-analysis".
    Schizophr Res. 2017 Feb 27. pii: S0920-9964(17)30112.
    PubMed     Text format    


  281. YUKSEL P, Kocazeybek B, Ozdemir A, Yolken RH, et al
    Stability of Toxoplasma gondii: Antibody levels in schizophrenia.
    Schizophr Res. 2017 Feb 27. pii: S0920-9964(17)30080.
    PubMed     Text format    


  282. BUKENAITE A, Stochl J, Mossaheb N, Schafer MR, et al
    Usefulness of the CAPE-P15 for detecting people at ultra-high risk for psychosis: Psychometric properties and cut-off values.
    Schizophr Res. 2017 Feb 26. pii: S0920-9964(17)30103.
    PubMed     Text format     Abstract available


  283. CHUNG Y, Haut KM, He G, van Erp TG, et al
    Ventricular enlargement and progressive reduction of cortical gray matter are linked in prodromal youth who develop psychosis.
    Schizophr Res. 2017 Feb 25. pii: S0920-9964(17)30100.
    PubMed     Text format     Abstract available


  284. JOHN J, Kukshal P, Bhatia T, Chowdari KV, et al
    Possible role of rare variants in Trace amine associated receptor 1 in schizophrenia.
    Schizophr Res. 2017 Feb 24. pii: S0920-9964(17)30109.
    PubMed     Text format     Abstract available


  285. VAN ROOIJEN G, Isvoranu AM, Meijer CJ, van Borkulo CD, et al
    A symptom network structure of the psychosis spectrum.
    Schizophr Res. 2017 Feb 22. pii: S0920-9964(17)30104.
    PubMed     Text format     Abstract available


  286. POUSA E, Ochoa S, Cobo J, Nieto L, et al
    A deeper view of insight in schizophrenia: Insight dimensions, unawareness and misattribution of particular symptoms and its relation with psychopathological factors.
    Schizophr Res. 2017 Feb 22. pii: S0920-9964(17)30101.
    PubMed     Text format     Abstract available


  287. HAN S, Zong X, Hu M, Yu Y, et al
    Frequency-selective alteration in the resting-state corticostriatal-thalamo-cortical circuit correlates with symptoms severity in first-episode drug-naive patients with schizophrenia.
    Schizophr Res. 2017 Feb 21. pii: S0920-9964(17)30108.
    PubMed     Text format     Abstract available


  288. CRESPO-FACORRO B, Ortiz-Garcia de la Foz V, Suarez-Pinilla P, Valdizan EM, et al
    Effects of aripiprazole, quetiapine and ziprasidone on plasma prolactin levels in individuals with first episode nonaffective psychosis: Analysis of a randomized open-label 1year study.
    Schizophr Res. 2017 Feb 17. pii: S0920-9964(17)30059.
    PubMed     Text format     Abstract available


  289. CANTILLON M, Prakash A, Alexander A, Ings R, et al
    Dopamine serotonin stabilizer RP5063: A randomized, double-blind, placebo-controlled multicenter trial of safety and efficacy in exacerbation of schizophrenia or schizoaffective disorder.
    Schizophr Res. 2017 Feb 16. pii: S0920-9964(17)30056.
    PubMed     Text format     Abstract available


  290. LEWINE R, Martin M, Hart M
    Sex versus gender differences in schizophrenia: The case for normal personality differences.
    Schizophr Res. 2017 Feb 16. pii: S0920-9964(17)30102.
    PubMed     Text format     Abstract available


  291. QUIDE Y, Ong XH, Mohnke S, Schnell K, et al
    Childhood trauma-related alterations in brain function during a Theory-of-Mind task in schizophrenia.
    Schizophr Res. 2017 Feb 15. pii: S0920-9964(17)30083.
    PubMed     Text format     Abstract available


  292. ITTIG S, Studerus E, Heitz U, Menghini-Muller S, et al
    Sex differences in prolactin levels in emerging psychosis: Indication for enhanced stress reactivity in women.
    Schizophr Res. 2017 Feb 14. pii: S0920-9964(17)30081.
    PubMed     Text format     Abstract available


  293. RODRIGUES R, Anderson KK
    The traumatic experience of first-episode psychosis: A systematic review and meta-analysis.
    Schizophr Res. 2017 Feb 14. pii: S0920-9964(17)30058.
    PubMed     Text format     Abstract available


  294. WEINSTEIN Y, Gelkopf M, Roe D, Levine SZ, et al
    The effect of different terror exposures on the course of schizophrenia: A twenty-year follow-up of a random sample.
    Schizophr Res. 2017 Feb 14. pii: S0920-9964(17)30075.
    PubMed     Text format    


  295. LOPEZ-GIMENEZ JF, de la Fuente Revenga M, Ruso-Julve F, Saunders JM, et al
    Validation of schizophrenia gene expression profile in a preclinical model of maternal infection during pregnancy.
    Schizophr Res. 2017 Feb 12. pii: S0920-9964(17)30076.
    PubMed     Text format    


  296. OESTREICH LK, Lyall AE, Pasternak O, Kikinis Z, et al
    Characterizing white matter changes in chronic schizophrenia: A free-water imaging multi-site study.
    Schizophr Res. 2017 Feb 10. pii: S0920-9964(17)30077.
    PubMed     Text format     Abstract available


  297. GEISER E, Retsa C, Knebel JF, Ferrari C, et al
    The coupling of low-level auditory dysfunction and oxidative stress in psychosis patients.
    Schizophr Res. 2017 Feb 9. pii: S0920-9964(17)30073.
    PubMed     Text format     Abstract available


  298. ROBERTS RC
    Postmortem studies on mitochondria in schizophrenia.
    Schizophr Res. 2017 Feb 9. pii: S0920-9964(17)30070.
    PubMed     Text format     Abstract available


  299. BRIEND F, Leroux E, Delcroix N, Razafimandimby A, et al
    Impact of rTMS on functional connectivity within the language network in schizophrenia patients with auditory hallucinations.
    Schizophr Res. 2017 Feb 8. pii: S0920-9964(17)30067.
    PubMed     Text format     Abstract available


  300. MEZQUIDA G, Cabrera B, Bioque M, Amoretti S, et al
    The course of negative symptoms in first-episode schizophrenia and its predictors: A prospective two-year follow-up study.
    Schizophr Res. 2017 Feb 6. pii: S0920-9964(17)30060.
    PubMed     Text format     Abstract available


  301. LY D, DeLisi LE
    Can antibiotics cause a psychosis?: Case report and review of the literature.
    Schizophr Res. 2017 Feb 6. pii: S0920-9964(17)30054.
    PubMed     Text format     Abstract available


  302. MUELLER DR, Khalesi Z, Benzing V, Castiglione CI, et al
    Does Integrated Neurocognitive Therapy (INT) reduce severe negative symptoms in schizophrenia outpatients?
    Schizophr Res. 2017 Feb 6. pii: S0920-9964(17)30050.
    PubMed     Text format     Abstract available


  303. GLAUSIER JR, Lewis DA
    GABA and schizophrenia: Where we stand and where we need to go.
    Schizophr Res. 2017 Feb 5. pii: S0920-9964(17)30066.
    PubMed     Text format    


  304. BERNARDO M, Bioque M, Cabrera B, Lobo A, et al
    Modelling gene-environment interaction in first episodes of psychosis.
    Schizophr Res. 2017 Feb 5. pii: S0920-9964(17)30068.
    PubMed     Text format     Abstract available


  305. SHARMA A, Vogel M, Weisbrod M, Roesch-Ely D, et al
    Pronounced inhibition-related hypofrontal dysfunction in early-onset schizophrenia as indexed by NoGo-P300 amplitude.
    Schizophr Res. 2017 Feb 4. pii: S0920-9964(17)30074.
    PubMed     Text format    


  306. LUNSFORD-AVERY JR, Goncalves BD, Brietzke E, Bressan RA, et al
    Adolescents at clinical-high risk for psychosis: Circadian rhythm disturbances predict worsened prognosis at 1-year follow-up.
    Schizophr Res. 2017 Feb 4. pii: S0920-9964(17)30065.
    PubMed     Text format     Abstract available


  307. ALUSTIZA I, Radua J, Pla M, Martin R, et al
    Meta-analysis of functional magnetic resonance imaging studies of timing and cognitive control in schizophrenia and bipolar disorder: Evidence of a primary time deficit.
    Schizophr Res. 2017 Feb 3. pii: S0920-9964(17)30052.
    PubMed     Text format     Abstract available


  308. BUCHY L, Barbato M, Makowski C, Bray S, et al
    Mapping structural covariance networks of facial emotion recognition in early psychosis: A pilot study.
    Schizophr Res. 2017 Feb 3. pii: S0920-9964(17)30062.
    PubMed     Text format     Abstract available


    January 2017
  309. BARR MS, Rajji TK, Zomorrodi R, Radhu N, et al
    Impaired theta-gamma coupling during working memory performance in schizophrenia.
    Schizophr Res. 2017 Jan 29. pii: S0920-9964(17)30057.
    PubMed     Text format     Abstract available


  310. GREENLAND-WHITE SE, Ragland JD, Niendam TA, Ferrer E, et al
    Episodic memory functions in first episode psychosis and clinical high risk individuals.
    Schizophr Res. 2017 Jan 28. pii: S0920-9964(17)30048.
    PubMed     Text format     Abstract available


  311. ALONSO-SOLIS A, Vives-Gilabert Y, Portella MJ, Rabella M, et al
    Altered amplitude of low frequency fluctuations in schizophrenia patients with persistent auditory verbal hallucinations.
    Schizophr Res. 2017 Jan 28. pii: S0920-9964(17)30055.
    PubMed     Text format     Abstract available


  312. HENGARTNER MP, Heekeren K, Dvorsky D, Walitza S, et al
    Course of psychotic symptoms, depression and global functioning in persons at clinical high risk of psychosis: Results of a longitudinal observation study over three years focusing on both converters and non-converters.
    Schizophr Res. 2017 Jan 27. pii: S0920-9964(17)30053.
    PubMed     Text format     Abstract available


  313. JOSEPH J, Kremen WS, Franz CE, Glatt SJ, et al
    Predictors of current functioning and functional decline in schizophrenia.
    Schizophr Res. 2017 Jan 27. pii: S0920-9964(17)30051.
    PubMed     Text format     Abstract available


  314. ZENG L, Kang C, Yuan J, Zhang Y, et al
    CYP2D6 polymorphisms are associated with effects of risperidone on neurocognitive performance in schizophrenia.
    Schizophr Res. 2017 Jan 26. pii: S0920-9964(17)30043.
    PubMed     Text format    


  315. FILATOVA S, Koivumaa-Honkanen H, Hirvonen N, Freeman A, et al
    Early motor developmental milestones and schizophrenia: A systematic review and meta-analysis.
    Schizophr Res. 2017 Jan 25. pii: S0920-9964(17)30042.
    PubMed     Text format     Abstract available


  316. HARBER L, Takeuchi H, Borlido C, Hamidian R, et al
    Factors associated with drug attitude in patients with schizophrenia spectrum disorders.
    Schizophr Res. 2017 Jan 25. pii: S0920-9964(17)30046.
    PubMed     Text format    


  317. CHANG X, Collin G, Xi Y, Cui L, et al
    Resting-state functional connectivity in medication-naive schizophrenia patients with and without auditory verbal hallucinations: A preliminary report.
    Schizophr Res. 2017 Jan 24. pii: S0920-9964(17)30037.
    PubMed     Text format     Abstract available


  318. KESHAVAN MS, Sudarshan M
    Deep dreaming, aberrant salience and psychosis: Connecting the dots by artificial neural networks.
    Schizophr Res. 2017 Jan 24. pii: S0920-9964(17)30029.
    PubMed     Text format     Abstract available


  319. EMSLEY R, Chiliza B, Asmal L, Kilian S, et al
    Neurological soft signs in first-episode schizophrenia: State- and trait-related relationships to psychopathology, cognition and antipsychotic medication effects.
    Schizophr Res. 2017 Jan 24. pii: S0920-9964(17)30047.
    PubMed     Text format     Abstract available


  320. SMESNY S, Milleit B, Schaefer MR, Hesse J, et al
    Effects of omega-3 PUFA on immune markers in adolescent individuals at ultra-high risk for psychosis - Results of the randomized controlled Vienna omega-3 study.
    Schizophr Res. 2017 Jan 23. pii: S0920-9964(17)30039.
    PubMed     Text format     Abstract available


  321. VINCENT PD, Demers MF, Doyon-Kemp V, Duchesneau J, et al
    One year mirror-image study using paliperidone palmitate for relapse prevention of schizophrenia in four university hospitals in Canada.
    Schizophr Res. 2017 Jan 21. pii: S0920-9964(17)30026.
    PubMed     Text format     Abstract available


  322. FIKSINSKI AM, Breetvelt EJ, Duijff SN, Bassett AS, et al
    Autism Spectrum and psychosis risk in the 22q11.2 deletion syndrome. Findings from a prospective longitudinal study.
    Schizophr Res. 2017 Jan 21. pii: S0920-9964(17)30044.
    PubMed     Text format     Abstract available


  323. KIM SW, Polari A, Melville F, Moller B, et al
    Are current labeling terms suitable for people who are at risk of psychosis?
    Schizophr Res. 2017 Jan 20. pii: S0920-9964(17)30040.
    PubMed     Text format     Abstract available


  324. PARK CH, Lee S, Kim T, Won WY, et al
    Different alterations in brain functional networks according to direct and indirect topological connections in patients with schizophrenia.
    Schizophr Res. 2017 Jan 18. pii: S0920-9964(17)30038.
    PubMed     Text format     Abstract available


  325. ANDRIANARISOA M, Boyer L, Godin O, Brunel L, et al
    Childhood trauma, depression and negative symptoms are independently associated with impaired quality of life in schizophrenia. Results from the national FACE-SZ cohort.
    Schizophr Res. 2017 Jan 18. pii: S0920-9964(16)30596.
    PubMed     Text format     Abstract available


  326. LIN CH, Wang FC, Lin SC, Huang YH, et al
    A randomized, double-blind, comparison of the efficacy and safety of low-dose olanzapine plus low-dose trifluoperazine versus full-dose olanzapine in the acute treatment of schizophrenia.
    Schizophr Res. 2017 Jan 18. pii: S0920-9964(17)30004.
    PubMed     Text format     Abstract available


  327. D'ADDARIO C, Micale V, Di Bartolomeo M, Stark T, et al
    A preliminary study of endocannabinoid system regulation in psychosis: Distinct alterations of CNR1 promoter DNA methylation in patients with schizophrenia.
    Schizophr Res. 2017 Jan 17. pii: S0920-9964(17)30031.
    PubMed     Text format     Abstract available


  328. KU HL, Wang JK, Lee HC, Lane TJ, et al
    Cerebral blood flow autoregulation is impaired in schizophrenia: A pilot study.
    Schizophr Res. 2017 Jan 17. pii: S0920-9964(17)30024.
    PubMed     Text format     Abstract available


  329. BAI Z, Wang G, Cai S, Ding X, et al
    Efficacy, acceptability and tolerability of 8 atypical antipsychotics in Chinese patients with acute schizophrenia: A network meta-analysis.
    Schizophr Res. 2017 Jan 17. pii: S0920-9964(17)30001.
    PubMed     Text format     Abstract available


  330. WU CHOU AI, Wang YC, Lin CL, Kao CH, et al
    Female schizophrenia patients and risk of breast cancer: A population-based cohort study.
    Schizophr Res. 2017 Jan 17. pii: S0920-9964(17)30028.
    PubMed     Text format     Abstract available


  331. PINTO JV, Passos IC, Gomes F, Reckziegel R, et al
    Peripheral biomarker signatures of bipolar disorder and schizophrenia: A machine learning approach.
    Schizophr Res. 2017 Jan 16. pii: S0920-9964(17)30023.
    PubMed     Text format    


  332. ALI FT, Abd El-Azeem EM, Hamed MA, Ali MA, et al
    Redox dysregulation, immuno-inflammatory alterations and genetic variants of BDNF and MMP-9 in schizophrenia: Pathophysiological and phenotypic implications.
    Schizophr Res. 2017 Jan 15. pii: S0920-9964(17)30027.
    PubMed     Text format     Abstract available


  333. BORDON N, O'Rourke S, Hutton P
    The feasibility and clinical benefits of improving facial affect recognition impairments in schizophrenia: Systematic review and meta-analysis.
    Schizophr Res. 2017 Jan 14. pii: S0920-9964(17)30025.
    PubMed     Text format     Abstract available


  334. GROT S, Legare VP, Lipp O, Soulieres I, et al
    Abnormal prefrontal and parietal activity linked to deficient active binding in working memory in schizophrenia.
    Schizophr Res. 2017 Jan 14. pii: S0920-9964(17)30030.
    PubMed     Text format     Abstract available


  335. LINDENMAYER JP, Fregenti S, Kang G, Ozog V, et al
    The relationship of cognitive improvement after cognitive remediation with social functioning in patients with schizophrenia and severe cognitive deficits.
    Schizophr Res. 2017 Jan 13. pii: S0920-9964(17)30008.
    PubMed     Text format     Abstract available


  336. NARLA ST, Lee YW, Benson CA, Sarder P, et al
    Common developmental genome deprogramming in schizophrenia - Role of Integrative Nuclear FGFR1 Signaling (INFS).
    Schizophr Res. 2017 Jan 13. pii: S0920-9964(16)30568.
    PubMed     Text format     Abstract available


  337. JARSKOG LF, Pedersen CA, Johnson JL, Hamer RM, et al
    A 12-week randomized controlled trial of twice-daily intranasal oxytocin for social cognitive deficits in people with schizophrenia.
    Schizophr Res. 2017 Jan 13. pii: S0920-9964(17)30007.
    PubMed     Text format     Abstract available


  338. MARTINEZ G, Alexandre C, Mam-Lam-Fook C, Bendjemaa N, et al
    Phenotypic continuum between autism and schizophrenia: Evidence from the Movie for the Assessment of Social Cognition (MASC).
    Schizophr Res. 2017 Jan 11. pii: S0920-9964(17)30013.
    PubMed     Text format     Abstract available


  339. KUMAR V, Venkatasubramanian G
    Extended (alternate day) antipsychotic dosing and dopamine supersensitivity psychosis: A case report.
    Schizophr Res. 2017 Jan 11. pii: S0920-9964(17)30009.
    PubMed     Text format    


  340. BLANCHARD JJ, Bradshaw KR, Garcia CP, Nasrallah HA, et al
    Examining the reliability and validity of the Clinical Assessment Interview for Negative Symptoms within the Management of Schizophrenia in Clinical Practice (MOSAIC) multisite national study.
    Schizophr Res. 2017 Jan 11. pii: S0920-9964(17)30011.
    PubMed     Text format     Abstract available


  341. DONG D, Wang Y, Chang X, Jiang Y, et al
    Shared abnormality of white matter integrity in schizophrenia and bipolar disorder: A comparative voxel-based meta-analysis.
    Schizophr Res. 2017 Jan 9. pii: S0920-9964(17)30005.
    PubMed     Text format     Abstract available


  342. SHOVESTUL BJ, Glassman M, Rowland LM, McMahon RP, et al
    Pilot study examining the relationship of childhood trauma, perceived stress, and medication use to serum kynurenic acid and kynurenine levels in schizophrenia.
    Schizophr Res. 2017 Jan 9. pii: S0920-9964(16)30601.
    PubMed     Text format    


  343. HAHN B, Harvey AN, Gold JM, Ross TJ, et al
    Load-dependent hyperdeactivation of the default mode network in people with schizophrenia.
    Schizophr Res. 2017 Jan 7. pii: S0920-9964(17)30002.
    PubMed     Text format     Abstract available


  344. BALAN S, Yamada K, Iwayama Y, Hashimoto T, et al
    Comprehensive association analysis of 27 genes from the GABAergic system in Japanese individuals affected with schizophrenia.
    Schizophr Res. 2017 Jan 7. pii: S0920-9964(17)30003.
    PubMed     Text format     Abstract available


  345. BENOIT A, Bowie CR, Lepage M
    Is cognitive insight relevant to functional capacity in schizophrenia?
    Schizophr Res. 2017 Jan 6. pii: S0920-9964(16)30569.
    PubMed     Text format    


  346. CONUS P, Cotton SM, Francey SM, O'Donoghue B, et al
    Predictors of favourable outcome in young people with a first episode psychosis without antipsychotic medication.
    Schizophr Res. 2017 Jan 5. pii: S0920-9964(16)30605.
    PubMed     Text format     Abstract available


  347. AGNEW-BLAIS J, Seidman LJ, Fitzmaurice GM, Smoller JW, et al
    The interplay of childhood behavior problems and IQ in the development of later schizophrenia and affective psychoses.
    Schizophr Res. 2017 Jan 3. pii: S0920-9964(16)30570.
    PubMed     Text format     Abstract available


  348. MELLOR-MARSA B, Caballero FF, Cabello M, Ayuso-Mateos JL, et al
    Disability multilevel modelling in first episodes of psychosis at 3-year follow-up.
    Schizophr Res. 2017 Jan 3. pii: S0920-9964(16)30588.
    PubMed     Text format     Abstract available


    December 2016
  349. LYSTAD JU, Falkum E, Haaland VO, Bull H, et al
    Cognitive remediation and occupational outcome in schizophrenia spectrum disorders: A 2year follow-up study.
    Schizophr Res. 2016 Dec 29. pii: S0920-9964(16)30594.
    PubMed     Text format     Abstract available


  350. TASIC L, Pontes JG, Carvalho MS, Cruz G, et al
    Metabolomics and lipidomics analyses by 1H nuclear magnetic resonance of schizophrenia patient serum reveal potential peripheral biomarkers for diagnosis.
    Schizophr Res. 2016 Dec 28. pii: S0920-9964(16)30599.
    PubMed     Text format     Abstract available


  351. MORANDI S, Golay P, Lambert M, Schimmelmann BG, et al
    Community Treatment Order: Identifying the need for more evidence based justification of its use in first episode psychosis patients.
    Schizophr Res. 2016 Dec 27. pii: S0920-9964(16)30597.
    PubMed     Text format     Abstract available


  352. KESHAVAN MS, DeLisi LE, Nasrallah HA
    Translational and spectrum aspects of Schizophrenia Research: The rationale for new journal's new subheading.
    Schizophr Res. 2016 Dec 27. pii: S0920-9964(16)30547.
    PubMed     Text format    


  353. YALINCETIN B, Bora E, Binbay T, Ulas H, et al
    Formal thought disorder in schizophrenia and bipolar disorder: A systematic review and meta-analysis.
    Schizophr Res. 2016 Dec 22. pii: S0920-9964(16)30589.
    PubMed     Text format     Abstract available


  354. ABE D, Arai M, Itokawa M
    Music-evoked emotions in schizophrenia.
    Schizophr Res. 2016 Dec 22. pii: S0920-9964(16)30587.
    PubMed     Text format     Abstract available


  355. BOPP MH, Zollner R, Jansen A, Dietsche B, et al
    White matter integrity and symptom dimensions of schizophrenia: A diffusion tensor imaging study.
    Schizophr Res. 2016 Dec 21. pii: S0920-9964(16)30556.
    PubMed     Text format     Abstract available


  356. GANELLA EP, Bartholomeusz CF, Seguin C, Whittle S, et al
    Functional brain networks in treatment-resistant schizophrenia.
    Schizophr Res. 2016 Dec 20. pii: S0920-9964(16)30566.
    PubMed     Text format     Abstract available


  357. KRAKOWSKI MI, Czobor P
    Proneness to aggression and its inhibition in schizophrenia: Interconnections between personality traits, cognitive function and emotional processing.
    Schizophr Res. 2016 Dec 19. pii: S0920-9964(16)30548.
    PubMed     Text format     Abstract available


  358. MILLMAN ZB, Weintraub MJ, Bentley E, DeVylder JE, et al
    Differential relations of locus of control to perceived social stress among help-seeking adolescents at low vs. high clinical risk of psychosis.
    Schizophr Res. 2016 Dec 17. pii: S0920-9964(16)30563.
    PubMed     Text format     Abstract available


  359. NEILSON E, Bois C, Gibson J, Duff B, et al
    Effects of environmental risks and polygenic loading for schizophrenia on cortical thickness.
    Schizophr Res. 2016 Dec 15. pii: S0920-9964(16)30567.
    PubMed     Text format     Abstract available


  360. BREITBORDE NJ, Maple AM, Bell EK, Dawson SC, et al
    Activity-regulated cytoskeleton-associated protein predicts response to cognitive remediation among individuals with first-episode psychosis.
    Schizophr Res. 2016 Dec 15. pii: S0920-9964(16)30564.
    PubMed     Text format    


  361. RAMANATHAN S, Mattiaccio LM, Coman IL, Botti JC, et al
    Longitudinal trajectories of cortical thickness as a biomarker for psychosis in individuals with 22q11.2 deletion syndrome.
    Schizophr Res. 2016 Dec 14. pii: S0920-9964(16)30551.
    PubMed     Text format     Abstract available


  362. CANCEL A, Comte M, Boutet C, Schneider FC, et al
    Childhood trauma and emotional processing circuits in schizophrenia: A functional connectivity study.
    Schizophr Res. 2016 Dec 13. pii: S0920-9964(16)30561.
    PubMed     Text format     Abstract available


  363. DESERNO L, Heinz A, Schlagenhauf F
    Computational approaches to schizophrenia: A perspective on negative symptoms.
    Schizophr Res. 2016 Dec 13. pii: S0920-9964(16)30448.
    PubMed     Text format     Abstract available


  364. BRATTON H, O'Rourke S, Tansey L, Hutton P, et al
    Social cognition and paranoia in forensic inpatients with schizophrenia: A cross-sectional study.
    Schizophr Res. 2016 Dec 12. pii: S0920-9964(16)30562.
    PubMed     Text format     Abstract available


  365. EVINS AE, Hoeppner SS, Schoenfeld DA, Hoeppner BB, et al
    Maintenance pharmacotherapy normalizes the relapse curve in recently abstinent tobacco smokers with schizophrenia and bipolar disorder.
    Schizophr Res. 2016 Dec 9. pii: S0920-9964(16)30511.
    PubMed     Text format     Abstract available


  366. RAHMANZADEH R, Eftekhari S, Khodaei Ardakani MR, Rahmanzade R, et al
    Effect of bumetanide, a selective NKCC1 inhibitor, on hallucinations of schizophrenic patients; a double-blind randomized clinical trial.
    Schizophr Res. 2016 Dec 9. pii: S0920-9964(16)30560.
    PubMed     Text format    


  367. MCCARTHY NS, Melton PE, Ward SV, Allan SM, et al
    Exome array analysis suggests an increased variant burden in families with schizophrenia.
    Schizophr Res. 2016 Dec 8. pii: S0920-9964(16)30565.
    PubMed     Text format     Abstract available


  368. SHIOZAWA P, Fasanella NA, Marinho C, Taiar I, et al
    Trigeminal nerve stimulation (TNS) for treating negative symptoms in schizophrenia: A case study.
    Schizophr Res. 2016 Dec 7. pii: S0920-9964(16)30528.
    PubMed     Text format    


  369. CURRIE A, Nelson B
    Can repetitive transcranial magnetic stimulation improve neurocognition in schizophrenia when combined with cognitive remediation?
    Schizophr Res. 2016 Dec 7. pii: S0920-9964(16)30509.
    PubMed     Text format    


  370. LAURSEN TM, Trabjerg BB, Mors O, Borglum AD, et al
    Association of the polygenic risk score for schizophrenia with mortality and suicidal behavior - A Danish population-based study.
    Schizophr Res. 2016 Dec 6. pii: S0920-9964(16)30559.
    PubMed     Text format     Abstract available


  371. ANTICEVIC A
    Understanding the role of thalamic circuits in schizophrenia neuropathology.
    Schizophr Res. 2016 Dec 6. pii: S0920-9964(16)30555.
    PubMed     Text format    


  372. HAHN LA, Mackinnon A, Foley DL, Morgan VA, et al
    The role of arterial elasticity and cardiovascular peripheral resistance as clinically relevant indices of health status in people with psychosis.
    Schizophr Res. 2016 Dec 6. pii: S0920-9964(16)30557.
    PubMed     Text format     Abstract available


  373. MECHELLI A, Lin A, Wood S, McGorry P, et al
    Using clinical information to make individualized prognostic predictions in people at ultra high risk for psychosis.
    Schizophr Res. 2016 Dec 3. pii: S0920-9964(16)30558.
    PubMed     Text format     Abstract available


  374. RAGAN C, Patel K, Edson J, Zhang ZH, et al
    Small non-coding RNA expression from anterior cingulate cortex in schizophrenia shows sex specific regulation.
    Schizophr Res. 2016 Dec 1. pii: S0920-9964(16)30517.
    PubMed     Text format     Abstract available


  375. SENGUPTA SM, MacDonald K, Fathalli F, Yim A, et al
    Polygenic Risk Score associated with specific symptom dimensions in first-episode psychosis.
    Schizophr Res. 2016 Dec 1. pii: S0920-9964(16)30549.
    PubMed     Text format     Abstract available


    November 2016
  376. OSBORNE KJ, Bernard JA, Gupta T, Dean DJ, et al
    Beat gestures and postural control in youth at ultrahigh risk for psychosis.
    Schizophr Res. 2016 Nov 30. pii: S0920-9964(16)30521.
    PubMed     Text format     Abstract available


  377. GIANFRANCESCO O, Warburton A, Collier DA, Bubb VJ, et al
    Novel brain expressed RNA identified at the MIR137 schizophrenia-associated locus.
    Schizophr Res. 2016 Nov 29. pii: S0920-9964(16)30529.
    PubMed     Text format     Abstract available


  378. LIN J, Geng X, Lee EH, Chan SK, et al
    Yoga reduces the brain's amplitude of low-frequency fluctuations in patients with early psychosis results of a randomized controlled trial.
    Schizophr Res. 2016 Nov 29. pii: S0920-9964(16)30550.
    PubMed     Text format    


  379. MOTHERSILL O, Tangney N, Morris DW, McCarthy H, et al
    Further evidence of alerted default network connectivity and association with theory of mind ability in schizophrenia.
    Schizophr Res. 2016 Nov 29. pii: S0920-9964(16)30553.
    PubMed     Text format     Abstract available


  380. COTTER J, Lin A, Drake RJ, Thompson A, et al
    Long-term employment among people at ultra-high risk for psychosis.
    Schizophr Res. 2016 Nov 27. pii: S0920-9964(16)30526.
    PubMed     Text format     Abstract available


  381. GUMLEY A, White R, Briggs A, Ford I, et al
    A parallel group randomised open blinded evaluation of Acceptance and Commitment Therapy for depression after psychosis: Pilot trial outcomes (ADAPT).
    Schizophr Res. 2016 Nov 25. pii: S0920-9964(16)30519.
    PubMed     Text format     Abstract available


  382. WANG C, Zhang Y
    Schizophrenia in mid-adulthood after prenatal exposure to the Chinese Famine of 1959-1961.
    Schizophr Res. 2016 Nov 25. pii: S0920-9964(16)30523.
    PubMed     Text format     Abstract available


  383. LEE JS, Kim CY, Joo YH, Newell D, et al
    Corrigendum to "Increased diffusivity in gray matter in recent onset schizophrenia is associated with clinical symptoms and social cognition" [Schizophr. Res. 176 (2-3) (Oct 2016) 144-150].
    Schizophr Res. 2016 Nov 25. pii: S0920-9964(16)30494.
    PubMed     Text format    


  384. BAYLISS JK, Bodarya K, Carson CM, Miller BJ, et al
    Recurrent urinary tract infections in children and adolescents with acute psychosis.
    Schizophr Res. 2016 Nov 23. pii: S0920-9964(16)30522.
    PubMed     Text format    


  385. COUGHLIN JM, Hayes LN, Tanaka T, Xiao M, et al
    Reduced superoxide dismutase-1 (SOD1) in cerebrospinal fluid of patients with early psychosis in association with clinical features.
    Schizophr Res. 2016 Nov 23. pii: S0920-9964(16)30492.
    PubMed     Text format     Abstract available


  386. O'KEEFFE J, Conway R, McGuire B
    A systematic review examining factors predicting favourable outcome in cognitive behavioural interventions for psychosis.
    Schizophr Res. 2016 Nov 23. pii: S0920-9964(16)30514.
    PubMed     Text format     Abstract available


  387. CHANG H, Li L, Li M, Xiao X, et al
    Rare and common variants at 16p11.2 are associated with schizophrenia.
    Schizophr Res. 2016 Nov 23. pii: S0920-9964(16)30524.
    PubMed     Text format     Abstract available


  388. ASMAL L, du Plessis S, Vink M, Fouche JP, et al
    Insight and white matter fractional anisotropy in first-episode schizophrenia.
    Schizophr Res. 2016 Nov 23. pii: S0920-9964(16)30498.
    PubMed     Text format     Abstract available


  389. COUNOTTE J, Pot-Kolder R, van Roon AM, Hoskam O, et al
    High psychosis liability is associated with altered autonomic balance during exposure to Virtual Reality social stressors.
    Schizophr Res. 2016 Nov 22. pii: S0920-9964(16)30518.
    PubMed     Text format     Abstract available


  390. BORA E, Pantelis C
    Challenges facing the identification of distinctive cognitive and neurobiological features of schizophrenia and bipolar disorder and the need for a data-driven approach: Response to Dr. Martino.
    Schizophr Res. 2016 Nov 22. pii: S0920-9964(16)30516.
    PubMed     Text format    


  391. CHO H, Gonzalez R, Lavaysse LM, Pence S, et al
    Do people with schizophrenia experience more negative emotion and less positive emotion in their daily lives? A meta-analysis of experience sampling studies.
    Schizophr Res. 2016 Nov 21. pii: S0920-9964(16)30510.
    PubMed     Text format     Abstract available


  392. MARTINO DJ, Samame C, Strejilevich SA
    Social cognition in schizophrenia and bipolar disorder: Just quantitative differences..?
    Schizophr Res. 2016 Nov 21. pii: S0920-9964(16)30515.
    PubMed     Text format    


  393. WANG SB, Wang YY, Ungvari GS, Ng CH, et al
    The MacArthur Competence Assessment Tools for assessing decision-making capacity in schizophrenia: A meta-analysis.
    Schizophr Res. 2016 Nov 18. pii: S0920-9964(16)30512.
    PubMed     Text format     Abstract available


  394. CARNEY R, Bradshaw T, Firth J, Cotter J, et al
    Lifestyle factors may be linked to symptoms of metabolic syndrome in people at risk for psychosis.
    Schizophr Res. 2016 Nov 16. pii: S0920-9964(16)30506.
    PubMed     Text format    


  395. LIZANO PL, Yao JK, Tandon N, Mothi SS, et al
    Association of sFlt-1 and worsening psychopathology in relatives at high risk for psychosis: A longitudinal study.
    Schizophr Res. 2016 Nov 15. pii: S0920-9964(16)30508.
    PubMed     Text format     Abstract available


  396. KOYANAGI A, Oh H, Haro JM, Hirayama F, et al
    Child death and maternal psychosis-like experiences in 44 low- and middle-income countries: The role of depression.
    Schizophr Res. 2016 Nov 15. pii: S0920-9964(16)30505.
    PubMed     Text format     Abstract available


  397. FUJII T, Hattori K, Miyakawa T, Ohashi Y, et al
    Metabolic profile alterations in the postmortem brains of patients with schizophrenia using capillary electrophoresis-mass spectrometry.
    Schizophr Res. 2016 Nov 15. pii: S0920-9964(16)30504.
    PubMed     Text format     Abstract available


  398. SELTEN JP, Termorshuizen F
    The serological evidence for maternal influenza as risk factor for psychosis in offspring is insufficient: critical review and meta-analysis.
    Schizophr Res. 2016 Nov 14. pii: S0920-9964(16)30499.
    PubMed     Text format     Abstract available


  399. AKKUS F, Treyer V, Ametamey SM, Johayem A, et al
    Metabotropic glutamate receptor 5 neuroimaging in schizophrenia.
    Schizophr Res. 2016 Nov 12. pii: S0920-9964(16)30501.
    PubMed     Text format     Abstract available


  400. DE LA SERNA E, Sugranyes G, Sanchez-Gistau V, Rodriguez-Toscano E, et al
    Neuropsychological characteristics of child and adolescent offspring of patients with schizophrenia or bipolar disorder.
    Schizophr Res. 2016 Nov 12. pii: S0920-9964(16)30500.
    PubMed     Text format     Abstract available


  401. CARSON CM, Phillip N, Miller BJ
    Urinary tract infections in children and adolescents with acute psychosis.
    Schizophr Res. 2016 Nov 10. pii: S0920-9964(16)30497.
    PubMed     Text format     Abstract available


  402. KRKOVIC K, Moritz S, Lincoln TM
    Neurocognitive deficits or stress overload: Why do individuals with schizophrenia show poor performance in neurocognitive tests?
    Schizophr Res. 2016 Nov 9. pii: S0920-9964(16)30495.
    PubMed     Text format     Abstract available


  403. BROWN AS, Gyllenberg D, Hinkka-Yli-Salomaki S, Sourander A, et al
    Altered growth trajectory of head circumference during infancy and schizophrenia in a National Birth Cohort.
    Schizophr Res. 2016 Nov 4. pii: S0920-9964(16)30476.
    PubMed     Text format     Abstract available


    October 2016
  404. BEN-SHACHAR D
    Mitochondrial multifaceted dysfunction in schizophrenia; complex I as a possible pathological target.
    Schizophr Res. 2016 Oct 29. pii: S0920-9964(16)30466.
    PubMed     Text format     Abstract available


  405. PADMANABHAN JL, Shah JL, Tandon N, Keshavan MS, et al
    The "polyenviromic risk score": Aggregating environmental risk factors predicts conversion to psychosis in familial high-risk subjects.
    Schizophr Res. 2016 Oct 29. pii: S0920-9964(16)30458.
    PubMed     Text format     Abstract available


  406. RAN MS, Wong YI, Yang SY, Ho PS, et al
    Marriage and outcomes of people with schizophrenia in rural China: 14-year follow-up study.
    Schizophr Res. 2016 Oct 28. pii: S0920-9964(16)30478.
    PubMed     Text format     Abstract available


  407. WILS RS, Gotfredsen DR, Hjorthoj C, Austin SF, et al
    Antipsychotic medication and remission of psychotic symptoms 10years after a first-episode psychosis.
    Schizophr Res. 2016 Oct 27. pii: S0920-9964(16)30474.
    PubMed     Text format     Abstract available


  408. NAKAZAWA T, Kikuchi M, Ishikawa M, Yamamori H, et al
    Differential gene expression profiles in neurons generated from lymphoblastoid B-cell line-derived iPS cells from monozygotic twin cases with treatment-resistant schizophrenia and discordant responses to clozapine.
    Schizophr Res. 2016 Oct 27. pii: S0920-9964(16)30456.
    PubMed     Text format     Abstract available


  409. DUNAYEVICH E, Buchanan RW, Chen CY, Yang J, et al
    Efficacy and safety of the glycine transporter type-1 inhibitor AMG 747 for the treatment of negative symptoms associated with schizophrenia.
    Schizophr Res. 2016 Oct 24. pii: S0920-9964(16)30471.
    PubMed     Text format     Abstract available


  410. MURRAY JD, Anticevic A
    Toward understanding thalamocortical dysfunction in schizophrenia through computational models of neural circuit dynamics.
    Schizophr Res. 2016 Oct 23. pii: S0920-9964(16)30465.
    PubMed     Text format     Abstract available


  411. KUNUTSOR SK, Laukkanen JA
    Serum gamma-glutamyltransferase is associated with future risk of psychosis - A prospective cohort study.
    Schizophr Res. 2016 Oct 21. pii: S0920-9964(16)30469.
    PubMed     Text format    


  412. HUI L, Han M, Yin GZ, Zhang Y, et al
    Association between DBH 19bp insertion/deletion polymorphism and cognition in schizophrenia with and without tardive dyskinesia.
    Schizophr Res. 2016 Oct 21. pii: S0920-9964(16)30472.
    PubMed     Text format     Abstract available


  413. IVANOVA SA, Osmanova DZ, Boiko AS, Pozhidaev IV, et al
    Prolactin gene polymorphism (-1149 G/T) is associated with hyperprolactinemia in patients with schizophrenia treated with antipsychotics.
    Schizophr Res. 2016 Oct 21. pii: S0920-9964(16)30473.
    PubMed     Text format     Abstract available


  414. MUELLER TM, Yates SD, Haroutunian V, Meador-Woodruff JH, et al
    Altered fucosyltransferase expression in the superior temporal gyrus of elderly patients with schizophrenia.
    Schizophr Res. 2016 Oct 20. pii: S0920-9964(16)30468.
    PubMed     Text format     Abstract available


  415. KOTLICKA-ANTCZAK M, Pawelczyk A, Karbownik MS, Pawelczyk T, et al
    Deficits in the identification of pleasant odors predict the transition of an at-risk mental state to psychosis.
    Schizophr Res. 2016 Oct 17. pii: S0920-9964(16)30463.
    PubMed     Text format     Abstract available


  416. BULGARI V, Iozzino L, Ferrari C, Picchioni M, et al
    Clinical and neuropsychological features of violence in schizophrenia: A prospective cohort study.
    Schizophr Res. 2016 Oct 17. pii: S0920-9964(16)30460.
    PubMed     Text format     Abstract available


  417. KIM JH, Kim JH, Son YD, Joo YH, et al
    Altered interregional correlations between serotonin transporter availability and cerebral glucose metabolism in schizophrenia: A high-resolution PET study using [11C]DASB and [18F]FDG.
    Schizophr Res. 2016 Oct 16. pii: S0920-9964(16)30464.
    PubMed     Text format     Abstract available


  418. CORDES J, Bechdolf A, Engelke C, Kahl KG, et al
    Prevalence of metabolic syndrome in female and male patients at risk of psychosis.
    Schizophr Res. 2016 Oct 14. pii: S0920-9964(16)30394.
    PubMed     Text format     Abstract available


  419. HARING L, Mottus R, Kajalaid K, Koch K, et al
    The course of cognitive functioning after first-episode of psychosis: A six month follow-up study.
    Schizophr Res. 2016 Oct 13. pii: S0920-9964(16)30461.
    PubMed     Text format     Abstract available


  420. TULLY S, Wells A, Pyle M, Hudson J, et al
    Measuring common responses to psychosis: Assessing the psychometric properties of a new measure.
    Schizophr Res. 2016 Oct 13. pii: S0920-9964(16)30459.
    PubMed     Text format     Abstract available


  421. RIDGEWELL C, Blackford JU, McHugo M, Heckers S, et al
    Personality traits predicting quality of life and overall functioning in schizophrenia.
    Schizophr Res. 2016 Oct 13. pii: S0920-9964(16)30451.
    PubMed     Text format     Abstract available


  422. STEVENSON RA, Park S, Cochran C, McIntosh LG, et al
    The associations between multisensory temporal processing and symptoms of schizophrenia.
    Schizophr Res. 2016 Oct 13. pii: S0920-9964(16)30444.
    PubMed     Text format     Abstract available


  423. GREENHALGH AM, Gonzalez-Blanco L, Garcia-Rizo C, Fernandez-Egea E, et al
    Meta-analysis of glucose tolerance, insulin, and insulin resistance in antipsychotic-naive patients with nonaffective psychosis.
    Schizophr Res. 2016 Oct 13. pii: S0920-9964(16)30435.
    PubMed     Text format     Abstract available


  424. DONDE C, Luck D, Grot S, Leitman DI, et al
    Tone-matching ability in patients with schizophrenia: A systematic review and meta-analysis.
    Schizophr Res. 2016 Oct 11. pii: S0920-9964(16)30453.
    PubMed     Text format     Abstract available


  425. STARC M, Murray JD, Santamauro N, Savic A, et al
    Schizophrenia is associated with a pattern of spatial working memory deficits consistent with cortical disinhibition.
    Schizophr Res. 2016 Oct 10. pii: S0920-9964(16)30455.
    PubMed     Text format     Abstract available


  426. WINTON-BROWN TT, Elanjithara T, Power P, Coentre R, et al
    Five-fold increased risk of relapse following breaks in antipsychotic treatment of first episode psychosis.
    Schizophr Res. 2016 Oct 10. pii: S0920-9964(16)30437.
    PubMed     Text format     Abstract available


  427. SANCHEZ-TORRES AM, Elosua MR, Lorente-Omenaca R, Moreno-Izco L, et al
    Lifetime psychopathological dimensions, cognitive impairment and functional outcome in psychosis.
    Schizophr Res. 2016 Oct 9. pii: S0920-9964(16)30447.
    PubMed     Text format     Abstract available


  428. LANGE C, Deutschenbaur L, Borgwardt S, Lang UE, et al
    Experimentally induced psychosocial stress in schizophrenia spectrum disorders: A systematic review.
    Schizophr Res. 2016 Oct 9. pii: S0920-9964(16)30452.
    PubMed     Text format     Abstract available


  429. BROSEY EA, Woodward ND
    Neuroanatomical correlates of perceptual aberrations in psychosis.
    Schizophr Res. 2016 Oct 8. pii: S0920-9964(16)30450.
    PubMed     Text format     Abstract available


  430. ZHAI D, Lang Y, Dong G, Liu Y, et al
    QTc interval lengthening in first-episode schizophrenia (FES) patients in the earliest stages of antipsychotic treatment.
    Schizophr Res. 2016 Oct 7. pii: S0920-9964(16)30449.
    PubMed     Text format     Abstract available


  431. KUANG C, Buchy L, Barbato M, Makowski C, et al
    A pilot study of cognitive insight and structural covariance in first-episode psychosis.
    Schizophr Res. 2016 Oct 6. pii: S0920-9964(16)30443.
    PubMed     Text format     Abstract available


  432. TARGUM SD, Risinger R, Du Y, Pendergrass JC, et al
    Effect of patient age on treatment response in a study of the acute exacerbation of psychosis in schizophrenia.
    Schizophr Res. 2016 Oct 1. pii: S0920-9964(16)30442.
    PubMed     Text format     Abstract available


    September 2016
  433. FALKENBERG I, Valli I, Raffin M, Broome MR, et al
    Pattern of activation during delayed matching to sample task predicts functional outcome in people at ultra high risk for psychosis.
    Schizophr Res. 2016 Sep 29. pii: S0920-9964(16)30431.
    PubMed     Text format     Abstract available


  434. CORNACCHIO D, Pinkham AE, Penn DL, Harvey PD, et al
    Self-assessment of social cognitive ability in individuals with schizophrenia: Appraising task difficulty and allocation of effort.
    Schizophr Res. 2016 Sep 29. pii: S0920-9964(16)30441.
    PubMed     Text format     Abstract available


  435. RAUTIO N, Miettunen J, Jaaskelainen E, Nordstrom T, et al
    Do adverse perinatal events predict mortality in schizophrenia during midlife?
    Schizophr Res. 2016 Sep 27. pii: S0920-9964(16)30439.
    PubMed     Text format     Abstract available


  436. SELLERS R, Varese F, Wells A, Morrison AP, et al
    A meta-analysis of metacognitive beliefs as implicated in the self-regulatory executive function model in clinical psychosis.
    Schizophr Res. 2016 Sep 23. pii: S0920-9964(16)30440.
    PubMed     Text format     Abstract available


  437. ROSENHECK R, Mueser KT, Sint K, Lin H, et al
    Supported employment and education in comprehensive, integrated care for first episode psychosis: Effects on work, school, and disability income.
    Schizophr Res. 2016 Sep 22. pii: S0920-9964(16)30432.
    PubMed     Text format     Abstract available


  438. HAHN LA, Mackinnon A, Dr DL, Winthrop VA, et al
    The value of counting WHO-defined cardiovascular risk factors for death and disability in a national sample of adults with psychosis.
    Schizophr Res. 2016 Sep 22. pii: S0920-9964(16)30436.
    PubMed     Text format     Abstract available


  439. MASSEY SH, Stern D, Alden EC, Petersen JE, et al
    Cortical thickness of neural substrates supporting cognitive empathy in individuals with schizophrenia.
    Schizophr Res. 2016 Sep 21. pii: S0920-9964(16)30433.
    PubMed     Text format     Abstract available


  440. NOEL JP, Cascio CJ, Wallace MT, Park S, et al
    The spatial self in schizophrenia and autism spectrum disorder.
    Schizophr Res. 2016 Sep 17. pii: S0920-9964(16)30429.
    PubMed     Text format     Abstract available


  441. MOLINS C, Roldan A, Corripio I, Isohanni M, et al
    Response to antipsychotic drugs in treatment-resistant schizophrenia: Conclusions based on systematic review.
    Schizophr Res. 2016 Sep 17. pii: S0920-9964(16)30424.
    PubMed     Text format    


  442. HONG S, Lee EE, Martin AS, Soontornniyomkij B, et al
    Abnormalities in chemokine levels in schizophrenia and their clinical correlates.
    Schizophr Res. 2016 Sep 17. pii: S0920-9964(16)30427.
    PubMed     Text format     Abstract available


  443. RICHARD EA, Khlestova E, Nanu R, Lisman JE, et al
    Potential synergistic action of 19 schizophrenia risk genes in the thalamus.
    Schizophr Res. 2016 Sep 16. pii: S0920-9964(16)30390.
    PubMed     Text format     Abstract available


  444. ROCHE E, Lyne J, O'Donoghue B, Segurado R, et al
    The prognostic value of formal thought disorder following first episode psychosis.
    Schizophr Res. 2016 Sep 14. pii: S0920-9964(16)30425.
    PubMed     Text format     Abstract available


  445. CALDANI S, Bucci MP, Lamy JC, Seassau M, et al
    Saccadic eye movements as markers of schizophrenia spectrum: Exploration in at-risk mental states.
    Schizophr Res. 2016 Sep 14. pii: S0920-9964(16)30385.
    PubMed     Text format     Abstract available


  446. CHEN J, Calhoun VD, Pearlson GD, Perrone-Bizzozero NI, et al
    Independent component analysis of SNPs reflects polygenic risk scores for schizophrenia.
    Schizophr Res. 2016 Sep 13. pii: S0920-9964(16)30393.
    PubMed     Text format     Abstract available


  447. SAMALIN L, de Chazeron I, Blanc O, Brunel L, et al
    Attitudes toward antipsychotic medications as a useful feature in exploring medication non-adherence in schizophrenia.
    Schizophr Res. 2016 Sep 13. pii: S0920-9964(16)30419.
    PubMed     Text format     Abstract available


  448. LANDIN-ROMERO R, McKenna PJ, Romaguera A, Alvarez-Moya E, et al
    Examining the continuum of psychosis: Frequency and characteristics of psychotic-like symptoms in relatives and non-relatives of patients with schizophrenia.
    Schizophr Res. 2016 Sep 12. pii: S0920-9964(16)30330.
    PubMed     Text format     Abstract available


  449. DUSI N, Bellani M, Perlini C, Squarcina L, et al
    Progressive disability and prefrontal shrinkage in schizophrenia patients with poor outcome: A 3-year longitudinal study.
    Schizophr Res. 2016 Sep 10. pii: S0920-9964(16)30395.
    PubMed     Text format     Abstract available


  450. FUJINO J, Hirose K, Tei S, Kawada R, et al
    Ambiguity aversion in schizophrenia: An fMRI study of decision-making under risk and ambiguity.
    Schizophr Res. 2016 Sep 9. pii: S0920-9964(16)30388.
    PubMed     Text format     Abstract available


  451. DUNCAN MJ, Arbour-Nicitopoulos K, Subramanieapillai M, Remington G, et al
    Revisiting the International Physical Activity Questionnaire (IPAQ): Assessing physical activity among individuals with schizophrenia.
    Schizophr Res. 2016 Sep 9. pii: S0920-9964(16)30392.
    PubMed     Text format     Abstract available


  452. RAKHSHAN P, Sorensen H, DeVylder J, Mittal V, et al
    Childhood pegboard task predicts adult-onset psychosis-spectrum disorder among a genetic high-risk sample.
    Schizophr Res. 2016 Sep 9. pii: S0920-9964(16)30367.
    PubMed     Text format     Abstract available


  453. POISSON A, Schluth Bolard C, Martin B, Babinet MN, et al
    16q12.2q21: A new susceptibility locus for schizophrenia?
    Schizophr Res. 2016 Sep 8. pii: S0920-9964(16)30389.
    PubMed     Text format    


  454. SANCHEZ-TORRES AM, Elosua MR, Lorente-Omenaca R, Moreno-Izco L, et al
    The Cognitive Assessment Interview: A comparative study in first episode and chronic patients with psychosis.
    Schizophr Res. 2016 Sep 8. pii: S0920-9964(16)30378.
    PubMed     Text format     Abstract available


  455. PEARSALL R, Gareze J, Park J, Walker A, et al
    Routine data linkage to identify and monitor diabetes in clozapine-treated patients with schizophrenia.
    Schizophr Res. 2016 Sep 7. pii: S0920-9964(16)30375.
    PubMed     Text format    


  456. CAQUEO-URIZAR A, Fond G, Urzua A, Boyer L, et al
    Violent behavior and aggression in schizophrenia: Prevalence and risk factors. A multicentric study from three Latin-America countries.
    Schizophr Res. 2016 Sep 7. pii: S0920-9964(16)30387.
    PubMed     Text format     Abstract available


  457. ZHAI D, Cui T, Xu Y, Feng Y, et al
    Cardiometabolic risk in first-episode schizophrenia (FES) patients with the earliest stages of both illness and antipsychotic treatment.
    Schizophr Res. 2016 Sep 7. pii: S0920-9964(16)30383.
    PubMed     Text format     Abstract available


  458. SCHIMANSKI ID, Mouat KL, Billinghurst BL, Linscott RJ, et al
    Preliminary evidence that schizophrenia liability at age 15 predicts suicidal ideation two years later.
    Schizophr Res. 2016 Sep 6. pii: S0920-9964(16)30380.
    PubMed     Text format     Abstract available


  459. BASLOW MH
    Is the tri-cellular N-acetylaspartylglutamate (NAAG) cycle related to the etiology of schizophrenia?
    Schizophr Res. 2016 Sep 6. pii: S0920-9964(16)30391.
    PubMed     Text format    


  460. ZAROGIANNI E, Storkey AJ, Johnstone EC, Owens DG, et al
    Improved individualized prediction of schizophrenia in subjects at familial high risk, based on neuroanatomical data, schizotypal and neurocognitive features.
    Schizophr Res. 2016 Sep 6. pii: S0920-9964(16)30377.
    PubMed     Text format     Abstract available


  461. RAZAFIMANDIMBY A, Herve PY, Marzloff V, Brazo P, et al
    Functional deficit of the medial prefrontal cortex during emotional sentence attribution in schizophrenia.
    Schizophr Res. 2016 Sep 6. pii: S0920-9964(16)30386.
    PubMed     Text format     Abstract available


  462. COBIA DJ, Smith MJ, Salinas I, Ng C, et al
    Progressive deterioration of thalamic nuclei relates to cortical network decline in schizophrenia.
    Schizophr Res. 2016 Sep 6. pii: S0920-9964(16)30353.
    PubMed     Text format     Abstract available


  463. BRIDGMAN AC, Barr MS, Goodman MS, Zomorrodi R, et al
    Effects of varenicline on motor cortical plasticity in non-smokers with schizophrenia.
    Schizophr Res. 2016 Sep 6. pii: S0920-9964(16)30382.
    PubMed     Text format     Abstract available


  464. MISIAK B, Wisniewski J, Fleszar MG, Frydecka D, et al
    Alterations in l-arginine metabolism in first-episode schizophrenia patients: Further evidence for early metabolic dysregulation.
    Schizophr Res. 2016 Sep 5. pii: S0920-9964(16)30381.
    PubMed     Text format    


    August 2016
  465. MORITZ S, Balzan RP, Bohn F, Veckenstedt R, et al
    Subjective versus objective cognition: Evidence for poor metacognitive monitoring in schizophrenia.
    Schizophr Res. 2016 Aug 31. pii: S0920-9964(16)30371.
    PubMed     Text format     Abstract available


  466. CARNEY R, Yung AR, Amminger GP, Bradshaw T, et al
    Substance use in youth at risk for psychosis.
    Schizophr Res. 2016 Aug 30. pii: S0920-9964(16)30376.
    PubMed     Text format     Abstract available


  467. KIMURA H, Wang C, Ishizuka K, Xing J, et al
    Identification of a rare variant in CHD8 that contributes to schizophrenia and autism spectrum disorder susceptibility.
    Schizophr Res. 2016 Aug 29. pii: S0920-9964(16)30373.
    PubMed     Text format    


  468. DANDASH O, Pantelis C, Fornito A
    Dopamine, fronto-striato-thalamic circuits and risk for psychosis.
    Schizophr Res. 2016 Aug 29. pii: S0920-9964(16)30370.
    PubMed     Text format     Abstract available


  469. VERMA D, Srivastava MK, Singh SK, Bhatia T, et al
    Lifetime suicide intent, executive function and insight in schizophrenia and schizoaffective disorders.
    Schizophr Res. 2016 Aug 29. pii: S0920-9964(16)30359.
    PubMed     Text format    


  470. SERE L, Cardona D, Flichtentrei D, Lopez P, et al
    Schizophrenia: Is it time to rename it? The opinions of Latin American psychiatrists.
    Schizophr Res. 2016 Aug 29. pii: S0920-9964(16)30369.
    PubMed     Text format    


  471. REDDY LF, Llerena K, Kern RS
    Predictors of employment in schizophrenia: The importance of intrinsic and extrinsic motivation.
    Schizophr Res. 2016 Aug 25. pii: S0920-9964(16)30356.
    PubMed     Text format     Abstract available


  472. BESTEHER B, Wagner G, Koch K, Schachtzabel C, et al
    Pronounced prefronto-temporal cortical thinning in schizophrenia: Neuroanatomical correlate of suicidal behavior?
    Schizophr Res. 2016 Aug 24. pii: S0920-9964(16)30360.
    PubMed     Text format     Abstract available


  473. DORPH-PETERSEN KA, Lewis DA
    Postmortem structural studies of the thalamus in schizophrenia.
    Schizophr Res. 2016 Aug 23. pii: S0920-9964(16)30357.
    PubMed     Text format     Abstract available


  474. CICERO DC, Klaunig MJ, Trask CL, Neis AM, et al
    Anomalous Self-Experiences and positive symptoms are independently associated with emotion processing deficits in schizophrenia.
    Schizophr Res. 2016 Aug 22. pii: S0920-9964(16)30368.
    PubMed     Text format     Abstract available


  475. LEE JS, Kim CY, Joo YH, Newell D, et al
    Increased diffusivity in gray matter in recent onset schizophrenia is associated with clinical symptoms and social cognition.
    Schizophr Res. 2016 Aug 20. pii: S0920-9964(16)30361.
    PubMed     Text format     Abstract available


  476. LIEMBURG EJ, Bruins J, van Beveren N, Islam MA, et al
    Cannabis and a lower BMI in psychosis: What is the role of AKT1?
    Schizophr Res. 2016 Aug 20. pii: S0920-9964(16)30364.
    PubMed     Text format     Abstract available


  477. STAIN HJ, Bucci S, Baker AL, Carr V, et al
    A randomised controlled trial of cognitive behaviour therapy versus non-directive reflective listening for young people at ultra high risk of developing psychosis: The detection and evaluation of psychological therapy (DEPTh) trial.
    Schizophr Res. 2016 Aug 20. pii: S0920-9964(16)30358.
    PubMed     Text format     Abstract available


  478. ADAMCZYK P, Daren A, Sulecka A, Bladzinski P, et al
    Do better communication skills promote sheltered employment in schizophrenia?
    Schizophr Res. 2016 Aug 18. pii: S0920-9964(16)30365.
    PubMed     Text format     Abstract available


  479. JEON DW, Shim JC, Kong BG, Moon JJ, et al
    Adjunctive varenicline treatment for smoking reduction in patients with schizophrenia: A randomized double-blind placebo-controlled trial.
    Schizophr Res. 2016 Aug 16. pii: S0920-9964(16)30366.
    PubMed     Text format     Abstract available


  480. YOSHIDA K, Suzuki T, Imasaka Y, Kubo KI, et al
    Corrigendum to "resilience in schizophrenia: A comparative study between a remote island and an urban area in Japan" [Schizophr. Res. Volume 171, Issues 1-3, March 2016, Pages 92-96].
    Schizophr Res. 2016 Aug 15. pii: S0920-9964(16)30363.
    PubMed     Text format    


  481. BROWN JS JR
    Cases of remission of psychosis following resection of pheochromocytoma or paraganglioma.
    Schizophr Res. 2016 Aug 14. pii: S0920-9964(16)30362.
    PubMed     Text format     Abstract available


  482. GIRALDO-CHICA M, Woodward ND
    Review of thalamocortical resting-state fMRI studies in schizophrenia.
    Schizophr Res. 2016 Aug 13. pii: S0920-9964(16)30355.
    PubMed     Text format     Abstract available


  483. MAMAH D, Musau A, Mutiso VN, Owoso A, et al
    Characterizing psychosis risk traits in Africa: A longitudinal study of Kenyan adolescents.
    Schizophr Res. 2016 Aug 10. pii: S0920-9964(16)30354.
    PubMed     Text format     Abstract available


  484. GOMES JS, Akiba H, Dias AM, Soares A, et al
    Trigeminal Nerve Stimulation for olfactory hallucinations in schizophrenia: case study.
    Schizophr Res. 2016 Aug 8. pii: S0920-9964(16)30352.
    PubMed     Text format    


  485. YOUNG A, Wimmer RD
    Implications for the thalamic reticular nucleus in impaired attention and sleep in schizophrenia.
    Schizophr Res. 2016 Aug 7. pii: S0920-9964(16)30327.
    PubMed     Text format     Abstract available


  486. HAIGH SM, Coffman BA, Murphy TK, Butera CD, et al
    Abnormal auditory pattern perception in schizophrenia.
    Schizophr Res. 2016 Aug 5. pii: S0920-9964(16)30323.
    PubMed     Text format     Abstract available


  487. WILLI TS, Lang DJ, Honer WG, Smith GN, et al
    Subcortical grey matter alterations in cocaine dependent individuals with substance-induced psychosis compared to non-psychotic cocaine users.
    Schizophr Res. 2016 Aug 4. pii: S0920-9964(16)30351.
    PubMed     Text format     Abstract available


  488. DRUCAROFF LJ, Costanzo EY, Castro MN, Ortiz-Villafane M, et al
    Hemispheric specialization of mood processing is abnormal in patients with schizophrenia.
    Schizophr Res. 2016 Aug 1. pii: S0920-9964(16)30350.
    PubMed     Text format    


    July 2016
  489. LI X, Thermenos HW, Wu Z, Momura Y, et al
    Abnormal interactions of verbal- and spatial-memory networks in young people at familial high-risk for schizophrenia.
    Schizophr Res. 2016 Jul 29. pii: S0920-9964(16)30348.
    PubMed     Text format     Abstract available


  490. PETRWINKLER, Mlada K, Krupchanka D, Agius M, et al
    Corrigendum to "Long-term hospitalizations for schizophrenia in the Czech Republic 1998-2012" (Schizophr. Res. vol. 175, issues 1-3, August 2016, pages 180-185).
    Schizophr Res. 2016 Jul 28. pii: S0920-9964(16)30347.
    PubMed     Text format    


  491. HALLFORD P, Clair DS, Halley L, Mustard C, et al
    A study of type-1 diabetes associated autoantibodies in schizophrenia.
    Schizophr Res. 2016 Jul 26. pii: S0920-9964(16)30346.
    PubMed     Text format     Abstract available


  492. CHUANG YA, Hu TM, Chen CH, Hsu SH, et al
    Rare mutations and hypermethylation of the ARC gene associated with schizophrenia.
    Schizophr Res. 2016 Jul 24. pii: S0920-9964(16)30345.
    PubMed     Text format     Abstract available


  493. SANTELMANN H, Franklin J, Busshoff J, Baethge C, et al
    Interrater reliability of schizoaffective disorder compared with schizophrenia, bipolar disorder, and unipolar depression - A systematic review and meta-analysis.
    Schizophr Res. 2016 Jul 22. pii: S0920-9964(16)30328.
    PubMed     Text format     Abstract available


  494. KITTIPEERACHON M, Chaichan W
    Intramuscular olanzapine versus intramuscular aripiprazole for the treatment of agitation in patients with schizophrenia: A pragmatic double-blind randomized trial.
    Schizophr Res. 2016 Jul 22. pii: S0920-9964(16)30333.
    PubMed     Text format     Abstract available


  495. VAN DEN BERG DP, van der Vleugel BM, de Bont PA, Staring AB, et al
    Predicting trauma-focused treatment outcome in psychosis.
    Schizophr Res. 2016 Jul 20. pii: S0920-9964(16)30332.
    PubMed     Text format     Abstract available


  496. PERGOLA G, Trizio S, Di Carlo P, Taurisano P, et al
    Grey matter volume patterns in thalamic nuclei are associated with familial risk for schizophrenia.
    Schizophr Res. 2016 Jul 20. pii: S0920-9964(16)30321.
    PubMed     Text format     Abstract available


  497. SADOWSKA-BARTOSZ I, Galiniak S, Bartosz G, Zuberek M, et al
    Antioxidant properties of atypical antipsychotic drugs used in the treatment of schizophrenia.
    Schizophr Res. 2016 Jul 20. pii: S0920-9964(16)30326.
    PubMed     Text format     Abstract available


  498. HESS JL, Tylee DS, Barve R, de Jong S, et al
    Transcriptome-wide mega-analyses reveal joint dysregulation of immunologic genes and transcription regulators in brain and blood in schizophrenia.
    Schizophr Res. 2016 Jul 19. pii: S0920-9964(16)30322.
    PubMed     Text format     Abstract available


  499. BORNHEIMER LA
    Moderating effects of positive symptoms of psychosis in suicidal ideation among adults diagnosed with schizophrenia.
    Schizophr Res. 2016 Jul 19. pii: S0920-9964(16)30325.
    PubMed     Text format     Abstract available


  500. MCCLEERY A, Lee J, Fiske AP, Ghermezi L, et al
    Longitudinal stability of social cognition in schizophrenia: A 5-year follow-up of social perception and emotion processing.
    Schizophr Res. 2016 Jul 18. pii: S0920-9964(16)30324.
    PubMed     Text format     Abstract available


  501. DURGAM S, Earley W, Li R, Li D, et al
    Long-term cariprazine treatment for the prevention of relapse in patients with schizophrenia: A randomized, double-blind, placebo-controlled trial.
    Schizophr Res. 2016 Jul 14. pii: S0920-9964(16)30312.
    PubMed     Text format     Abstract available


  502. SHIM M, Hwang HJ, Kim DW, Lee SH, et al
    Machine-learning-based diagnosis of schizophrenia using combined sensor-level and source-level EEG features.
    Schizophr Res. 2016 Jul 14. pii: S0920-9964(16)30227.
    PubMed     Text format     Abstract available


  503. WOOD L, Burke E, Byrne R, Enache G, et al
    Semi-structured Interview Measure of Stigma (SIMS) in psychosis: Assessment of psychometric properties.
    Schizophr Res. 2016 Jul 13. pii: S0920-9964(16)30275.
    PubMed     Text format     Abstract available


  504. ZENI-GRAIFF M, Rizzo LB, Mansur RB, Maurya PK, et al
    Peripheral immuno-inflammatory abnormalities in ultra-high risk of developing psychosis.
    Schizophr Res. 2016 Jul 13. pii: S0920-9964(16)30313.
    PubMed     Text format     Abstract available


  505. CELLA M, Edwards C, Wykes T
    A question of time: A study of time use in people with schizophrenia.
    Schizophr Res. 2016 Jul 12. pii: S0920-9964(16)30315.
    PubMed     Text format     Abstract available


  506. LEVINE SZ, Levav I, Pugachova I, Yoffe R, et al
    Transgenerational effects of genocide exposure on the risk and course of schizophrenia: A population-based study.
    Schizophr Res. 2016 Jul 8. pii: S0920-9964(16)30286.
    PubMed     Text format     Abstract available


  507. GUAN F, Zhang T, Li L, Fu D, et al
    Two-stage replication of previous genome-wide association studies of AS3MT-CNNM2-NT5C2 gene cluster region in a large schizophrenia case-control sample from Han Chinese population.
    Schizophr Res. 2016 Jul 8. pii: S0920-9964(16)30320.
    PubMed     Text format     Abstract available


  508. WOMER FY, Tang Y, Harms MP, Bai C, et al
    Sexual dimorphism of the cerebellar vermis in schizophrenia.
    Schizophr Res. 2016 Jul 8. pii: S0920-9964(16)30310.
    PubMed     Text format     Abstract available


  509. DOLLFUS S, Lyne J
    Negative symptoms: History of the concept and their position in diagnosis of schizophrenia.
    Schizophr Res. 2016 Jul 8. pii: S0920-9964(16)30291.
    PubMed     Text format    


  510. MORRA LF, Strauss GP
    Severity of hypertension predicts the generalized neurocognitive deficit in schizophrenia.
    Schizophr Res. 2016 Jul 7. pii: S0920-9964(16)30317.
    PubMed     Text format     Abstract available


  511. SAWA A, Sedlak TW
    Oxidative stress and inflammation in schizophrenia.
    Schizophr Res. 2016 Jul 6. pii: S0920-9964(16)30281.
    PubMed     Text format    


  512. ZHANG B, Deng L, Wu H, Lu X, et al
    Relationship between long-term use of a typical antipsychotic medication by Chinese schizophrenia patients and the bone turnover markers serum osteocalcin and beta-CrossLaps.
    Schizophr Res. 2016 Jul 2. pii: S0920-9964(16)30316.
    PubMed     Text format     Abstract available


    June 2016
  513. GURURAJAN A, Malone DT
    Does cannabidiol have a role in the treatment of schizophrenia?
    Schizophr Res. 2016 Jun 30. pii: S0920-9964(16)30289.
    PubMed     Text format     Abstract available


  514. FALKAI P, Schmitt A
    News from the graveyard: Neuropathological research on schizophrenia is alive and productive.
    Schizophr Res. 2016 Jun 29. pii: S0920-9964(16)30311.
    PubMed     Text format    


  515. GOGHARI VM, Harrow M
    Twenty year multi-follow-up of different types of hallucinations in schizophrenia, schizoaffective disorder, bipolar disorder, and depression.
    Schizophr Res. 2016 Jun 24. pii: S0920-9964(16)30309.
    PubMed     Text format     Abstract available


  516. GRENT-'T-JONG T, Rivolta D, Sauer A, Grube M, et al
    MEG-measured visually induced gamma-band oscillations in chronic schizophrenia: Evidence for impaired generation of rhythmic activity in ventral stream regions.
    Schizophr Res. 2016 Jun 24. pii: S0920-9964(16)30270.
    PubMed     Text format     Abstract available


  517. LIM A, Hoek HW, Deen ML, Blom JD, et al
    Prevalence and classification of hallucinations in multiple sensory modalities in schizophrenia spectrum disorders.
    Schizophr Res. 2016 Jun 24. pii: S0920-9964(16)30277.
    PubMed     Text format     Abstract available


  518. MICHAEL J, Park S
    Anomalous bodily experiences and perceived social isolation in schizophrenia: An extension of the Social Deafferentation Hypothesis.
    Schizophr Res. 2016 Jun 23. pii: S0920-9964(16)30280.
    PubMed     Text format     Abstract available


  519. ON ZX, Cotton S, Farhall J, Killackey E, et al
    Relationship between duration of untreated psychosis and neurocognition and social cognition in first-episode psychosis.
    Schizophr Res. 2016 Jun 23. pii: S0920-9964(16)30285.
    PubMed     Text format     Abstract available


  520. KIRKBRIDE JB, Perez J, Jones PB
    Neighbourhood communalities and ultra-high risk psychosis: An emergent literature.
    Schizophr Res. 2016 Jun 22. pii: S0920-9964(16)30288.
    PubMed     Text format    


  521. KEANE BP, Silverstein SM, Wang Y, Roche MW, et al
    Seeing more clearly through psychosis: Depth inversion illusions are normal in bipolar disorder but reduced in schizophrenia.
    Schizophr Res. 2016 Jun 22. pii: S0920-9964(16)30282.
    PubMed     Text format     Abstract available


  522. KUHL JO, Laursen TM, Thorup A, Nordentoft M, et al
    The incidence of schizophrenia and schizophrenia spectrum disorders in Denmark in the period 2000-2012. A register-based study.
    Schizophr Res. 2016 Jun 21. pii: S0920-9964(16)30290.
    PubMed     Text format     Abstract available


  523. SANTOS CM, Peres FF, Diana MC, Justi V, et al
    Peripubertal exposure to environmental enrichment prevents schizophrenia-like behaviors in the SHR strain animal model.
    Schizophr Res. 2016 Jun 21. pii: S0920-9964(16)30273.
    PubMed     Text format     Abstract available


  524. EDWARDS AC, Bacanu SA, Bigdeli TB, Moscati A, et al
    Evaluating the dopamine hypothesis of schizophrenia in a large-scale genome-wide association study.
    Schizophr Res. 2016 Jun 20. pii: S0920-9964(16)30283.
    PubMed     Text format     Abstract available


  525. COX DA, Gottschalk MG, Wesseling H, Ernst A, et al
    Proteomic systems evaluation of the molecular validity of preclinical psychosis models compared to schizophrenia brain pathology.
    Schizophr Res. 2016 Jun 19. pii: S0920-9964(16)30279.
    PubMed     Text format     Abstract available


  526. SAVILL M, Orfanos S, Reininghaus U, Wykes T, et al
    The relationship between experiential deficits of negative symptoms and subjective quality of life in schizophrenia.
    Schizophr Res. 2016 Jun 18. pii: S0920-9964(16)30284.
    PubMed     Text format     Abstract available


  527. SALLMEN M, Suvisaari J, Lindbohm ML, Malaspina D, et al
    Paternal occupational lead exposure and offspring risks for schizophrenia.
    Schizophr Res. 2016 Jun 15. pii: S0920-9964(16)30271.
    PubMed     Text format     Abstract available


  528. LEE EE, Eyler LT, Wolkowitz OM, Martin AS, et al
    Elevated plasma F2-isoprostane levels in schizophrenia.
    Schizophr Res. 2016 Jun 15. pii: S0920-9964(16)30278.
    PubMed     Text format     Abstract available


  529. BORA E, Veznedaroglu B, Vahip S
    Theory of mind and executive functions in schizophrenia and bipolar disorder: A cross-diagnostic latent class analysis for identification of neuropsychological subtypes.
    Schizophr Res. 2016 Jun 14. pii: S0920-9964(16)30274.
    PubMed     Text format     Abstract available


  530. RAFFARD S, Bortolon C, Khoramshahi M, Salesse RN, et al
    Humanoid robots versus humans: How is emotional valence of facial expressions recognized by individuals with schizophrenia? An exploratory study.
    Schizophr Res. 2016 Jun 9. pii: S0920-9964(16)30268.
    PubMed     Text format     Abstract available


  531. IWASHIRO N, Koike S, Satomura Y, Suga M, et al
    Letter to the editor; A corrigendum with respect to our research article entitled "Association between impaired brain activity and volume at the sub-region of Broca's area in ultra-high risk and first-episode schizophrenia: A multi-modal neuroimaging
    Schizophr Res. 2016 Jun 6. pii: S0920-9964(16)30267.
    PubMed     Text format    


  532. FERRARELLI F, Tononi G
    Reduced sleep spindle activity point to a TRN-MD thalamus-PFC circuit dysfunction in schizophrenia.
    Schizophr Res. 2016 Jun 3. pii: S0920-9964(16)30247.
    PubMed     Text format     Abstract available


  533. ALVARADO-ALANIS P, Leon-Ortiz P, Reyes-Madrigal F, Favila R, et al
    Corrigendum to "abnormal white matter integrity in antipsychotic-naive first-episode psychosis patients assessed by a DTI principal component analysis" [Schizophr. Res. 162 (1-3) (march 2015) 14-21].
    Schizophr Res. 2016 Jun 2. pii: S0920-9964(16)30249.
    PubMed     Text format    


  534. RANDALL JR, Chateau D, Smith M, Taylor C, et al
    An early intervention for psychosis and its effect on criminal accusations and suicidal behaviour using a matched-cohort design.
    Schizophr Res. 2016 Jun 1. pii: S0920-9964(16)30244.
    PubMed     Text format     Abstract available


  535. DICKERSON F, Adamos MB, Katsafanas E, Khushalani S, et al
    The association among smoking, HSV-1 exposure, and cognitive functioning in schizophrenia, bipolar disorder, and non-psychiatric controls.
    Schizophr Res. 2016 Jun 1. pii: S0920-9964(16)30246.
    PubMed     Text format     Abstract available


    May 2016
  536. STUBBS B, Firth J, Berry A, Schuch FB, et al
    How much physical activity do people with schizophrenia engage in? A systematic review, comparative meta-analysis and meta-regression.
    Schizophr Res. 2016 May 31. pii: S0920-9964(16)30241.
    PubMed     Text format     Abstract available


  537. PERALTA V, Cuesta MJ
    Characteristics and clinical correlates of dimensions of delusional experience in schizophrenia and delusional disorder.
    Schizophr Res. 2016 May 31. pii: S0920-9964(16)30248.
    PubMed     Text format    


  538. TAKEUCHI H, Fervaha G, Lee J, Remington G, et al
    What symptom domains are associated with patient distress in schizophrenia?
    Schizophr Res. 2016 May 31. pii: S0920-9964(16)30245.
    PubMed     Text format    


  539. WOOD L, Byrne R, Varese F, Morrison AP, et al
    Psychosocial interventions for internalised stigma in people with a schizophrenia-spectrum diagnosis: A systematic narrative synthesis and meta-analysis.
    Schizophr Res. 2016 May 30. pii: S0920-9964(16)30219.
    PubMed     Text format     Abstract available


  540. DE DEYNE S, Elvevag B, Hui CL, Poon VW, et al
    Rich semantic networks applied to schizophrenia: A new framework.
    Schizophr Res. 2016 May 28. pii: S0920-9964(16)30240.
    PubMed     Text format    


  541. REDDY LF, Green MF, Wynn JK, Rinck M, et al
    Approaching anger in schizophrenia: What an implicit task tells you that self-report does not.
    Schizophr Res. 2016 May 27. pii: S0920-9964(16)30242.
    PubMed     Text format     Abstract available


  542. MCFADDEN WC, Jaffe AE, Ye T, Paltan-Ortiz JD, et al
    Assessment of genetic risk for distribution of total interstitial white matter neurons in dorsolateral prefrontal cortex: role in schizophrenia.
    Schizophr Res. 2016 May 27. pii: S0920-9964(16)30156.
    PubMed     Text format    


  543. FU YY, Zhang T, Xiu MH, Tang W, et al
    Altered serum levels of interleukin-3 in first-episode drug-naive and chronic medicated schizophrenia.
    Schizophr Res. 2016 May 26. pii: S0920-9964(16)30232.
    PubMed     Text format     Abstract available


  544. PINACHO R, Villalmanzo N, Meana JJ, Ferrer I, et al
    Altered CSNK1E, FABP4 and NEFH protein levels in the dorsolateral prefrontal cortex in schizophrenia.
    Schizophr Res. 2016 May 25. pii: S0920-9964(16)30220.
    PubMed     Text format     Abstract available


  545. HASSAN AN, Stuart EA, De Luca V
    Childhood maltreatment increases the risk of suicide attempt in schizophrenia.
    Schizophr Res. 2016 May 25. pii: S0920-9964(16)30236.
    PubMed     Text format     Abstract available


  546. HESLIN M, Lappin JM, Donoghue K, Lomas B, et al
    Ten-year outcomes in first episode psychotic major depression patients compared with schizophrenia and bipolar patients.
    Schizophr Res. 2016 May 25. pii: S0920-9964(16)30198.
    PubMed     Text format     Abstract available


  547. FOTI D, Perlman G, Hajcak G, Mohanty A, et al
    Impaired error processing in late-phase psychosis: Four-year stability and relationships with negative symptoms.
    Schizophr Res. 2016 May 24. pii: S0920-9964(16)30230.
    PubMed     Text format     Abstract available


  548. SEOW LS, Ong C, Mahesh MV, Sagayadevan V, et al
    A systematic review on comorbid post-traumatic stress disorder in schizophrenia.
    Schizophr Res. 2016 May 23. pii: S0920-9964(16)30225.
    PubMed     Text format     Abstract available


  549. SAPRA M, Lawson D, Iranmanesh A, Varma A, et al
    Adiposity-independent hypoadiponectinemia as a potential marker of insulin resistance and inflammation in schizophrenia patients treated with second generation antipsychotics.
    Schizophr Res. 2016 May 19. pii: S0920-9964(16)30221.
    PubMed     Text format     Abstract available


  550. GALDERISI S, Rossi A, Rocca P, Bertolino A, et al
    Pathways to functional outcome in subjects with schizophrenia living in the community and their unaffected first-degree relatives.
    Schizophr Res. 2016 May 18. pii: S0920-9964(16)30189.
    PubMed     Text format     Abstract available


  551. CELIK C, Balikci A, Ozdemir B, Oznur T, et al
    BDNF and other biological markers are associated with schizophrenia onset and positive symptoms: A different approach.
    Schizophr Res. 2016 May 18. pii: S0920-9964(16)30226.
    PubMed     Text format    


  552. BAUDIN G, Godin O, Lajnef M, Aouizerate B, et al
    Differential effects of childhood trauma and cannabis use disorders in patients suffering from schizophrenia.
    Schizophr Res. 2016 May 18. pii: S0920-9964(16)30190.
    PubMed     Text format     Abstract available


  553. MORITZ S, Ludtke T, Westermann S, Hermeneit J, et al
    Dysfunctional coping with stress in psychosis. An investigation with the Maladaptive and Adaptive Coping Styles (MAX) questionnaire.
    Schizophr Res. 2016 May 17. pii: S0920-9964(16)30174.
    PubMed     Text format     Abstract available


  554. MORITZ S, Schroder J, Klein JP, Lincoln TM, et al
    Effects of online intervention for depression on mood and positive symptoms in schizophrenia.
    Schizophr Res. 2016 May 17. pii: S0920-9964(16)30182.
    PubMed     Text format     Abstract available


  555. HOU CL, Xiang YT, Wang ZL, Everall I, et al
    Cognitive functioning in individuals at ultra-high risk for psychosis, first-degree relatives of patients with psychosis and patients with first-episode schizophrenia.
    Schizophr Res. 2016 May 16. pii: S0920-9964(16)30183.
    PubMed     Text format     Abstract available


  556. ROMINGER C, Bleier A, Fitz W, Marksteiner J, et al
    Auditory top-down control and affective theory of mind in schizophrenia with and without hallucinations.
    Schizophr Res. 2016 May 16. pii: S0920-9964(16)30228.
    PubMed     Text format     Abstract available


  557. KANE JM, Skuban A, Hobart M, Ouyang J, et al
    Overview of short- and long-term tolerability and safety of brexpiprazole in patients with schizophrenia.
    Schizophr Res. 2016 May 14. pii: S0920-9964(16)30162.
    PubMed     Text format     Abstract available


  558. MIZUNO Y, Hofer A, Suzuki T, Frajo-Apor B, et al
    Clinical and biological correlates of resilience in patients with schizophrenia and bipolar disorder: A cross-sectional study.
    Schizophr Res. 2016 May 13. pii: S0920-9964(16)30196.
    PubMed     Text format     Abstract available


  559. GALDERISI S, Farden A, Kaiser S
    Dissecting negative symptoms of schizophrenia: History, assessment, pathophysiological mechanisms and treatment.
    Schizophr Res. 2016 May 13. pii: S0920-9964(16)30195.
    PubMed     Text format    


  560. DEAN B, Copolov D, Scarr E
    Understanding the pathophysiology of schizophrenia: Contributions from the Melbourne Psychiatric Brain Bank.
    Schizophr Res. 2016 May 12. pii: S0920-9964(16)30186.
    PubMed     Text format     Abstract available


  561. BARKER V, Bois C, Neilson E, Johnstone EC, et al
    Childhood adversity and hippocampal and amygdala volumes in a population at familial high risk of schizophrenia.
    Schizophr Res. 2016 May 11. pii: S0920-9964(16)30177.
    PubMed     Text format     Abstract available


  562. CERETTA AP, Schaffer LF, de Freitas CM, Reinheimer JB, et al
    Gabapentin prevents behavioral changes on the amphetamine-induced animal model of schizophrenia.
    Schizophr Res. 2016 May 11. pii: S0920-9964(16)30193.
    PubMed     Text format    


  563. ALBACETE A, Bosque C, Custal N, Crespo JM, et al
    Emotional intelligence in non-psychotic first-degree relatives of people with schizophrenia.
    Schizophr Res. 2016 May 10. pii: S0920-9964(16)30188.
    PubMed     Text format     Abstract available


  564. AOKI A, Aoki Y, Goulden R, Kasai K, et al
    Change in newspaper coverage of schizophrenia in Japan over 20-year period.
    Schizophr Res. 2016 May 10. pii: S0920-9964(16)30175.
    PubMed     Text format     Abstract available


  565. NELSON B, Yuen HP, Lin A, Wood SJ, et al
    Further examination of the reducing transition rate in ultra high risk for psychosis samples: The possible role of earlier intervention.
    Schizophr Res. 2016 May 9. pii: S0920-9964(16)30191.
    PubMed     Text format     Abstract available


  566. DEIGHTON S, Buchy L, Cadenhead KS, Cannon TD, et al
    Traumatic brain injury in individuals at clinical high risk for psychosis.
    Schizophr Res. 2016 May 7. pii: S0920-9964(16)30192.
    PubMed     Text format     Abstract available


  567. KINDLER J, Schultze-Lutter F, Michel C, Martz-Irngartinger A, et al
    Abnormal involuntary movements are linked to psychosis-risk in children and adolescents: Results of a population-based study.
    Schizophr Res. 2016 May 7. pii: S0920-9964(16)30181.
    PubMed     Text format     Abstract available


  568. PACCALET T, Gilbert E, Berthelot N, Marquet P, et al
    Liability indicators aggregate many years before transition to illness in offspring descending from kindreds affected by schizophrenia or bipolar disorder.
    Schizophr Res. 2016 May 6. pii: S0920-9964(16)30187.
    PubMed     Text format    


  569. BERNIER D, Bartha R, McAllindon D, Hanstock CC, et al
    Illness versus substance use effects on the frontal white matter in early phase schizophrenia: A 4Tesla H-MRS study.
    Schizophr Res. 2016 May 5. pii: S0920-9964(16)30172.
    PubMed     Text format     Abstract available


  570. KOYANAGI A, Stickley A, Haro JM
    Subclinical psychosis and pain in an English national sample: The role of common mental disorders.
    Schizophr Res. 2016 May 5. pii: S0920-9964(16)30180.
    PubMed     Text format     Abstract available


  571. PINACHO R, Vila E, Prades R, Tarrago T, et al
    The glial phosphorylase of glycogen isoform is reduced in the dorsolateral prefrontal cortex in chronic schizophrenia.
    Schizophr Res. 2016 May 4. pii: S0920-9964(16)30169.
    PubMed     Text format     Abstract available


  572. MILLER BJ, Goldsmith DR, Paletta N, Wong J, et al
    Parental type 2 diabetes in patients with non-affective psychosis.
    Schizophr Res. 2016 May 4. pii: S0920-9964(16)30184.
    PubMed     Text format     Abstract available


  573. MALLA A, Mustafa S, Rho A, Abadi S, et al
    Therapeutic effectiveness and tolerability of aripiprazole as initial choice of treatment in first episode psychosis in an early intervention service: A one-year outcome study.
    Schizophr Res. 2016 May 3. pii: S0920-9964(16)30185.
    PubMed     Text format     Abstract available


  574. CORRELL CU, Skuban A, Hobart M, Ouyang J, et al
    Efficacy of brexpiprazole in patients with acute schizophrenia: Review of three randomized, double-blind, placebo-controlled studies.
    Schizophr Res. 2016 May 3. pii: S0920-9964(16)30161.
    PubMed     Text format     Abstract available


  575. VIKHREVA OV, Rakhmanova VI, Orlovskaya DD, Uranova NA, et al
    Ultrastructural alterations of oligodendrocytes in prefrontal white matter in schizophrenia: A post-mortem morphometric study.
    Schizophr Res. 2016 May 2. pii: S0920-9964(16)30173.
    PubMed     Text format     Abstract available


  576. PAKSARIAN D, Merikangas KR, Calkins ME, Gur RE, et al
    Erratum to "Racial-ethnic disparities in empirically-derived subtypes of subclinical psychosis among a U.S. sample of youths" [Schizophr. Res. 170 (2016) 205-210].
    Schizophr Res. 2016;173.
    PubMed     Text format    


    April 2016
  577. DUNN W, Rassovsky Y, Wynn JK, Wu AD, et al
    Modulation of neurophysiological auditory processing measures by bilateral transcranial direct current stimulation in schizophrenia.
    Schizophr Res. 2016 Apr 28. pii: S0920-9964(16)30171.
    PubMed     Text format     Abstract available


  578. MILLARD SP, Shofer J, Braff D, Calkins M, et al
    Prioritizing schizophrenia endophenotypes for future genetic studies: An example using data from the COGS-1 family study.
    Schizophr Res. 2016 Apr 28. pii: S0920-9964(16)30160.
    PubMed     Text format     Abstract available


  579. JOHANSSON AS, Owe-Larsson B, Hetta J, Lundkvist GB, et al
    Altered circadian clock gene expression in patients with schizophrenia.
    Schizophr Res. 2016 Apr 28. pii: S0920-9964(16)30178.
    PubMed     Text format     Abstract available


  580. GEE B, Hodgekins J, Fowler D, Marshall M, et al
    The course of negative symptom in first episode psychosis and the relationship with social recovery.
    Schizophr Res. 2016 Apr 28. pii: S0920-9964(16)30166.
    PubMed     Text format     Abstract available


  581. CZEPIELEWSKI LS, Massuda R, Panizzutti B, da Rosa ED, et al
    Telomere length in subjects with schizophrenia, their unaffected siblings and healthy controls: Evidence of accelerated aging.
    Schizophr Res. 2016 Apr 27. pii: S0920-9964(16)30135.
    PubMed     Text format     Abstract available


  582. STEPHAN-OTTO C, Siddi S, Cuevas Esteban J, Senior C, et al
    Neural activity during object perception in schizophrenia patients is associated with illness duration and affective symptoms.
    Schizophr Res. 2016 Apr 26. pii: S0920-9964(16)30170.
    PubMed     Text format     Abstract available


  583. GARCIA-BEA A, Walker MA, Hyde TM, Kleinman JE, et al
    Metabotropic glutamate receptor 3 (mGlu3; mGluR3; GRM3) in schizophrenia: Antibody characterisation and a semi-quantitative western blot study.
    Schizophr Res. 2016 Apr 26. pii: S0920-9964(16)30164.
    PubMed     Text format     Abstract available


  584. CASEY D, Brown L, Galwani R, Islam Z, et al
    Predictors of engagement in first-episode psychosis.
    Schizophr Res. 2016 Apr 25. pii: S0920-9964(16)30179.
    PubMed     Text format     Abstract available


  585. UHRIG S, Hirth N, Broccoli L, von Wilmsdorff M, et al
    Reduced oxytocin receptor gene expression and binding sites in different brain regions in schizophrenia: A post-mortem study.
    Schizophr Res. 2016 Apr 25. pii: S0920-9964(16)30168.
    PubMed     Text format     Abstract available


  586. BORA E, Pantelis C
    Social cognition in schizophrenia in comparison to bipolar disorder: A meta-analysis.
    Schizophr Res. 2016 Apr 22. pii: S0920-9964(16)30167.
    PubMed     Text format     Abstract available


  587. HUBER CG, Hochstrasser L, Meister K, Schimmelmann BG, et al
    Evidence for an agitated-aggressive syndrome in early-onset psychosis correlated with antisocial personality disorder, forensic history, and substance use disorder.
    Schizophr Res. 2016 Apr 22. pii: S0920-9964(16)30176.
    PubMed     Text format     Abstract available


  588. KLINE E, Millman ZB, Denenny D, Wilson C, et al
    Trauma and psychosis symptoms in a sample of help-seeking youth.
    Schizophr Res. 2016 Apr 20. pii: S0920-9964(16)30155.
    PubMed     Text format     Abstract available


  589. JOHN J, Bhatia T, Kukshal P, Chandna P, et al
    Association study of MiRSNPs with schizophrenia, tardive dyskinesia and cognition.
    Schizophr Res. 2016 Apr 19. pii: S0920-9964(16)30123.
    PubMed     Text format     Abstract available


  590. VERU F, Jordan G, Joober R, Malla A, et al
    Adolescent vs. adult onset of a first episode psychosis: Impact on remission of positive and negative symptoms.
    Schizophr Res. 2016 Apr 18. pii: S0920-9964(16)30127.
    PubMed     Text format     Abstract available


  591. VOGEL T, Smieskova R, Schmidt A, Walter A, et al
    Increased superior frontal gyrus activation during working memory processing in psychosis: Significant relation to cumulative antipsychotic medication and to negative symptoms.
    Schizophr Res. 2016 Apr 18. pii: S0920-9964(16)30125.
    PubMed     Text format     Abstract available


  592. OHI K, Kikuchi M, Ikeda M, Yamamori H, et al
    Polygenetic components for schizophrenia, bipolar disorder and rheumatoid arthritis predict risk of schizophrenia.
    Schizophr Res. 2016 Apr 17. pii: S0920-9964(16)30158.
    PubMed     Text format    


  593. SAIA-CEREDA VM, Cassoli JS, Schmitt A, Falkai P, et al
    Differential proteome and phosphoproteome may impact cell signaling in the corpus callosum of schizophrenia patients.
    Schizophr Res. 2016 Apr 16. pii: S0920-9964(16)30114.
    PubMed     Text format     Abstract available


  594. VAN HAREN NE, Kahn RS
    Progressive brain tissue loss in schizophrenia.
    Schizophr Res. 2016 Apr 16. pii: S0920-9964(16)30115.
    PubMed     Text format    


  595. WINKLER P, Mlada K, Krupchanka D, Agius M, et al
    Long-term hospitalizations for schizophrenia in the Czech Republic 1998-2012.
    Schizophr Res. 2016 Apr 16. pii: S0920-9964(16)30157.
    PubMed     Text format     Abstract available


  596. VITA A, Deste G, Barlati S, Grano A, et al
    Does cognitive remediation modify the use of psychiatric services and the patterns of care of patients with schizophrenia?
    Schizophr Res. 2016 Apr 16. pii: S0920-9964(16)30126.
    PubMed     Text format     Abstract available


  597. BONFILS KA, Lysaker PH, Minor KS, Salyers MP, et al
    Affective empathy in schizophrenia: a meta-analysis.
    Schizophr Res. 2016 Apr 16. pii: S0920-9964(16)30129.
    PubMed     Text format     Abstract available


  598. WANG MY, Ho NF, Sum MY, Collinson SL, et al
    Impact of duration of untreated psychosis and premorbid intelligence on cognitive functioning in patients with first-episode schizophrenia.
    Schizophr Res. 2016 Apr 14. pii: S0920-9964(16)30134.
    PubMed     Text format     Abstract available


  599. MAVROGIORGOU P, Dunnweber M, Juckel G
    Obsessive compulsive symptoms (OCS) in patients with schizophrenia are rare.
    Schizophr Res. 2016 Apr 13. pii: S0920-9964(16)30132.
    PubMed     Text format    


  600. HAIGH SM, Gupta A, Barb SM, Glass SA, et al
    Differential sensory fMRI signatures in autism and schizophrenia: Analysis of amplitude and trial-to-trial variability.
    Schizophr Res. 2016 Apr 12. pii: S0920-9964(16)30128.
    PubMed     Text format     Abstract available


  601. BJORKQUIST OA, Olsen EK, Nelson BD, Herbener ES, et al
    Altered amygdala-prefrontal connectivity during emotion perception in schizophrenia.
    Schizophr Res. 2016 Apr 12. pii: S0920-9964(16)30136.
    PubMed     Text format     Abstract available


  602. WIMBERLEY T, Pedersen CB, MacCabe JH, Stovring H, et al
    Inverse association between urbanicity and treatment resistance in schizophrenia.
    Schizophr Res. 2016 Apr 8. pii: S0920-9964(16)30113.
    PubMed     Text format     Abstract available


  603. GONZALEZ-PENAS J, Amigo J, Santome L, Sobrino B, et al
    Targeted resequencing of regulatory regions at schizophrenia risk loci: Role of rare functional variants at chromatin repressive states.
    Schizophr Res. 2016 Apr 8. pii: S0920-9964(16)30121.
    PubMed     Text format     Abstract available


  604. ISITT JJ, Nadipelli VR, Kouassi A, Fava M, et al
    Health-related quality of life in acute schizophrenia patients treated with RBP-7000 once monthly risperidone: An 8-week, randomized, double-blind, placebo-controlled, multicenter phase 3 study.
    Schizophr Res. 2016 Apr 7. pii: S0920-9964(16)30105.
    PubMed     Text format     Abstract available


  605. OHI K, Shimada T, Nitta Y, Kihara H, et al
    Specific gene expression patterns of 108 schizophrenia-associated loci in cortex.
    Schizophr Res. 2016 Apr 6. pii: S0920-9964(16)30124.
    PubMed     Text format     Abstract available


  606. CHOU PH, Chu CS, Lin CH, Cheng C, et al
    Use of atypical antipsychotics and risks of cataract development in patients with schizophrenia: A population-based, nested case-control study.
    Schizophr Res. 2016 Apr 6. pii: S0920-9964(16)30120.
    PubMed     Text format     Abstract available


  607. GONZALEZ-BLANCO L, Greenhalgh AM, Garcia-Rizo C, Egea EF, et al
    Prolactin concentrations in antipsychotic-naive patients with schizophrenia and related disorders: A meta-analysis.
    Schizophr Res. 2016 Apr 5. pii: S0920-9964(16)30111.
    PubMed     Text format     Abstract available


  608. SHIN YS, Kim SY, Lee TY, Hur JW, et al
    Longitudinal change in neurocognition and its relation to symptomatic and functional changes over 2years in individuals at clinical high-risk for psychosis.
    Schizophr Res. 2016 Apr 5. pii: S0920-9964(16)30116.
    PubMed     Text format     Abstract available


  609. ONWUAMEZE OE, Titone D, Ho BC
    Transitive inference deficits in unaffected biological relatives of schizophrenia patients.
    Schizophr Res. 2016 Apr 2. pii: S0920-9964(16)30071.
    PubMed     Text format     Abstract available


  610. HUI CL, Poon VW, Ko WT, Miao HY, et al
    Risk factors for antipsychotic medication non-adherence behaviors and attitudes in adult-onset psychosis.
    Schizophr Res. 2016 Apr 2. pii: S0920-9964(16)30118.
    PubMed     Text format     Abstract available


  611. BERGH S, Hjorthoj C, Sorensen HJ, Fagerlund B, et al
    Predictors and longitudinal course of cognitive functioning in schizophrenia spectrum disorders, 10years after baseline: The OPUS study.
    Schizophr Res. 2016 Apr 2. pii: S0920-9964(16)30117.
    PubMed     Text format     Abstract available


  612. NIEMAN DH, Dragt S, van Duin ED, Denneman N, et al
    COMT ValMet genotype and cannabis use in people with an At Risk Mental State for psychosis: Exploring Gene x Environment interactions.
    Schizophr Res. 2016 Apr 1. pii: S0920-9964(16)30108.
    PubMed     Text format     Abstract available


  613. GREENWOOD KE, Morris R, Smith V, Jones AM, et al
    Virtual shopping: A viable alternative to direct assessment of real life function?
    Schizophr Res. 2016;172.
    PubMed     Text format     Abstract available


  614. BLANCO-LOPEZ MJ, Cudeiro-Blanco J, Iglesias G, Gago A, et al
    A simple, repeated rTMS protocol effectively removes auditory verbal hallucinations in a single patient study.
    Schizophr Res. 2016;172.
    PubMed     Text format    


  615. STONE WS, Mesholam-Gately RI, Giuliano AJ, Woodberry KA, et al
    Healthy adolescent performance on the MATRICS Consensus Cognitive Battery (MCCB): Developmental data from two samples of volunteers.
    Schizophr Res. 2016;172.
    PubMed     Text format     Abstract available


  616. DE SOUSA P, Sellwood W, Spray A, Bentall RP, et al
    The affective reactivity of psychotic speech: The role of internal source monitoring in explaining increased thought disorder under emotional challenge.
    Schizophr Res. 2016;172.
    PubMed     Text format     Abstract available


    March 2016
  617. COFFMAN BA, Haigh SM, Murphy TK, Salisbury DF, et al
    Event-related potentials demonstrate deficits in acoustic segmentation in schizophrenia.
    Schizophr Res. 2016 Mar 28. pii: S0920-9964(16)30103.
    PubMed     Text format     Abstract available


  618. SHUKLA AA, Jha M, Birchfield T, Mukherjee S, et al
    COMT val158met polymorphism and molecular alterations in the human dorsolateral prefrontal cortex: Differences in controls and in schizophrenia.
    Schizophr Res. 2016 Mar 24. pii: S0920-9964(16)30112.
    PubMed     Text format     Abstract available


  619. WRIGHT B, Peters E, Ettinger U, Kuipers E, et al
    Effects of environmental noise on cognitive (dys)functions in schizophrenia: A pilot within-subjects experimental study.
    Schizophr Res. 2016 Mar 23. pii: S0920-9964(16)30110.
    PubMed     Text format     Abstract available


  620. CHANG WC, Kwong VW, Chan GH, Jim OT, et al
    Prediction of functional remission in first-episode psychosis: 12-month follow-up of the randomized-controlled trial on extended early intervention in Hong Kong.
    Schizophr Res. 2016 Mar 23. pii: S0920-9964(16)30109.
    PubMed     Text format     Abstract available


  621. ANTONUCCI LA, Taurisano P, Fazio L, Gelao B, et al
    Association of familial risk for schizophrenia with thalamic and medial prefrontal functional connectivity during attentional control.
    Schizophr Res. 2016 Mar 21. pii: S0920-9964(16)30107.
    PubMed     Text format     Abstract available


  622. POTVIN S, Lungu O, Lipp O, Lalonde P, et al
    Increased ventro-medial prefrontal activations in schizophrenia smokers during cigarette cravings.
    Schizophr Res. 2016 Mar 18. pii: S0920-9964(16)30104.
    PubMed     Text format     Abstract available


  623. OMER S, Finnegan M, Pringle DG, Kinsella A, et al
    Socioeconomic status at birth and risk for first episode psychosis in rural Ireland: Eliminating the features of urbanicity in the Cavan-Monaghan First Episode Psychosis Study (CAMFEPS).
    Schizophr Res. 2016 Mar 17. pii: S0920-9964(16)30098.
    PubMed     Text format     Abstract available


  624. CUI LB, Liu K, Li C, Wang LX, et al
    Putamen-related regional and network functional deficits in first-episode schizophrenia with auditory verbal hallucinations.
    Schizophr Res. 2016 Mar 16. pii: S0920-9964(16)30093.
    PubMed     Text format     Abstract available


  625. WU CS, Cheng IC, Feng J, Chen CL, et al
    Comparison of treatment effectiveness and medical costs for different long-acting injectable antipsychotics in patients with schizophrenia in Taiwan: A nationwide population-based cohort study.
    Schizophr Res. 2016 Mar 14. pii: S0920-9964(16)30091.
    PubMed     Text format     Abstract available


  626. ARMSTRONG HF, Bartels MN, Paslavski O, Cain D, et al
    The impact of aerobic exercise training on cardiopulmonary functioning in individuals with schizophrenia.
    Schizophr Res. 2016 Mar 11. pii: S0920-9964(16)30102.
    PubMed     Text format    


  627. VOLK DW, Edelson JR, Lewis DA
    Altered expression of developmental regulators of parvalbumin and somatostatin neurons in the prefrontal cortex in schizophrenia.
    Schizophr Res. 2016 Mar 10. pii: S0920-9964(16)30094.
    PubMed     Text format     Abstract available


  628. RAUTIO N, Kakela J, Nordstrom T, Miettunen J, et al
    Prognosis of schizophrenia spectrum disorder may not be predetermined during early development - the Northern Finland Birth Cohort 1966.
    Schizophr Res. 2016 Mar 9. pii: S0920-9964(16)30092.
    PubMed     Text format     Abstract available


  629. KANAHARA N, Kimura H, Iyo M
    Reply to "concern over your recent paper on risperidone long-acting injectable for treatment-resistant schizophrenia".
    Schizophr Res. 2016 Mar 9. pii: S0920-9964(16)30099.
    PubMed     Text format    


  630. BARAKAUSKAS VE, Moradian A, Barr AM, Beasley CL, et al
    Quantitative mass spectrometry reveals changes in SNAP-25 isoforms in schizophrenia.
    Schizophr Res. 2016 Mar 9. pii: S0920-9964(16)30095.
    PubMed     Text format     Abstract available


  631. NAEEM F, Johal R, McKenna C, Rathod S, et al
    Cognitive Behavior Therapy for psychosis based Guided Self-help (CBTp-GSH) delivered by frontline mental health professionals: Results of a feasibility study.
    Schizophr Res. 2016 Mar 9. pii: S0920-9964(16)30096.
    PubMed     Text format     Abstract available


  632. TARRICONE I, Boydell J, Kokona A, Triolo F, et al
    Risk of psychosis and internal migration: Results from the Bologna First Episode Psychosis study.
    Schizophr Res. 2016 Mar 8. pii: S0920-9964(16)30088.
    PubMed     Text format     Abstract available


  633. THERMENOS HW, Juelich RJ, DiChiara SR, Mesholam-Gately RI, et al
    Hyperactivity of caudate, parahippocampal, and prefrontal regions during working memory in never-medicated persons at clinical high-risk for psychosis.
    Schizophr Res. 2016 Mar 7. pii: S0920-9964(16)30078.
    PubMed     Text format     Abstract available


  634. BERNSTEIN HG, Hildebrandt J, Dobrowolny H, Steiner J, et al
    Morphometric analysis of the cerebral expression of ATP-binding cassette transporter protein ABCB1 in chronic schizophrenia: Circumscribed deficits in the habenula.
    Schizophr Res. 2016 Mar 3. pii: S0920-9964(16)30090.
    PubMed     Text format     Abstract available


  635. DEPP CA, Moore RC, Perivoliotis D, Holden JL, et al
    Social behavior, interaction appraisals, and suicidal ideation in schizophrenia: The dangers of being alone.
    Schizophr Res. 2016 Mar 2. pii: S0920-9964(16)30083.
    PubMed     Text format     Abstract available


  636. DAVIDSON CA, Johannesen JK, Fiszdon JM
    Role of learning potential in cognitive remediation: Construct and predictive validity.
    Schizophr Res. 2016;171.
    PubMed     Text format     Abstract available


    February 2016
  637. GARDSJORD ES, Romm KL, Friis S, Barder HE, et al
    Subjective quality of life in first-episode psychosis. A ten year follow-up study.
    Schizophr Res. 2016 Feb 29. pii: S0920-9964(16)30087.
    PubMed     Text format     Abstract available


  638. MALASPINA D, Kranz TM, Heguy A, Harroch S, et al
    Prefrontal neuronal integrity predicts symptoms and cognition in schizophrenia and is sensitive to genetic heterogeneity.
    Schizophr Res. 2016 Feb 26. pii: S0920-9964(16)30085.
    PubMed     Text format     Abstract available


  639. BRANDT AS, Unschuld PG, Pradhan S, Lim IA, et al
    Age-related changes in anterior cingulate cortex glutamate in schizophrenia: A H MRS Study at 7Tesla.
    Schizophr Res. 2016 Feb 26. pii: S0920-9964(16)30073.
    PubMed     Text format     Abstract available


  640. MOE AM, Breitborde NJ, Shakeel MK, Gallagher CJ, et al
    Idea density in the life-stories of people with schizophrenia: Associations with narrative qualities and psychiatric symptoms.
    Schizophr Res. 2016 Feb 26. pii: S0920-9964(16)30072.
    PubMed     Text format     Abstract available


  641. SALGADO-PINEDA P, Landin-Romero R, Portillo F, Bosque C, et al
    Examining hippocampal function in schizophrenia using a virtual reality spatial navigation task.
    Schizophr Res. 2016 Feb 25. pii: S0920-9964(16)30089.
    PubMed     Text format     Abstract available


  642. FRAJO-APOR B, Pardeller S, Kemmler G, Welte AS, et al
    Emotional Intelligence deficits in schizophrenia: The impact of non-social cognition.
    Schizophr Res. 2016 Feb 25. pii: S0920-9964(16)30082.
    PubMed     Text format     Abstract available


  643. STEINER J, Brisch R, Schiltz K, Dobrowolny H, et al
    GABAergic system impairment in the hippocampus and superior temporal gyrus of patients with paranoid schizophrenia: A post-mortem study.
    Schizophr Res. 2016 Feb 24. pii: S0920-9964(16)30074.
    PubMed     Text format     Abstract available


  644. LITMAN RE, Smith MA, Doherty JJ, Cross A, et al
    AZD8529, a positive allosteric modulator at the mGluR2 receptor, does not improve symptoms in schizophrenia: A proof of principle study.
    Schizophr Res. 2016 Feb 24. pii: S0920-9964(16)30057.
    PubMed     Text format     Abstract available


  645. LANDOLT K, Rossler W, Ajdacic-Gross V, Derks EM, et al
    Predictors of discontinuation of antipsychotic medication and subsequent outcomes in the European First Episode Schizophrenia Trial (EUFEST).
    Schizophr Res. 2016 Feb 24. pii: S0920-9964(16)30046.
    PubMed     Text format     Abstract available


  646. MOSKOW DM, Addington J, Bearden CE, Cadenhead KS, et al
    The relations of age and pubertal development with cortisol and daily stress in youth at clinical risk for psychosis.
    Schizophr Res. 2016 Feb 20. pii: S0920-9964(16)30058.
    PubMed     Text format     Abstract available


  647. BATTY RA, Francis A, Thomas N, Hopwood M, et al
    Predicting co-morbid traumatic brain injury and psychosis from neuropsychological profile.
    Schizophr Res. 2016 Feb 19. pii: S0920-9964(16)30076.
    PubMed     Text format    


  648. BUCHY L, Barbato M, MacMaster FP, Bray S, et al
    Cognitive insight is associated with cortical thickness in first-episode psychosis.
    Schizophr Res. 2016 Feb 18. pii: S0920-9964(16)30081.
    PubMed     Text format     Abstract available


  649. XIAO X, Li M
    Replication of Han Chinese GWAS loci for schizophrenia via meta-analysis of four independent samples.
    Schizophr Res. 2016 Feb 18. pii: S0920-9964(16)30075.
    PubMed     Text format     Abstract available


  650. ALLSWEDE DM, Buka SL, Yolken RH, Torrey EF, et al
    Elevated maternal cytokine levels at birth and risk for psychosis in adult offspring.
    Schizophr Res. 2016 Feb 17. pii: S0920-9964(16)30077.
    PubMed     Text format     Abstract available


  651. FORERO DA, Herteleer L, De Zutter S, Norrback KF, et al
    A network of synaptic genes associated with schizophrenia and bipolar disorder.
    Schizophr Res. 2016 Feb 15. pii: S0920-9964(16)30068.
    PubMed     Text format     Abstract available


  652. NIELSEN PR, Meyer U, Mortensen PB
    Individual and combined effects of maternal anemia and prenatal infection on risk for schizophrenia in offspring.
    Schizophr Res. 2016 Feb 15. pii: S0920-9964(16)30080.
    PubMed     Text format     Abstract available


  653. DAGANI J, Sisti D, Abelli M, Di Paolo L, et al
    Do we need oxytocin to treat schizophrenia? A randomized clinical trial.
    Schizophr Res. 2016 Feb 13. pii: S0920-9964(16)30067.
    PubMed     Text format     Abstract available


  654. DARRELL-BERRY H, Berry K, Bucci S
    The relationship between paranoia and aggression in psychosis: A systematic review.
    Schizophr Res. 2016 Feb 12. pii: S0920-9964(16)30065.
    PubMed     Text format     Abstract available


  655. LEE MR, Wehring HJ, McMahon RP, Liu F, et al
    Relationship of plasma oxytocin levels to baseline symptoms and symptom changes during three weeks of daily oxytocin administration in people with schizophrenia.
    Schizophr Res. 2016 Feb 12. pii: S0920-9964(16)30070.
    PubMed     Text format     Abstract available


  656. OAKLEY C, Harris S, Fahy T, Murphy D, et al
    Childhood adversity and conduct disorder: A developmental pathway to violence in schizophrenia.
    Schizophr Res. 2016 Feb 12. pii: S0920-9964(16)30047.
    PubMed     Text format     Abstract available


  657. PIERRE JM, Gandal M, Son M
    Cannabis-induced psychosis associated with high potency "wax dabs".
    Schizophr Res. 2016 Feb 11. pii: S0920-9964(16)30056.
    PubMed     Text format     Abstract available


  658. KNOCHEL C, Reuter J, Reinke B, Stablein M, et al
    Cortical thinning in bipolar disorder and schizophrenia.
    Schizophr Res. 2016 Feb 11. pii: S0920-9964(16)30063.
    PubMed     Text format     Abstract available


  659. PINNER AL, Tucholski J, Haroutunian V, McCullumsmith RE, et al
    Decreased protein S-palmitoylation in dorsolateral prefrontal cortex in schizophrenia.
    Schizophr Res. 2016 Feb 11. pii: S0920-9964(16)30055.
    PubMed     Text format     Abstract available


  660. ROMERO-FERREIRO MV, Aguado L, Rodriguez-Torresano J, Palomo T, et al
    Facial affect recognition in early and late-stage schizophrenia patients.
    Schizophr Res. 2016 Feb 10. pii: S0920-9964(16)30066.
    PubMed     Text format     Abstract available


  661. IWASHIRO N, Koike S, Satomura Y, Suga M, et al
    Association between impaired brain activity and volume at the sub-region of Broca's area in ultra-high risk and first-episode schizophrenia: A multi-modal neuroimaging study.
    Schizophr Res. 2016 Feb 9. pii: S0920-9964(16)30061.
    PubMed     Text format     Abstract available


  662. PERES FF, Diana MC, Suiama MA, Justi V, et al
    Peripubertal treatment with cannabidiol prevents the emergence of psychosis in an animal model of schizophrenia.
    Schizophr Res. 2016 Feb 4. pii: S0920-9964(16)30060.
    PubMed     Text format    


  663. CAO B, Wang DF, Xu MY, Liu YQ, et al
    Vitamin B and the risk of schizophrenia: A meta-analysis.
    Schizophr Res. 2016 Feb 4. pii: S0920-9964(16)30051.
    PubMed     Text format    


  664. KOCAZEYBEK B, Yuksel P
    A contribution to the Torrey et al.'s "cat ownership in childhood is a significant risk factor for later developing schizophrenia" study.
    Schizophr Res. 2016 Feb 4. pii: S0920-9964(16)30052.
    PubMed     Text format    


  665. NIENOW TM, MacDonald AW 3rd, Lim KO
    TDCS produces incremental gain when combined with working memory training in patients with schizophrenia: A proof of concept pilot study.
    Schizophr Res. 2016 Feb 4. pii: S0920-9964(16)30053.
    PubMed     Text format    


  666. VENTURA J, Subotnik KL, Ered A, Hellemann GS, et al
    Cognitive Assessment Interview (CAI): Validity as a co-primary measure of cognition across phases of schizophrenia.
    Schizophr Res. 2016 Feb 4. pii: S0920-9964(16)30030.
    PubMed     Text format     Abstract available


  667. ZENG B, Ardekani BA, Tang Y, Zhang T, et al
    Abnormal white matter microstructure in drug-naive first episode schizophrenia patients before and after eight weeks of antipsychotic treatment.
    Schizophr Res. 2016 Feb 3. pii: S0920-9964(16)30050.
    PubMed     Text format     Abstract available


  668. KIMHY D, Lauriola V, Bartels MN, Armstrong HF, et al
    Aerobic exercise for cognitive deficits in schizophrenia - The impact of frequency, duration, and fidelity with target training intensity.
    Schizophr Res. 2016 Feb 3. pii: S0920-9964(16)30054.
    PubMed     Text format    


  669. TARASENKO M, Perez VB, Pianka ST, Vinogradov S, et al
    Measuring the capacity for auditory system plasticity: An examination of performance gains during initial exposure to auditory-targeted cognitive training in schizophrenia.
    Schizophr Res. 2016 Feb 2. pii: S0920-9964(16)30017.
    PubMed     Text format     Abstract available


  670. GADELHA A, Coleman J, Breen G, Mazzoti DR, et al
    Genome-wide investigation of schizophrenia associated plasma Ndel1 enzyme activity.
    Schizophr Res. 2016 Feb 2. pii: S0920-9964(16)30043.
    PubMed     Text format     Abstract available


  671. XU Z, Muller M, Heekeren K, Theodoridou A, et al
    Pathways between stigma and suicidal ideation among people at risk of psychosis.
    Schizophr Res. 2016 Feb 1. pii: S0920-9964(16)30048.
    PubMed     Text format     Abstract available


  672. LODHI RJ, Masand S, Malik A, Shivakumar K, et al
    Changes in biomarkers of bone turnover in an aripiprazole add-on or switching study.
    Schizophr Res. 2016;170.
    PubMed     Text format     Abstract available


    January 2016
  673. PU S, Nakagome K, Itakura M, Iwata M, et al
    The association between cognitive deficits and prefrontal hemodynamic responses during performance of working memory task in patients with schizophrenia.
    Schizophr Res. 2016 Jan 30. pii: S0920-9964(16)30045.
    PubMed     Text format     Abstract available


  674. LALANDE D, Theriault L, Kalinova E, Fortin A, et al
    The effect of exercise on sleep quality and psychological, physiological, and biological correlates in patients with schizophrenia: A pilot study.
    Schizophr Res. 2016 Jan 28. pii: S0920-9964(16)30041.
    PubMed     Text format    


  675. KNOCHEL C, Stablein M, Prvulovic D, Ghinea D, et al
    Shared and distinct gray matter abnormalities in schizophrenia, schizophrenia relatives and bipolar disorder in association with cognitive impairment.
    Schizophr Res. 2016 Jan 28. pii: S0920-9964(16)30025.
    PubMed     Text format     Abstract available


  676. KARPOUZIAN TM, Alden EC, Reilly JL, Smith MJ, et al
    High functioning individuals with schizophrenia have preserved social perception but not mentalizing abilities.
    Schizophr Res. 2016 Jan 27. pii: S0920-9964(16)30031.
    PubMed     Text format     Abstract available


  677. LALLY J, Tully J, Robertson D, Stubbs B, et al
    Augmentation of clozapine with electroconvulsive therapy in treatment resistant schizophrenia: A systematic review and meta-analysis.
    Schizophr Res. 2016 Jan 27. pii: S0920-9964(16)30024.
    PubMed     Text format     Abstract available


  678. FULLARD JF, Halene TB, Giambartolomei C, Haroutunian V, et al
    Understanding the genetic liability to schizophrenia through the neuroepigenome.
    Schizophr Res. 2016 Jan 27. pii: S0920-9964(16)30039.
    PubMed     Text format     Abstract available


  679. BUCCI P, Mucci A, Piegari G, Nobile M, et al
    Characterization of premorbid functioning during childhood in patients with deficit vs. non-deficit schizophrenia and in their healthy siblings.
    Schizophr Res. 2016 Jan 26. pii: S0920-9964(16)30035.
    PubMed     Text format     Abstract available


  680. BI R, Tang J, Zhang W, Li X, et al
    Mitochondrial genome variations and functional characterization in Han Chinese families with schizophrenia.
    Schizophr Res. 2016 Jan 25. pii: S0920-9964(16)30011.
    PubMed     Text format     Abstract available


  681. HO RT, Fong TC, Wan AH, Au-Yeung FS, et al
    A randomized controlled trial on the psychophysiological effects of physical exercise and Tai-chi in patients with chronic schizophrenia.
    Schizophr Res. 2016 Jan 25. pii: S0920-9964(16)30038.
    PubMed     Text format     Abstract available


  682. BLIKSTED V, Ubukata S, Koelkebeck K
    Discriminating autism spectrum disorders from schizophrenia by investigation of mental state attribution on an on-line mentalizing task: A review and meta-analysis.
    Schizophr Res. 2016 Jan 23. pii: S0920-9964(16)30028.
    PubMed     Text format     Abstract available


  683. VUKADINOVIC Z
    Elevated striatal dopamine and efference copy failure in schizophrenia.
    Schizophr Res. 2016 Jan 23. pii: S0920-9964(16)30040.
    PubMed     Text format    


  684. CSUKLY G, Farkas K, Marosi C, Szabo A, et al
    Deficits in low beta desynchronization reflect impaired emotional processing in schizophrenia.
    Schizophr Res. 2016 Jan 23. pii: S0920-9964(16)30029.
    PubMed     Text format     Abstract available


  685. BURTON CZ, Harvey PD, Patterson TL, Twamley EW, et al
    Neurocognitive insight and objective cognitive functioning in schizophrenia.
    Schizophr Res. 2016 Jan 23. pii: S0920-9964(16)30022.
    PubMed     Text format     Abstract available


  686. SUGAI T, Suzuki Y, Yamazaki M, Shimoda K, et al
    Difference in prevalence of metabolic syndrome between Japanese outpatients and inpatients with schizophrenia: A nationwide survey.
    Schizophr Res. 2016 Jan 22. pii: S0920-9964(16)30016.
    PubMed     Text format     Abstract available


  687. LENG CH, Chou MH, Lin SH, Yang YK, et al
    Estimation of life expectancy, loss-of-life expectancy, and lifetime healthcare expenditures for schizophrenia in Taiwan.
    Schizophr Res. 2016 Jan 22. pii: S0920-9964(16)30036.
    PubMed     Text format     Abstract available


  688. STUBBS B, Williams J, Gaughran F, Craig T, et al
    How sedentary are people with psychosis? A systematic review and meta-analysis.
    Schizophr Res. 2016 Jan 21. pii: S0920-9964(16)30037.
    PubMed     Text format     Abstract available


  689. HOFER A, Mizuno Y, Frajo-Apor B, Kemmler G, et al
    Resilience, internalized stigma, self-esteem, and hopelessness among people with schizophrenia: Cultural comparison in Austria and Japan.
    Schizophr Res. 2016 Jan 21. pii: S0920-9964(16)30034.
    PubMed     Text format     Abstract available


  690. LABAD J, Barbero JD, Gutierrez-Zotes A, Montalvo I, et al
    Free thyroxine levels are associated with cognitive changes in individuals with a first episode of psychosis: A prospective 1-year follow-up study.
    Schizophr Res. 2016 Jan 21. pii: S0920-9964(16)30026.
    PubMed     Text format     Abstract available


  691. LIU C, Xue Z, Palaniyappan L, Zhou L, et al
    Abnormally increased and incoherent resting-state activity is shared between patients with schizophrenia and their unaffected siblings.
    Schizophr Res. 2016 Jan 21. pii: S0920-9964(16)30021.
    PubMed     Text format     Abstract available


  692. YOSHIDA K, Suzuki T, Imasaka Y, Kubo KI, et al
    Resilience in schizophrenia: A comparative study between a remote island and an urban area in Japan.
    Schizophr Res. 2016 Jan 21. pii: S0920-9964(16)30033.
    PubMed     Text format     Abstract available


  693. TONNA M, Ottoni R, Paglia F, Ossola P, et al
    Obsessive-compulsive symptoms interact with disorganization in influencing social functioning in schizophrenia.
    Schizophr Res. 2016 Jan 20. pii: S0920-9964(16)30001.
    PubMed     Text format     Abstract available


  694. PARIKH V, Kutlu MG, Gould TJ
    nAChR dysfunction as a common substrate for schizophrenia and comorbid nicotine addiction: Current trends and perspectives.
    Schizophr Res. 2016 Jan 20. pii: S0920-9964(16)30018.
    PubMed     Text format     Abstract available


  695. TREEN D, Batlle S, Molla L, Forcadell E, et al
    Are there glutamate abnormalities in subjects at high risk mental state for psychosis? A review of the evidence.
    Schizophr Res. 2016 Jan 20. pii: S0920-9964(16)30002.
    PubMed     Text format     Abstract available


  696. KOH MT, Shao Y, Sherwood A, Smith DR, et al
    Impaired hippocampal-dependent memory and reduced parvalbumin-positive interneurons in a ketamine mouse model of schizophrenia.
    Schizophr Res. 2016 Jan 19. pii: S0920-9964(16)30023.
    PubMed     Text format     Abstract available


  697. SUN Y, Chen Y, Lee R, Bezerianos A, et al
    Disruption of brain anatomical networks in schizophrenia: A longitudinal, diffusion tensor imaging based study.
    Schizophr Res. 2016 Jan 19. pii: S0920-9964(16)30027.
    PubMed     Text format     Abstract available


  698. BRIDGMAN AC, Barr MS, Goodman MS, Chen R, et al
    Deficits in GABA receptor function and working memory in non-smokers with schizophrenia.
    Schizophr Res. 2016 Jan 18. pii: S0920-9964(16)30008.
    PubMed     Text format     Abstract available


  699. HAMAZAKI K, Maekawa M, Toyota T, Iwayama Y, et al
    Fatty acid composition and fatty acid binding protein expression in the postmortem frontal cortex of patients with schizophrenia: A case-control study.
    Schizophr Res. 2016 Jan 17. pii: S0920-9964(16)30014.
    PubMed     Text format     Abstract available


  700. PISKULIC D, Liu L, Cadenhead KS, Cannon TD, et al
    Social cognition over time in individuals at clinical high risk for psychosis: Findings from the NAPLS-2 cohort.
    Schizophr Res. 2016 Jan 16. pii: S0920-9964(16)30020.
    PubMed     Text format     Abstract available


  701. KELLEY ME, Wan CR, Broussard B, Crisafio A, et al
    Marijuana use in the immediate 5-year premorbid period is associated with increased risk of onset of schizophrenia and related psychotic disorders.
    Schizophr Res. 2016 Jan 16. pii: S0920-9964(16)30015.
    PubMed     Text format     Abstract available


  702. EKSTROM T, Maher S, Shinn A, Ongur D, et al
    Face identity discrimination in schizophrenia: Impairments to faces with high exposure in society.
    Schizophr Res. 2016 Jan 15. pii: S0920-9964(16)30009.
    PubMed     Text format    


  703. ALESSANDRINI M, Lancon C, Fond G, Faget-Agius C, et al
    A structural equation modelling approach to explore the determinants of quality of life in schizophrenia.
    Schizophr Res. 2016 Jan 15. pii: S0920-9964(16)30010.
    PubMed     Text format     Abstract available


  704. PENADES R, Pujol N, Catalan R, Masana G, et al
    Cortical thickness in regions of frontal and temporal lobes is associated with responsiveness to cognitive remediation therapy in schizophrenia.
    Schizophr Res. 2016 Jan 14. pii: S0920-9964(16)30004.
    PubMed     Text format     Abstract available


  705. WILSON C, Smith ME, Thompson E, Demro C, et al
    Context matters: The impact of neighborhood crime and paranoid symptoms on psychosis risk assessment.
    Schizophr Res. 2016 Jan 14. pii: S0920-9964(16)30007.
    PubMed     Text format     Abstract available


  706. YAKOVENKO I, Clark CM, Hodgins DC, Goghari VM, et al
    A qualitative analysis of the effects of a comorbid disordered gambling diagnosis with schizophrenia.
    Schizophr Res. 2016 Jan 14. pii: S0920-9964(15)30081.
    PubMed     Text format     Abstract available


  707. YAMANAKA H, Kanahara N, Suzuki T, Takase M, et al
    Impact of dopamine supersensitivity psychosis in treatment-resistant schizophrenia: An analysis of multi-factors predicting long-term prognosis.
    Schizophr Res. 2016 Jan 13. pii: S0920-9964(16)30013.
    PubMed     Text format     Abstract available


  708. CARNEY R, Cotter J, Bradshaw T, Firth J, et al
    Cardiometabolic risk factors in young people at ultra-high risk for psychosis: A systematic review and meta-analysis.
    Schizophr Res. 2016 Jan 12. pii: S0920-9964(16)30012.
    PubMed     Text format     Abstract available


  709. KOIKE S, Satomura Y, Kawasaki S, Nishimura Y, et al
    Association between rostral prefrontal cortical activity and functional outcome in first-episode psychosis: a longitudinal functional near-infrared spectroscopy study.
    Schizophr Res. 2016 Jan 11. pii: S0920-9964(16)30006.
    PubMed     Text format     Abstract available


  710. VANCAMPFORT D, Stubbs B, Probst M, De Hert M, et al
    Physical activity as a vital sign in patients with schizophrenia: Evidence and clinical recommendations.
    Schizophr Res. 2016 Jan 9. pii: S0920-9964(16)30005.
    PubMed     Text format     Abstract available


  711. CHANG WC, Hui CL, Chan SK, Lee EH, et al
    Impact of avolition and cognitive impairment on functional outcome in first-episode schizophrenia-spectrum disorder: a prospective one-year follow-up study.
    Schizophr Res. 2016 Jan 9. pii: S0920-9964(16)30003.
    PubMed     Text format     Abstract available


  712. HETTIGE NC, Cole CB, Khalid S, De Luca V, et al
    Polygenic risk score prediction of antipsychotic dosage in schizophrenia.
    Schizophr Res. 2016 Jan 8. pii: S0920-9964(15)30087.
    PubMed     Text format     Abstract available


  713. MCCARTHY JM, Treadway MT, Bennett ME, Blanchard JJ, et al
    Inefficient effort allocation and negative symptoms in individuals with schizophrenia.
    Schizophr Res. 2016 Jan 4. pii: S0920-9964(15)30090.
    PubMed     Text format     Abstract available


  714. HOCHBERGER WC, Hill SK, Nelson CL, Reilly JL, et al
    Unitary construct of generalized cognitive ability underlying BACS performance across psychotic disorders and in their first-degree relatives.
    Schizophr Res. 2016;170:156-61.
    PubMed     Text format     Abstract available


    December 2015
  715. JAHN DR, Bennett ME, Park SG, Gur RE, et al
    The interactive effects of negative symptoms and social role functioning on suicide ideation in individuals with schizophrenia.
    Schizophr Res. 2015 Dec 30. pii: S0920-9964(15)30084.
    PubMed     Text format     Abstract available


  716. STRAUSS GP, Vertinski M, Vogel SJ, Ringdahl EN, et al
    Negative symptoms in bipolar disorder and schizophrenia: A psychometric evaluation of the brief negative symptom scale across diagnostic categories.
    Schizophr Res. 2015 Dec 29. pii: S0920-9964(15)30088.
    PubMed     Text format     Abstract available


  717. ALPHS L, Mao L, Lynn Starr H, Benson C, et al
    A pragmatic analysis comparing once-monthly paliperidone palmitate versus daily oral antipsychotic treatment in patients with schizophrenia.
    Schizophr Res. 2015 Dec 29. pii: S0920-9964(15)30085.
    PubMed     Text format     Abstract available


  718. TSOUTSOULAS C, Mulsant BH, Kalache SM, Kumar S, et al
    The influence of medical burden severity and cognition on functional competence in older community-dwelling individuals with schizophrenia.
    Schizophr Res. 2015 Dec 24. pii: S0920-9964(15)30082.
    PubMed     Text format     Abstract available


  719. COLIZZI M, Carra E, Fraietta S, Lally J, et al
    Substance use, medication adherence and outcome one year following a first episode of psychosis.
    Schizophr Res. 2015 Dec 21. pii: S0920-9964(15)30058.
    PubMed     Text format     Abstract available


  720. REID MA, White DM, Kraguljac NV, Lahti AC, et al
    A combined diffusion tensor imaging and magnetic resonance spectroscopy study of patients with schizophrenia.
    Schizophr Res. 2015 Dec 21. pii: S0920-9964(15)30076.
    PubMed     Text format     Abstract available


  721. COHEN AS, Callaway DA, Mitchell KR, Larsen JT, et al
    A temporal examination of co-activated emotion valence networks in schizophrenia and schizotypy.
    Schizophr Res. 2015 Dec 19. pii: S0920-9964(15)30083.
    PubMed     Text format     Abstract available


  722. LIU T, Zheng X
    Cultural revolution and onset of schizophrenia in China.
    Schizophr Res. 2015 Dec 17. pii: S0920-9964(15)30059.
    PubMed     Text format    


  723. PAKSARIAN D, Merikangas KR, Calkins ME, Gur RE, et al
    Racial-ethnic disparities in empirically-derived subtypes of subclinical psychosis among a U.S. sample of youths.
    Schizophr Res. 2015 Dec 17. pii: S0920-9964(15)30077.
    PubMed     Text format     Abstract available


  724. NANDA P, Tandon N, Mathew IT, Padmanabhan JL, et al
    Impulsivity across the psychosis spectrum: Correlates of cortical volume, suicidal history, and social and global function.
    Schizophr Res. 2015 Dec 17. pii: S0920-9964(15)30073.
    PubMed     Text format     Abstract available


  725. SHIM S, Shuman M, Duncan E
    An emerging role of cGMP in the treatment of schizophrenia: A review.
    Schizophr Res. 2015 Dec 16. pii: S0920-9964(15)30057.
    PubMed     Text format     Abstract available


  726. STRAUSS GP, Whearty KM, Morra LF, Sullivan SK, et al
    Avolition in schizophrenia is associated with reduced willingness to expend effort for reward on a Progressive Ratio task.
    Schizophr Res. 2015 Dec 14. pii: S0920-9964(15)30079.
    PubMed     Text format     Abstract available


  727. MAHER S, Mashhoon Y, Ekstrom T, Lukas S, et al
    Deficient cortical face-sensitive N170 responses and basic visual processing in schizophrenia.
    Schizophr Res. 2015 Dec 12. pii: S0920-9964(15)30078.
    PubMed     Text format     Abstract available


  728. LIZANO PL, Keshavan MS, Tandon N, Mathew IT, et al
    Angiogenic and immune signatures in plasma of young relatives at familial high-risk for psychosis and first-episode patients: A preliminary study.
    Schizophr Res. 2015 Dec 11. pii: S0920-9964(15)30074.
    PubMed     Text format     Abstract available


  729. LYSTAD JU, Falkum E, Haaland VO, Bull H, et al
    Neurocognition and occupational functioning in schizophrenia spectrum disorders: The MATRICS Consensus Cognitive Battery (MCCB) and workplace assessments.
    Schizophr Res. 2015 Dec 11. pii: S0920-9964(15)30075.
    PubMed     Text format     Abstract available


  730. HELLE S, Ringen PA, Melle I, Larsen TK, et al
    Cannabis use is associated with 3years earlier onset of schizophrenia spectrum disorder in a naturalistic, multi-site sample (N=1119).
    Schizophr Res. 2015 Dec 9. pii: S0920-9964(15)30070.
    PubMed     Text format     Abstract available


  731. WANG X, Yu X, Appelbaum PS, Tang H, et al
    Longitudinal informed consent competency in stable community patients with schizophrenia: A one-week training and one-year follow-up study.
    Schizophr Res. 2015 Dec 8. pii: S0920-9964(15)30062.
    PubMed     Text format     Abstract available


  732. CHI MH, Hsiao CY, Chen KC, Lee LT, et al
    The readmission rate and medical cost of patients with schizophrenia after first hospitalization - A 10-year follow-up population-based study.
    Schizophr Res. 2015 Dec 8. pii: S0920-9964(15)30068.
    PubMed     Text format     Abstract available


  733. ENGEL M, Fritzsche A, Lincoln TM
    Anticipation and experience of emotions in patients with schizophrenia and negative symptoms. An experimental study in a social context.
    Schizophr Res. 2015 Dec 7. pii: S0920-9964(15)30071.
    PubMed     Text format     Abstract available


  734. SHASTEEN JR, Pinkham AE, Kelsven S, Ludwig K, et al
    Intact implicit processing of facial threat cues in schizophrenia.
    Schizophr Res. 2015 Dec 7. pii: S0920-9964(15)30072.
    PubMed     Text format     Abstract available


  735. DU Y, Pearlson GD, Yu Q, He H, et al
    Interaction among subsystems within default mode network diminished in schizophrenia patients: A dynamic connectivity approach.
    Schizophr Res. 2015 Dec 3. pii: S0920-9964(15)30064.
    PubMed     Text format     Abstract available


    November 2015
  736. RAMAGE EM, Klimas N, Vogel SJ, Vertinski M, et al
    Concurrent sound segregation impairments in schizophrenia: The contribution of auditory-specific and general cognitive factors.
    Schizophr Res. 2015 Nov 28. pii: S0920-9964(15)30066.
    PubMed     Text format     Abstract available


  737. LIN A, Wardenaar KJ, Pontillo M, De Crescenzo F, et al
    Is it still correct to differentiate between early and very early onset psychosis?
    Schizophr Res. 2015 Nov 27. pii: S0920-9964(15)30063.
    PubMed     Text format     Abstract available


  738. VINK M, de Leeuw M, Pouwels R, van den Munkhof HE, et al
    Diminishing striatal activation across adolescent development during reward anticipation in offspring of schizophrenia patients.
    Schizophr Res. 2015 Nov 26. pii: S0920-9964(15)30061.
    PubMed     Text format     Abstract available


  739. MYLES H, Myles N, Antic NA, Adams R, et al
    Obstructive sleep apnea and schizophrenia: A systematic review to inform clinical practice.
    Schizophr Res. 2015 Nov 24. pii: S0920-9964(15)30060.
    PubMed     Text format     Abstract available


  740. MALAN-MULLER S, Kilian S, van den Heuvel LL, Bardien S, et al
    A systematic review of genetic variants associated with metabolic syndrome in patients with schizophrenia.
    Schizophr Res. 2015 Nov 24. pii: S0920-9964(15)30054.
    PubMed     Text format     Abstract available


  741. BRENT BK, Rosso IM, Thermenos HW, Holt DJ, et al
    Alterations of lateral temporal cortical gray matter and facial memory as vulnerability indicators for schizophrenia: An MRI study in youth at familial high-risk for schizophrenia.
    Schizophr Res. 2015 Nov 24. pii: S0920-9964(15)30056.
    PubMed     Text format     Abstract available


  742. WATANUKI T, Matsuo K, Egashira K, Nakashima M, et al
    Precentral and inferior prefrontal hypoactivation during facial emotion recognition in patients with schizophrenia: A functional near-infrared spectroscopy study.
    Schizophr Res. 2015 Nov 20. pii: S0920-9964(15)30055.
    PubMed     Text format     Abstract available


  743. DICKERSON F, Origoni A, Schroeder J, Schweinfurth LA, et al
    Mortality in schizophrenia and bipolar disorder: Clinical and serological predictors.
    Schizophr Res. 2015 Nov 19. pii: S0920-9964(15)30053.
    PubMed     Text format     Abstract available


  744. GAEBEL W, Riesbeck M, Wolwer W, Klimke A, et al
    Predictors for symptom re-exacerbation after targeted stepwise drug discontinuation in first-episode schizophrenia: Results of the first-episode study within the German research network on schizophrenia.
    Schizophr Res. 2015 Nov 19. pii: S0920-9964(15)30024.
    PubMed     Text format     Abstract available


  745. ZHANG XY, Chen DC, Tan YL, Tan SP, et al
    BDNF polymorphisms are associated with schizophrenia onset and positive symptoms.
    Schizophr Res. 2015 Nov 18. pii: S0920-9964(15)30052.
    PubMed     Text format     Abstract available


  746. EMAMI S, Guimond S, Mallar Chakravarty M, Lepage M, et al
    Cortical thickness and low insight into symptoms in enduring schizophrenia.
    Schizophr Res. 2015 Nov 18. pii: S0920-9964(15)30016.
    PubMed     Text format     Abstract available


  747. VANMEERTEN NJ, Dubke RE, Stanwyck JJ, Kang SS, et al
    Abnormal early brain responses during visual search are evident in schizophrenia but not bipolar affective disorder.
    Schizophr Res. 2015 Nov 18. pii: S0920-9964(15)30050.
    PubMed     Text format     Abstract available


  748. GREENWOOD TA, Lazzeroni LC, Calkins ME, Freedman R, et al
    Genetic assessment of additional endophenotypes from the Consortium on the Genetics of Schizophrenia Family Study.
    Schizophr Res. 2015 Nov 17. pii: S0920-9964(15)30051.
    PubMed     Text format     Abstract available


  749. BREITBORDE NJ, Dawley D, Bell EK, Vanuk JR, et al
    A personalized paced-breathing intervention to increase heart rate variability among individuals with first-episode psychosis following stress exposure.
    Schizophr Res. 2015 Nov 16. pii: S0920-9964(15)30048.
    PubMed     Text format    


  750. BERNA F, Misdrahi D, Boyer L, Aouizerate B, et al
    Akathisia: prevalence and risk factors in a community-dwelling sample of patients with schizophrenia. Results from the FACE-SZ dataset.
    Schizophr Res. 2015 Nov 15. pii: S0920-9964(15)30040.
    PubMed     Text format     Abstract available


  751. FAN N, Luo Y, Xu K, Zhang M, et al
    Relationship of serum levels of TNF-alpha, IL-6 and IL-18 and schizophrenia-like symptoms in chronic ketamine abusers.
    Schizophr Res. 2015 Nov 14. pii: S0920-9964(15)30049.
    PubMed     Text format     Abstract available


  752. KEINANEN J, Mantere O, Kieseppa T, Mantyla T, et al
    Early insulin resistance predicts weight gain and waist circumference increase in first-episode psychosis - A one year follow-up study.
    Schizophr Res. 2015 Nov 14. pii: S0920-9964(15)30045.
    PubMed     Text format    


  753. KOGA M, Serritella AV, Sawa A, Sedlak TW, et al
    Implications for reactive oxygen species in schizophrenia pathogenesis.
    Schizophr Res. 2015 Nov 14. pii: S0920-9964(15)00337.
    PubMed     Text format     Abstract available


  754. LYNGBERG K, Buchy L, Liu L, Perkins D, et al
    Patterns of premorbid functioning in individuals at clinical high risk of psychosis.
    Schizophr Res. 2015 Nov 14. pii: S0920-9964(15)30047.
    PubMed     Text format     Abstract available


  755. HEALD A, Sein K, Anderson S, Pendlebury J, et al
    Diet, exercise and the metabolic syndrome in schizophrenia: A cross-sectional study.
    Schizophr Res. 2015 Nov 14. pii: S0920-9964(15)30043.
    PubMed     Text format    


  756. MAUNEY SA, Pietersen CY, Sonntag KC, Woo TW, et al
    Differentiation of oligodendrocyte precursors is impaired in the prefrontal cortex in schizophrenia.
    Schizophr Res. 2015 Nov 14. pii: S0920-9964(15)30042.
    PubMed     Text format     Abstract available


  757. SCHAEFFER DJ, Rodrigue AL, Burton CR, Pierce JE, et al
    White matter structural integrity differs between people with schizophrenia and healthy groups as a function of cognitive control.
    Schizophr Res. 2015 Nov 13. pii: S0920-9964(15)30044.
    PubMed     Text format     Abstract available


  758. MUNOZ-NEGRO JE, Ibanez-Casas I, de Portugal E, Ochoa S, et al
    A dimensional comparison between delusional disorder, schizophrenia and schizoaffective disorder.
    Schizophr Res. 2015 Nov 13. pii: S0920-9964(15)30039.
    PubMed     Text format    


  759. KRAAN T, van Dam DS, Velthorst E, de Ruigh EL, et al
    Childhood trauma and clinical outcome in patients at ultra-high risk of transition to psychosis.
    Schizophr Res. 2015 Nov 13. pii: S0920-9964(15)30026.
    PubMed     Text format    


    October 2015
  760. BEHDINAN T, Foussias G, Wheeler AL, Stefanik L, et al
    Neuroimaging predictors of functional outcomes in schizophrenia at baseline and 6-month follow-up.
    Schizophr Res. 2015 Oct 23. pii: S0920-9964(15)30023.
    PubMed     Text format     Abstract available


  761. SASS LA, Borda JP
    Phenomenology and neurobiology of self disorder in schizophrenia: Secondary factors.
    Schizophr Res. 2015 Oct 23. pii: S0920-9964(15)00520.
    PubMed     Text format    


  762. MAMAH D, Wen J, Luo J, Ulrich X, et al
    Subcomponents of brain T2* relaxation in schizophrenia, bipolar disorder and siblings: A Gradient Echo Plural Contrast Imaging (GEPCI) study.
    Schizophr Res. 2015 Oct 23. pii: S0920-9964(15)30004.
    PubMed     Text format     Abstract available


    July 2015
  763. NICOTRA E, Casu G, Piras S, Marchese G, et al
    On the use of the Positive and Negative Syndrome Scale in randomized clinical trials.
    Schizophr Res. 2015;165.
    PubMed     Text format     Abstract available


    May 2015
  764. RAMANATHAN S, Miewald J, Montrose D, Keshavan MS, et al
    Can age at sexual maturity act as a predictive biomarker for prodromal negative symptoms?
    Schizophr Res. 2015;164.
    PubMed     Text format     Abstract available


    March 2015
  765. SUN Y, Hu D, Liang J, Bao YP, et al
    Association between variants of zinc finger genes and psychiatric disorders: systematic review and meta-analysis.
    Schizophr Res. 2015;162.
    PubMed     Text format     Abstract available


  766. TAKAGI S, Balu DT, Coyle JT
    Subchronic pharmacological and chronic genetic NMDA receptor hypofunction differentially regulate the Akt signaling pathway and Arc expression in juvenile and adult mice.
    Schizophr Res. 2015;162.
    PubMed     Text format     Abstract available


    February 2015
  767. JOHNSON KL, Desmarais SL, Swartz MS, Van Dorn RA, et al
    Latent class analysis of discordance between results of drug use assessments in the CATIE data.
    Schizophr Res. 2015;161.
    PubMed     Text format     Abstract available


  768. BASKAK B, Baran Z, Ozguven HD, Karaboga I, et al
    Prefrontal activity measured by functional near infrared spectroscopy during probabilistic inference in subjects with persecutory delusions.
    Schizophr Res. 2015;161.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Schizophrenia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: